id	sid	tid	token	lemma	pos
fcis-31417	1	1	frontiers	frontier	NOUN
fcis-31417	1	2	in	in	ADP
fcis-31417	1	3	computing	computing	NOUN
fcis-31417	1	4	and	and	CCONJ
fcis-31417	1	5	intelligent	intelligent	ADJ
fcis-31417	1	6	systems	system	NOUN
fcis-31417	1	7	issn	issn	VERB
fcis-31417	1	8	:	:	PUNCT
fcis-31417	1	9	2832	2832	NUM
fcis-31417	1	10	-	-	SYM
fcis-31417	1	11	6024	6024	NUM
fcis-31417	1	12	|	|	NOUN
fcis-31417	1	13	vol	vol	NOUN
fcis-31417	1	14	.	.	PROPN
fcis-31417	2	1	13	13	NUM
fcis-31417	2	2	,	,	PUNCT
fcis-31417	2	3	no	no	INTJ
fcis-31417	2	4	.	.	NOUN
fcis-31417	2	5	1	1	NUM
fcis-31417	2	6	,	,	PUNCT
fcis-31417	2	7	2025	2025	NUM
fcis-31417	2	8	34	34	NUM
fcis-31417	2	9	multimodal	multimodal	NOUN
fcis-31417	2	10	model	model	NOUN
fcis-31417	2	11	based	base	VERB
fcis-31417	2	12	on	on	ADP
fcis-31417	2	13	ct	ct	NUM
fcis-31417	2	14	images	image	NOUN
fcis-31417	2	15	and	and	CCONJ
fcis-31417	2	16	liquid	liquid	ADJ
fcis-31417	2	17	biopsy	biopsy	NOUN
fcis-31417	2	18	to	to	PART
fcis-31417	2	19	predict	predict	VERB
fcis-31417	2	20	lung	lung	NOUN
fcis-31417	2	21	cancer	cancer	NOUN
fcis-31417	2	22	survival	survival	NOUN
fcis-31417	2	23	liyan	liyan	VERB
fcis-31417	2	24	zhong	zhong	PROPN
fcis-31417	2	25	*	*	PUNCT
fcis-31417	2	26	department	department	PROPN
fcis-31417	2	27	of	of	ADP
fcis-31417	2	28	mathematics	mathematic	NOUN
fcis-31417	2	29	and	and	CCONJ
fcis-31417	2	30	computer	computer	NOUN
fcis-31417	2	31	science	science	NOUN
fcis-31417	2	32	,	,	PUNCT
fcis-31417	2	33	youjiang	youjiang	PROPN
fcis-31417	2	34	medical	medical	PROPN
fcis-31417	2	35	university	university	PROPN
fcis-31417	2	36	for	for	ADP
fcis-31417	2	37	nationalities	nationality	NOUN
fcis-31417	2	38	,	,	PUNCT
fcis-31417	2	39	baise	baise	PROPN
fcis-31417	2	40	guangxi	guangxi	PROPN
fcis-31417	2	41	,	,	PUNCT
fcis-31417	2	42	533000	533000	NUM
fcis-31417	2	43	,	,	PUNCT
fcis-31417	2	44	china	china	PROPN
fcis-31417	2	45	*	*	PUNCT
fcis-31417	2	46	corresponding	correspond	VERB
fcis-31417	2	47	author	author	NOUN
fcis-31417	2	48	email	email	NOUN
fcis-31417	2	49	:	:	PUNCT
fcis-31417	3	1	zhliyanmath@163.com	zhliyanmath@163.com	PROPN
fcis-31417	3	2	abstract	abstract	NOUN
fcis-31417	3	3	:	:	PUNCT
fcis-31417	3	4	this	this	DET
fcis-31417	3	5	study	study	NOUN
fcis-31417	3	6	aims	aim	VERB
fcis-31417	3	7	to	to	PART
fcis-31417	3	8	build	build	VERB
fcis-31417	3	9	a	a	DET
fcis-31417	3	10	multimodal	multimodal	NOUN
fcis-31417	3	11	model	model	NOUN
fcis-31417	3	12	based	base	VERB
fcis-31417	3	13	on	on	ADP
fcis-31417	3	14	ct	ct	NUM
fcis-31417	3	15	images	image	NOUN
fcis-31417	3	16	and	and	CCONJ
fcis-31417	3	17	liquid	liquid	ADJ
fcis-31417	3	18	biopsy	biopsy	NOUN
fcis-31417	3	19	to	to	PART
fcis-31417	3	20	accurately	accurately	ADV
fcis-31417	3	21	predict	predict	VERB
fcis-31417	3	22	the	the	DET
fcis-31417	3	23	survival	survival	NOUN
fcis-31417	3	24	of	of	ADP
fcis-31417	3	25	lung	lung	NOUN
fcis-31417	3	26	cancer	cancer	NOUN
fcis-31417	3	27	patients	patient	NOUN
fcis-31417	3	28	.	.	PUNCT
fcis-31417	4	1	data	datum	NOUN
fcis-31417	4	2	of	of	ADP
fcis-31417	4	3	500	500	NUM
fcis-31417	4	4	lung	lung	NOUN
fcis-31417	4	5	cancer	cancer	NOUN
fcis-31417	4	6	patients	patient	NOUN
fcis-31417	4	7	were	be	AUX
fcis-31417	4	8	collected	collect	VERB
fcis-31417	4	9	,	,	PUNCT
fcis-31417	4	10	ct	ct	NUM
fcis-31417	4	11	images	image	NOUN
fcis-31417	4	12	were	be	AUX
fcis-31417	4	13	standardized	standardize	VERB
fcis-31417	4	14	and	and	CCONJ
fcis-31417	4	15	120	120	NUM
fcis-31417	4	16	imaging	imaging	NOUN
fcis-31417	4	17	features	feature	NOUN
fcis-31417	4	18	were	be	AUX
fcis-31417	4	19	innovatively	innovatively	ADV
fcis-31417	4	20	extracted	extract	VERB
fcis-31417	4	21	,	,	PUNCT
fcis-31417	4	22	and	and	CCONJ
fcis-31417	4	23	advanced	advanced	ADJ
fcis-31417	4	24	second	second	ADJ
fcis-31417	4	25	-	-	PUNCT
fcis-31417	4	26	generation	generation	NOUN
fcis-31417	4	27	sequencing	sequence	VERB
fcis-31417	4	28	technology	technology	NOUN
fcis-31417	4	29	was	be	AUX
fcis-31417	4	30	used	use	VERB
fcis-31417	4	31	to	to	PART
fcis-31417	4	32	detect	detect	VERB
fcis-31417	4	33	liquid	liquid	ADJ
fcis-31417	4	34	biopsy	biopsy	NOUN
fcis-31417	4	35	indicators	indicator	NOUN
fcis-31417	4	36	such	such	ADJ
fcis-31417	4	37	as	as	ADP
fcis-31417	4	38	ctdna	ctdna	NOUN
fcis-31417	4	39	.	.	PUNCT
fcis-31417	5	1	a	a	DET
fcis-31417	5	2	fusion	fusion	NOUN
fcis-31417	5	3	strategy	strategy	NOUN
fcis-31417	5	4	based	base	VERB
fcis-31417	5	5	on	on	ADP
fcis-31417	5	6	the	the	DET
fcis-31417	5	7	attention	attention	NOUN
fcis-31417	5	8	mechanism	mechanism	NOUN
fcis-31417	5	9	was	be	AUX
fcis-31417	5	10	used	use	VERB
fcis-31417	5	11	to	to	PART
fcis-31417	5	12	construct	construct	VERB
fcis-31417	5	13	a	a	DET
fcis-31417	5	14	multimodal	multimodal	NOUN
fcis-31417	5	15	model	model	NOUN
fcis-31417	5	16	,	,	PUNCT
fcis-31417	5	17	and	and	CCONJ
fcis-31417	5	18	performance	performance	NOUN
fcis-31417	5	19	was	be	AUX
fcis-31417	5	20	evaluated	evaluate	VERB
fcis-31417	5	21	after	after	ADP
fcis-31417	5	22	training	training	NOUN
fcis-31417	5	23	and	and	CCONJ
fcis-31417	5	24	optimization	optimization	NOUN
fcis-31417	5	25	.	.	PUNCT
fcis-31417	6	1	the	the	DET
fcis-31417	6	2	results	result	NOUN
fcis-31417	6	3	showed	show	VERB
fcis-31417	6	4	that	that	SCONJ
fcis-31417	6	5	the	the	DET
fcis-31417	6	6	model	model	NOUN
fcis-31417	6	7	had	have	VERB
fcis-31417	6	8	an	an	DET
fcis-31417	6	9	accuracy	accuracy	NOUN
fcis-31417	6	10	of	of	ADP
fcis-31417	6	11	85	85	NUM
fcis-31417	6	12	%	%	NOUN
fcis-31417	6	13	in	in	ADP
fcis-31417	6	14	predicting	predict	VERB
fcis-31417	6	15	lung	lung	NOUN
fcis-31417	6	16	cancer	cancer	NOUN
fcis-31417	6	17	survival	survival	NOUN
fcis-31417	6	18	,	,	PUNCT
fcis-31417	6	19	with	with	ADP
fcis-31417	6	20	a	a	DET
fcis-31417	6	21	consistency	consistency	NOUN
fcis-31417	6	22	index	index	NOUN
fcis-31417	6	23	(	(	PUNCT
fcis-31417	6	24	c	c	NOUN
fcis-31417	6	25	-	-	PUNCT
fcis-31417	6	26	index	index	NOUN
fcis-31417	6	27	)	)	PUNCT
fcis-31417	6	28	of	of	ADP
fcis-31417	6	29	0.82	0.82	NUM
fcis-31417	6	30	.	.	PUNCT
fcis-31417	7	1	it	it	PRON
fcis-31417	7	2	performed	perform	VERB
fcis-31417	7	3	well	well	ADV
fcis-31417	7	4	in	in	ADP
fcis-31417	7	5	different	different	ADJ
fcis-31417	7	6	stages	stage	NOUN
fcis-31417	7	7	of	of	ADP
fcis-31417	7	8	lung	lung	NOUN
fcis-31417	7	9	cancer	cancer	NOUN
fcis-31417	7	10	,	,	PUNCT
fcis-31417	7	11	and	and	CCONJ
fcis-31417	7	12	the	the	DET
fcis-31417	7	13	accuracy	accuracy	NOUN
fcis-31417	7	14	was	be	AUX
fcis-31417	7	15	improved	improve	VERB
fcis-31417	7	16	by	by	ADP
fcis-31417	7	17	15	15	NUM
fcis-31417	7	18	%	%	NOUN
fcis-31417	7	19	compared	compare	VERB
fcis-31417	7	20	with	with	ADP
fcis-31417	7	21	the	the	DET
fcis-31417	7	22	single	single	ADJ
fcis-31417	7	23	-	-	PUNCT
fcis-31417	7	24	modal	modal	NOUN
fcis-31417	7	25	model	model	NOUN
fcis-31417	7	26	.	.	PUNCT
fcis-31417	8	1	although	although	SCONJ
fcis-31417	8	2	the	the	DET
fcis-31417	8	3	multimodal	multimodal	NOUN
fcis-31417	8	4	model	model	NOUN
fcis-31417	8	5	is	be	AUX
fcis-31417	8	6	affected	affect	VERB
fcis-31417	8	7	by	by	ADP
fcis-31417	8	8	data	datum	NOUN
fcis-31417	8	9	heterogeneity	heterogeneity	NOUN
fcis-31417	8	10	,	,	PUNCT
fcis-31417	8	11	it	it	PRON
fcis-31417	8	12	shows	show	VERB
fcis-31417	8	13	great	great	ADJ
fcis-31417	8	14	potential	potential	NOUN
fcis-31417	8	15	in	in	ADP
fcis-31417	8	16	the	the	DET
fcis-31417	8	17	personalized	personalized	ADJ
fcis-31417	8	18	treatment	treatment	NOUN
fcis-31417	8	19	of	of	ADP
fcis-31417	8	20	lung	lung	NOUN
fcis-31417	8	21	cancer	cancer	NOUN
fcis-31417	8	22	.	.	PUNCT
fcis-31417	9	1	in	in	ADP
fcis-31417	9	2	the	the	DET
fcis-31417	9	3	future	future	NOUN
fcis-31417	9	4	,	,	PUNCT
fcis-31417	9	5	it	it	PRON
fcis-31417	9	6	is	be	AUX
fcis-31417	9	7	necessary	necessary	ADJ
fcis-31417	9	8	to	to	PART
fcis-31417	9	9	expand	expand	VERB
fcis-31417	9	10	the	the	DET
fcis-31417	9	11	sample	sample	NOUN
fcis-31417	9	12	size	size	NOUN
fcis-31417	9	13	and	and	CCONJ
fcis-31417	9	14	multi	multi	ADJ
fcis-31417	9	15	-	-	ADJ
fcis-31417	9	16	center	center	ADJ
fcis-31417	9	17	verification	verification	NOUN
fcis-31417	9	18	to	to	PART
fcis-31417	9	19	further	far	ADV
fcis-31417	9	20	improve	improve	VERB
fcis-31417	9	21	the	the	DET
fcis-31417	9	22	model	model	NOUN
fcis-31417	9	23	performance	performance	NOUN
fcis-31417	9	24	.	.	PUNCT
fcis-31417	10	1	keywords	keyword	NOUN
fcis-31417	10	2	:	:	PUNCT
fcis-31417	10	3	lung	lung	NOUN
fcis-31417	10	4	cancer	cancer	NOUN
fcis-31417	10	5	;	;	PUNCT
fcis-31417	10	6	ct	ct	NUM
fcis-31417	10	7	imaging	imaging	NOUN
fcis-31417	10	8	;	;	PUNCT
fcis-31417	10	9	liquid	liquid	ADJ
fcis-31417	10	10	biopsy	biopsy	NOUN
fcis-31417	10	11	;	;	PUNCT
fcis-31417	10	12	multimodal	multimodal	NOUN
fcis-31417	10	13	model	model	NOUN
fcis-31417	10	14	;	;	PUNCT
fcis-31417	10	15	survival	survival	NOUN
fcis-31417	10	16	prediction	prediction	NOUN
fcis-31417	10	17	.	.	PUNCT
fcis-31417	11	1	1	1	X
fcis-31417	11	2	.	.	X
fcis-31417	11	3	introduction	introduction	NOUN
fcis-31417	11	4	as	as	ADP
fcis-31417	11	5	one	one	NUM
fcis-31417	11	6	of	of	ADP
fcis-31417	11	7	the	the	DET
fcis-31417	11	8	malignant	malignant	ADJ
fcis-31417	11	9	tumors	tumor	NOUN
fcis-31417	11	10	with	with	ADP
fcis-31417	11	11	the	the	DET
fcis-31417	11	12	highest	high	ADJ
fcis-31417	11	13	morbidity	morbidity	NOUN
fcis-31417	11	14	and	and	CCONJ
fcis-31417	11	15	mortality	mortality	NOUN
fcis-31417	11	16	in	in	ADP
fcis-31417	11	17	the	the	DET
fcis-31417	11	18	world	world	NOUN
fcis-31417	12	1	,	,	PUNCT
fcis-31417	12	2	the	the	DET
fcis-31417	12	3	core	core	NOUN
fcis-31417	12	4	challenge	challenge	NOUN
fcis-31417	12	5	of	of	ADP
fcis-31417	12	6	its	its	PRON
fcis-31417	12	7	clinical	clinical	ADJ
fcis-31417	12	8	diagnosis	diagnosis	NOUN
fcis-31417	12	9	and	and	CCONJ
fcis-31417	12	10	treatment	treatment	NOUN
fcis-31417	12	11	is	be	AUX
fcis-31417	12	12	to	to	PART
fcis-31417	12	13	accurately	accurately	ADV
fcis-31417	12	14	assess	assess	VERB
fcis-31417	12	15	the	the	DET
fcis-31417	12	16	prognosis	prognosis	NOUN
fcis-31417	12	17	of	of	ADP
fcis-31417	12	18	patients	patient	NOUN
fcis-31417	12	19	in	in	ADP
fcis-31417	12	20	order	order	NOUN
fcis-31417	12	21	to	to	PART
fcis-31417	12	22	develop	develop	VERB
fcis-31417	12	23	individualized	individualized	ADJ
fcis-31417	12	24	treatment	treatment	NOUN
fcis-31417	12	25	plans	plan	NOUN
fcis-31417	12	26	.	.	PUNCT
fcis-31417	13	1	according	accord	VERB
fcis-31417	13	2	to	to	ADP
fcis-31417	13	3	globocan	globocan	PROPN
fcis-31417	13	4	2023	2023	NUM
fcis-31417	13	5	data	datum	NOUN
fcis-31417	13	6	,	,	PUNCT
fcis-31417	13	7	there	there	PRON
fcis-31417	13	8	are	be	VERB
fcis-31417	13	9	2.2	2.2	NUM
fcis-31417	13	10	million	million	NUM
fcis-31417	13	11	new	new	ADJ
fcis-31417	13	12	cases	case	NOUN
fcis-31417	13	13	of	of	ADP
fcis-31417	13	14	lung	lung	NOUN
fcis-31417	13	15	cancer	cancer	NOUN
fcis-31417	13	16	and	and	CCONJ
fcis-31417	13	17	more	more	ADJ
fcis-31417	13	18	than	than	ADP
fcis-31417	13	19	1.8	1.8	NUM
fcis-31417	13	20	million	million	NUM
fcis-31417	13	21	deaths	death	NOUN
fcis-31417	13	22	worldwide	worldwide	ADV
fcis-31417	13	23	each	each	DET
fcis-31417	13	24	year	year	NOUN
fcis-31417	13	25	,	,	PUNCT
fcis-31417	13	26	with	with	ADP
fcis-31417	13	27	a	a	DET
fcis-31417	13	28	5	5	NUM
fcis-31417	13	29	-	-	PUNCT
fcis-31417	13	30	year	year	NOUN
fcis-31417	13	31	survival	survival	NOUN
fcis-31417	13	32	rate	rate	NOUN
fcis-31417	13	33	of	of	ADP
fcis-31417	13	34	only	only	ADV
fcis-31417	13	35	19	19	NUM
fcis-31417	13	36	%	%	NOUN
fcis-31417	13	37	,	,	PUNCT
fcis-31417	13	38	significantly	significantly	ADV
fcis-31417	13	39	lower	low	ADJ
fcis-31417	13	40	than	than	ADP
fcis-31417	13	41	other	other	ADJ
fcis-31417	13	42	common	common	ADJ
fcis-31417	13	43	malignant	malignant	ADJ
fcis-31417	13	44	tumors	tumor	NOUN
fcis-31417	13	45	.	.	PUNCT
fcis-31417	14	1	this	this	DET
fcis-31417	14	2	grim	grim	ADJ
fcis-31417	14	3	situation	situation	NOUN
fcis-31417	14	4	is	be	AUX
fcis-31417	14	5	largely	largely	ADV
fcis-31417	14	6	due	due	ADJ
fcis-31417	14	7	to	to	ADP
fcis-31417	14	8	the	the	DET
fcis-31417	14	9	limitations	limitation	NOUN
fcis-31417	14	10	of	of	ADP
fcis-31417	14	11	the	the	DET
fcis-31417	14	12	existing	exist	VERB
fcis-31417	14	13	prognostic	prognostic	ADJ
fcis-31417	14	14	evaluation	evaluation	NOUN
fcis-31417	14	15	system	system	NOUN
fcis-31417	14	16	[	[	X
fcis-31417	14	17	1	1	NUM
fcis-31417	14	18	]	]	PUNCT
fcis-31417	14	19	.	.	PUNCT
fcis-31417	15	1	the	the	DET
fcis-31417	15	2	tnm	tnm	PROPN
fcis-31417	15	3	staging	staging	NOUN
fcis-31417	15	4	system	system	NOUN
fcis-31417	15	5	commonly	commonly	ADV
fcis-31417	15	6	used	use	VERB
fcis-31417	15	7	in	in	ADP
fcis-31417	15	8	clinical	clinical	ADJ
fcis-31417	15	9	practice	practice	NOUN
fcis-31417	15	10	can	can	AUX
fcis-31417	15	11	reflect	reflect	VERB
fcis-31417	15	12	the	the	DET
fcis-31417	15	13	degree	degree	NOUN
fcis-31417	15	14	of	of	ADP
fcis-31417	15	15	tumor	tumor	NOUN
fcis-31417	15	16	progression	progression	NOUN
fcis-31417	15	17	,	,	PUNCT
fcis-31417	15	18	but	but	CCONJ
fcis-31417	15	19	it	it	PRON
fcis-31417	15	20	can	can	AUX
fcis-31417	15	21	not	not	PART
fcis-31417	15	22	quantify	quantify	VERB
fcis-31417	15	23	the	the	DET
fcis-31417	15	24	intrinsic	intrinsic	ADJ
fcis-31417	15	25	biological	biological	ADJ
fcis-31417	15	26	aggressiveness	aggressiveness	NOUN
fcis-31417	15	27	of	of	ADP
fcis-31417	15	28	the	the	DET
fcis-31417	15	29	tumor	tumor	NOUN
fcis-31417	15	30	.	.	PUNCT
fcis-31417	16	1	studies	study	NOUN
fcis-31417	16	2	have	have	AUX
fcis-31417	16	3	confirmed	confirm	VERB
fcis-31417	16	4	that	that	SCONJ
fcis-31417	16	5	the	the	DET
fcis-31417	16	6	survival	survival	NOUN
fcis-31417	16	7	difference	difference	NOUN
fcis-31417	16	8	of	of	ADP
fcis-31417	16	9	lung	lung	NOUN
fcis-31417	16	10	cancer	cancer	NOUN
fcis-31417	16	11	patients	patient	NOUN
fcis-31417	16	12	with	with	ADP
fcis-31417	16	13	the	the	DET
fcis-31417	16	14	same	same	ADJ
fcis-31417	16	15	tnm	tnm	NOUN
fcis-31417	16	16	stage	stage	NOUN
fcis-31417	16	17	can	can	AUX
fcis-31417	16	18	reach	reach	VERB
fcis-31417	16	19	3	3	NUM
fcis-31417	16	20	-	-	SYM
fcis-31417	16	21	5	5	NUM
fcis-31417	16	22	times	time	NOUN
fcis-31417	16	23	,	,	PUNCT
fcis-31417	16	24	indicating	indicate	VERB
fcis-31417	16	25	that	that	SCONJ
fcis-31417	16	26	the	the	DET
fcis-31417	16	27	evaluation	evaluation	NOUN
fcis-31417	16	28	model	model	NOUN
fcis-31417	16	29	that	that	PRON
fcis-31417	16	30	relies	rely	VERB
fcis-31417	16	31	solely	solely	ADV
fcis-31417	16	32	on	on	ADP
fcis-31417	16	33	macroscopic	macroscopic	ADJ
fcis-31417	16	34	pathological	pathological	ADJ
fcis-31417	16	35	characteristics	characteristic	NOUN
fcis-31417	16	36	can	can	AUX
fcis-31417	16	37	no	no	ADV
fcis-31417	16	38	longer	long	ADV
fcis-31417	16	39	meet	meet	VERB
fcis-31417	16	40	the	the	DET
fcis-31417	16	41	needs	need	NOUN
fcis-31417	16	42	of	of	ADP
fcis-31417	16	43	precision	precision	NOUN
fcis-31417	16	44	medicine	medicine	NOUN
fcis-31417	16	45	.	.	PUNCT
fcis-31417	17	1	the	the	DET
fcis-31417	17	2	development	development	NOUN
fcis-31417	17	3	of	of	ADP
fcis-31417	17	4	imaging	imaging	NOUN
fcis-31417	17	5	technology	technology	NOUN
fcis-31417	17	6	provides	provide	VERB
fcis-31417	17	7	a	a	DET
fcis-31417	17	8	new	new	ADJ
fcis-31417	17	9	perspective	perspective	NOUN
fcis-31417	17	10	for	for	ADP
fcis-31417	17	11	the	the	DET
fcis-31417	17	12	prognosis	prognosis	NOUN
fcis-31417	17	13	evaluation	evaluation	NOUN
fcis-31417	17	14	of	of	ADP
fcis-31417	17	15	lung	lung	NOUN
fcis-31417	17	16	cancer	cancer	NOUN
fcis-31417	17	17	.	.	PUNCT
fcis-31417	18	1	ct	ct	NUM
fcis-31417	18	2	images	image	NOUN
fcis-31417	18	3	can	can	AUX
fcis-31417	18	4	clearly	clearly	ADV
fcis-31417	18	5	show	show	VERB
fcis-31417	18	6	the	the	DET
fcis-31417	18	7	size	size	NOUN
fcis-31417	18	8	,	,	PUNCT
fcis-31417	18	9	morphology	morphology	NOUN
fcis-31417	18	10	,	,	PUNCT
fcis-31417	18	11	location	location	NOUN
fcis-31417	18	12	and	and	CCONJ
fcis-31417	18	13	invasion	invasion	NOUN
fcis-31417	18	14	range	range	NOUN
fcis-31417	18	15	of	of	ADP
fcis-31417	18	16	tumors	tumor	NOUN
fcis-31417	18	17	[	[	X
fcis-31417	18	18	2	2	NUM
fcis-31417	18	19	]	]	PUNCT
fcis-31417	18	20	.	.	PUNCT
fcis-31417	19	1	through	through	ADP
fcis-31417	19	2	imaging	image	VERB
fcis-31417	19	3	genomics	genomic	NOUN
fcis-31417	19	4	analysis	analysis	NOUN
fcis-31417	19	5	,	,	PUNCT
fcis-31417	19	6	a	a	DET
fcis-31417	19	7	large	large	ADJ
fcis-31417	19	8	number	number	NOUN
fcis-31417	19	9	of	of	ADP
fcis-31417	19	10	quantitative	quantitative	ADJ
fcis-31417	19	11	features	feature	NOUN
fcis-31417	19	12	can	can	AUX
fcis-31417	19	13	be	be	AUX
fcis-31417	19	14	extracted	extract	VERB
fcis-31417	19	15	to	to	PART
fcis-31417	19	16	reflect	reflect	VERB
fcis-31417	19	17	the	the	DET
fcis-31417	19	18	microstructure	microstructure	ADJ
fcis-31417	19	19	and	and	CCONJ
fcis-31417	19	20	growth	growth	NOUN
fcis-31417	19	21	pattern	pattern	NOUN
fcis-31417	19	22	of	of	ADP
fcis-31417	19	23	tumors	tumor	NOUN
fcis-31417	19	24	.	.	PUNCT
fcis-31417	20	1	in	in	ADP
fcis-31417	20	2	recent	recent	ADJ
fcis-31417	20	3	years	year	NOUN
fcis-31417	20	4	,	,	PUNCT
fcis-31417	20	5	research	research	NOUN
fcis-31417	20	6	on	on	ADP
fcis-31417	20	7	prognostic	prognostic	ADJ
fcis-31417	20	8	models	model	NOUN
fcis-31417	20	9	based	base	VERB
fcis-31417	20	10	on	on	ADP
fcis-31417	20	11	ct	ct	PROPN
fcis-31417	20	12	imaging	imaging	NOUN
fcis-31417	20	13	has	have	AUX
fcis-31417	20	14	made	make	VERB
fcis-31417	20	15	some	some	DET
fcis-31417	20	16	progress	progress	NOUN
fcis-31417	20	17	.	.	PUNCT
fcis-31417	21	1	for	for	ADP
fcis-31417	21	2	example	example	NOUN
fcis-31417	21	3	,	,	PUNCT
fcis-31417	21	4	the	the	DET
fcis-31417	21	5	cindex	cindex	NOUN
fcis-31417	21	6	of	of	ADP
fcis-31417	21	7	the	the	DET
fcis-31417	21	8	lung	lung	NOUN
fcis-31417	21	9	adenocarcinoma	adenocarcinoma	PROPN
fcis-31417	21	10	imaging	imaging	NOUN
fcis-31417	21	11	model	model	NOUN
fcis-31417	21	12	constructed	construct	VERB
fcis-31417	21	13	by	by	ADP
fcis-31417	21	14	li	li	PROPN
fcis-31417	21	15	et	et	PROPN
fcis-31417	21	16	al	al	PROPN
fcis-31417	21	17	.	.	PROPN
fcis-31417	22	1	(	(	PUNCT
fcis-31417	22	2	2022	2022	NUM
fcis-31417	22	3	)	)	PUNCT
fcis-31417	22	4	reached	reach	VERB
fcis-31417	22	5	0.73	0.73	NUM
fcis-31417	22	6	,	,	PUNCT
fcis-31417	22	7	but	but	CCONJ
fcis-31417	22	8	the	the	DET
fcis-31417	22	9	model	model	NOUN
fcis-31417	22	10	only	only	ADV
fcis-31417	22	11	incorporates	incorporate	VERB
fcis-31417	22	12	basic	basic	ADJ
fcis-31417	22	13	features	feature	NOUN
fcis-31417	22	14	such	such	ADJ
fcis-31417	22	15	as	as	ADP
fcis-31417	22	16	tumor	tumor	NOUN
fcis-31417	22	17	diameter	diameter	NOUN
fcis-31417	22	18	and	and	CCONJ
fcis-31417	22	19	edge	edge	NOUN
fcis-31417	22	20	burrs	burr	NOUN
fcis-31417	22	21	,	,	PUNCT
fcis-31417	22	22	and	and	CCONJ
fcis-31417	22	23	does	do	AUX
fcis-31417	22	24	not	not	PART
fcis-31417	22	25	involve	involve	VERB
fcis-31417	22	26	deeper	deep	ADJ
fcis-31417	22	27	texture	texture	ADJ
fcis-31417	22	28	heterogeneity	heterogeneity	NOUN
fcis-31417	23	1	[	[	X
fcis-31417	23	2	3	3	NUM
fcis-31417	23	3	]	]	PUNCT
fcis-31417	23	4	.	.	PUNCT
fcis-31417	24	1	more	more	ADV
fcis-31417	24	2	importantly	importantly	ADV
fcis-31417	24	3	,	,	PUNCT
fcis-31417	24	4	imaging	imaging	NOUN
fcis-31417	24	5	features	feature	NOUN
fcis-31417	24	6	are	be	AUX
fcis-31417	24	7	easily	easily	ADV
fcis-31417	24	8	affected	affect	VERB
fcis-31417	24	9	by	by	ADP
fcis-31417	24	10	technical	technical	ADJ
fcis-31417	24	11	factors	factor	NOUN
fcis-31417	24	12	such	such	ADJ
fcis-31417	24	13	as	as	ADP
fcis-31417	24	14	scanning	scan	VERB
fcis-31417	24	15	layer	layer	NOUN
fcis-31417	24	16	thickness	thickness	NOUN
fcis-31417	24	17	(	(	PUNCT
fcis-31417	24	18	1	1	NUM
fcis-31417	24	19	mm	mm	PROPN
fcis-31417	24	20	vs	vs	ADP
fcis-31417	24	21	5	5	NUM
fcis-31417	24	22	mm	mm	NOUN
fcis-31417	24	23	)	)	PUNCT
fcis-31417	24	24	and	and	CCONJ
fcis-31417	24	25	reconstruction	reconstruction	NOUN
fcis-31417	24	26	algorithm	algorithm	NOUN
fcis-31417	24	27	(	(	PUNCT
fcis-31417	24	28	bone	bone	NOUN
fcis-31417	24	29	algorithm	algorithm	NOUN
fcis-31417	24	30	vs	vs	ADP
fcis-31417	24	31	soft	soft	ADJ
fcis-31417	24	32	tissue	tissue	NOUN
fcis-31417	24	33	algorithm	algorithm	NOUN
fcis-31417	24	34	)	)	PUNCT
fcis-31417	24	35	.	.	PUNCT
fcis-31417	25	1	the	the	DET
fcis-31417	25	2	consistency	consistency	NOUN
fcis-31417	25	3	of	of	ADP
fcis-31417	25	4	data	datum	NOUN
fcis-31417	25	5	from	from	ADP
fcis-31417	25	6	different	different	ADJ
fcis-31417	25	7	centers	center	NOUN
fcis-31417	25	8	is	be	AUX
fcis-31417	25	9	only	only	ADV
fcis-31417	25	10	68%-75	68%-75	NUM
fcis-31417	25	11	%	%	NOUN
fcis-31417	25	12	,	,	PUNCT
fcis-31417	25	13	which	which	PRON
fcis-31417	25	14	seriously	seriously	ADV
fcis-31417	25	15	limits	limit	VERB
fcis-31417	25	16	its	its	PRON
fcis-31417	25	17	clinical	clinical	ADJ
fcis-31417	25	18	promotion	promotion	NOUN
fcis-31417	25	19	.	.	PUNCT
fcis-31417	26	1	the	the	DET
fcis-31417	26	2	rise	rise	NOUN
fcis-31417	26	3	of	of	ADP
fcis-31417	26	4	liquid	liquid	ADJ
fcis-31417	26	5	biopsy	biopsy	NOUN
fcis-31417	26	6	technology	technology	NOUN
fcis-31417	26	7	provides	provide	VERB
fcis-31417	26	8	a	a	DET
fcis-31417	26	9	noninvasive	noninvasive	ADJ
fcis-31417	26	10	means	mean	NOUN
fcis-31417	26	11	for	for	ADP
fcis-31417	26	12	molecular	molecular	ADJ
fcis-31417	26	13	assessment	assessment	NOUN
fcis-31417	26	14	of	of	ADP
fcis-31417	26	15	tumors	tumor	NOUN
fcis-31417	26	16	[	[	X
fcis-31417	26	17	4	4	NUM
fcis-31417	26	18	]	]	PUNCT
fcis-31417	26	19	.	.	PUNCT
fcis-31417	27	1	the	the	DET
fcis-31417	27	2	mutation	mutation	NOUN
fcis-31417	27	3	abundance	abundance	NOUN
fcis-31417	27	4	(	(	PUNCT
fcis-31417	27	5	mrd	mrd	PROPN
fcis-31417	27	6	)	)	PUNCT
fcis-31417	27	7	of	of	ADP
fcis-31417	27	8	circulating	circulate	VERB
fcis-31417	27	9	tumor	tumor	NOUN
fcis-31417	27	10	dna	dna	PROPN
fcis-31417	27	11	(	(	PUNCT
fcis-31417	27	12	ctdna	ctdna	NOUN
fcis-31417	27	13	)	)	PUNCT
fcis-31417	27	14	has	have	AUX
fcis-31417	27	15	been	be	AUX
fcis-31417	27	16	shown	show	VERB
fcis-31417	27	17	to	to	PART
fcis-31417	27	18	be	be	AUX
fcis-31417	27	19	closely	closely	ADV
fcis-31417	27	20	related	relate	VERB
fcis-31417	27	21	to	to	ADP
fcis-31417	27	22	postoperative	postoperative	ADJ
fcis-31417	27	23	recurrence	recurrence	NOUN
fcis-31417	27	24	of	of	ADP
fcis-31417	27	25	lung	lung	NOUN
fcis-31417	27	26	cancer	cancer	NOUN
fcis-31417	27	27	.	.	PUNCT
fcis-31417	28	1	several	several	ADJ
fcis-31417	28	2	phase	phase	NOUN
fcis-31417	28	3	iii	iii	NUM
fcis-31417	28	4	clinical	clinical	ADJ
fcis-31417	28	5	trials	trial	NOUN
fcis-31417	28	6	have	have	AUX
fcis-31417	28	7	shown	show	VERB
fcis-31417	28	8	that	that	SCONJ
fcis-31417	28	9	the	the	DET
fcis-31417	28	10	2	2	NUM
fcis-31417	28	11	-	-	PUNCT
fcis-31417	28	12	year	year	NOUN
fcis-31417	28	13	recurrence	recurrence	NOUN
fcis-31417	28	14	rate	rate	NOUN
fcis-31417	28	15	of	of	ADP
fcis-31417	28	16	mrd	mrd	ADJ
fcis-31417	28	17	-	-	ADJ
fcis-31417	28	18	positive	positive	ADJ
fcis-31417	28	19	patients	patient	NOUN
fcis-31417	28	20	is	be	AUX
fcis-31417	28	21	72	72	NUM
fcis-31417	28	22	%	%	NOUN
fcis-31417	28	23	,	,	PUNCT
fcis-31417	28	24	significantly	significantly	ADV
fcis-31417	28	25	higher	high	ADJ
fcis-31417	28	26	than	than	ADP
fcis-31417	28	27	the	the	DET
fcis-31417	28	28	18	18	NUM
fcis-31417	28	29	%	%	NOUN
fcis-31417	28	30	of	of	ADP
fcis-31417	28	31	negative	negative	ADJ
fcis-31417	28	32	patients	patient	NOUN
fcis-31417	28	33	.	.	PUNCT
fcis-31417	29	1	however	however	ADV
fcis-31417	29	2	,	,	PUNCT
fcis-31417	29	3	liquid	liquid	ADJ
fcis-31417	29	4	biopsy	biopsy	NOUN
fcis-31417	29	5	has	have	VERB
fcis-31417	29	6	inherent	inherent	ADJ
fcis-31417	29	7	defects	defect	NOUN
fcis-31417	29	8	:	:	PUNCT
fcis-31417	29	9	on	on	ADP
fcis-31417	29	10	the	the	DET
fcis-31417	29	11	one	one	NUM
fcis-31417	29	12	hand	hand	NOUN
fcis-31417	29	13	,	,	PUNCT
fcis-31417	29	14	the	the	DET
fcis-31417	29	15	detection	detection	NOUN
fcis-31417	29	16	rate	rate	NOUN
fcis-31417	29	17	of	of	ADP
fcis-31417	29	18	ctdna	ctdna	NOUN
fcis-31417	29	19	in	in	ADP
fcis-31417	29	20	early	early	ADJ
fcis-31417	29	21	lung	lung	NOUN
fcis-31417	29	22	cancer	cancer	NOUN
fcis-31417	29	23	is	be	AUX
fcis-31417	29	24	only	only	ADV
fcis-31417	29	25	45%-60	45%-60	NUM
fcis-31417	29	26	%	%	NOUN
fcis-31417	29	27	,	,	PUNCT
fcis-31417	29	28	which	which	PRON
fcis-31417	29	29	is	be	AUX
fcis-31417	29	30	prone	prone	ADJ
fcis-31417	29	31	to	to	ADP
fcis-31417	29	32	false	false	ADJ
fcis-31417	29	33	negatives	negative	NOUN
fcis-31417	29	34	;	;	PUNCT
fcis-31417	29	35	on	on	ADP
fcis-31417	29	36	the	the	DET
fcis-31417	29	37	other	other	ADJ
fcis-31417	29	38	hand	hand	NOUN
fcis-31417	29	39	,	,	PUNCT
fcis-31417	29	40	its	its	PRON
fcis-31417	29	41	test	test	NOUN
fcis-31417	29	42	results	result	NOUN
fcis-31417	29	43	are	be	AUX
fcis-31417	29	44	affected	affect	VERB
fcis-31417	29	45	by	by	ADP
fcis-31417	29	46	factors	factor	NOUN
fcis-31417	29	47	such	such	ADJ
fcis-31417	29	48	as	as	ADP
fcis-31417	29	49	blood	blood	NOUN
fcis-31417	29	50	collection	collection	NOUN
fcis-31417	29	51	time	time	NOUN
fcis-31417	29	52	(	(	PUNCT
fcis-31417	29	53	morning	morning	NOUN
fcis-31417	29	54	vs	vs	ADP
fcis-31417	29	55	afternoon	afternoon	NOUN
fcis-31417	29	56	)	)	PUNCT
fcis-31417	29	57	and	and	CCONJ
fcis-31417	29	58	specimen	speciman	NOUN
fcis-31417	29	59	storage	storage	NOUN
fcis-31417	29	60	temperature	temperature	NOUN
fcis-31417	29	61	(	(	PUNCT
fcis-31417	29	62	4	4	NUM
fcis-31417	29	63	℃	℃	PROPN
fcis-31417	29	64	vs	vs	ADP
fcis-31417	29	65	-20	-20	NUM
fcis-31417	29	66	℃	℃	PROPN
fcis-31417	29	67	)	)	PUNCT
fcis-31417	29	68	,	,	PUNCT
fcis-31417	29	69	and	and	CCONJ
fcis-31417	29	70	the	the	DET
fcis-31417	29	71	coefficient	coefficient	NOUN
fcis-31417	29	72	of	of	ADP
fcis-31417	29	73	variation	variation	NOUN
fcis-31417	29	74	can	can	AUX
fcis-31417	29	75	reach	reach	VERB
fcis-31417	29	76	15%-20	15%-20	NUM
fcis-31417	29	77	%	%	NOUN
fcis-31417	29	78	.	.	PUNCT
fcis-31417	30	1	in	in	ADP
fcis-31417	30	2	addition	addition	NOUN
fcis-31417	30	3	,	,	PUNCT
fcis-31417	30	4	a	a	DET
fcis-31417	30	5	single	single	ADJ
fcis-31417	30	6	molecular	molecular	ADJ
fcis-31417	30	7	marker	marker	NOUN
fcis-31417	30	8	is	be	AUX
fcis-31417	30	9	difficult	difficult	ADJ
fcis-31417	30	10	to	to	PART
fcis-31417	30	11	cover	cover	VERB
fcis-31417	30	12	the	the	DET
fcis-31417	30	13	spatial	spatial	ADJ
fcis-31417	30	14	heterogeneity	heterogeneity	NOUN
fcis-31417	30	15	of	of	ADP
fcis-31417	30	16	tumors	tumor	NOUN
fcis-31417	30	17	.	.	PUNCT
fcis-31417	31	1	for	for	ADP
fcis-31417	31	2	example	example	NOUN
fcis-31417	31	3	,	,	PUNCT
fcis-31417	31	4	the	the	DET
fcis-31417	31	5	difference	difference	NOUN
fcis-31417	31	6	in	in	ADP
fcis-31417	31	7	egfr	egfr	ADJ
fcis-31417	31	8	mutation	mutation	NOUN
fcis-31417	31	9	status	status	NOUN
fcis-31417	31	10	between	between	ADP
fcis-31417	31	11	different	different	ADJ
fcis-31417	31	12	metastatic	metastatic	ADJ
fcis-31417	31	13	lesions	lesion	NOUN
fcis-31417	31	14	of	of	ADP
fcis-31417	31	15	the	the	DET
fcis-31417	31	16	same	same	ADJ
fcis-31417	31	17	patient	patient	NOUN
fcis-31417	31	18	is	be	AUX
fcis-31417	31	19	as	as	ADV
fcis-31417	31	20	high	high	ADJ
fcis-31417	31	21	as	as	ADP
fcis-31417	31	22	23	23	NUM
fcis-31417	31	23	%	%	NOUN
fcis-31417	31	24	.	.	PUNCT
fcis-31417	32	1	multimodal	multimodal	NOUN
fcis-31417	32	2	data	datum	NOUN
fcis-31417	32	3	fusion	fusion	NOUN
fcis-31417	32	4	is	be	AUX
fcis-31417	32	5	expected	expect	VERB
fcis-31417	32	6	to	to	PART
fcis-31417	32	7	break	break	VERB
fcis-31417	32	8	through	through	ADP
fcis-31417	32	9	the	the	DET
fcis-31417	32	10	limitations	limitation	NOUN
fcis-31417	32	11	of	of	ADP
fcis-31417	32	12	a	a	DET
fcis-31417	32	13	single	single	ADJ
fcis-31417	32	14	data	datum	NOUN
fcis-31417	32	15	source	source	NOUN
fcis-31417	32	16	by	by	ADP
fcis-31417	32	17	integrating	integrate	VERB
fcis-31417	32	18	biological	biological	ADJ
fcis-31417	32	19	information	information	NOUN
fcis-31417	32	20	of	of	ADP
fcis-31417	32	21	different	different	ADJ
fcis-31417	32	22	dimensions	dimension	NOUN
fcis-31417	33	1	[	[	X
fcis-31417	33	2	5	5	NUM
fcis-31417	33	3	]	]	PUNCT
fcis-31417	33	4	.	.	PUNCT
fcis-31417	34	1	from	from	ADP
fcis-31417	34	2	a	a	DET
fcis-31417	34	3	technical	technical	ADJ
fcis-31417	34	4	principle	principle	ADJ
fcis-31417	34	5	point	point	NOUN
fcis-31417	34	6	of	of	ADP
fcis-31417	34	7	view	view	NOUN
fcis-31417	34	8	,	,	PUNCT
fcis-31417	34	9	the	the	DET
fcis-31417	34	10	grayscale	grayscale	NOUN
fcis-31417	34	11	co	co	NOUN
fcis-31417	34	12	-	-	NOUN
fcis-31417	34	13	occurrence	occurrence	ADJ
fcis-31417	34	14	matrix	matrix	NOUN
fcis-31417	34	15	of	of	ADP
fcis-31417	34	16	ct	ct	NUM
fcis-31417	34	17	images	image	NOUN
fcis-31417	34	18	can	can	AUX
fcis-31417	34	19	quantify	quantify	VERB
fcis-31417	34	20	the	the	DET
fcis-31417	34	21	compactness	compactness	NOUN
fcis-31417	34	22	of	of	ADP
fcis-31417	34	23	tumor	tumor	NOUN
fcis-31417	34	24	cells	cell	NOUN
fcis-31417	34	25	,	,	PUNCT
fcis-31417	34	26	while	while	SCONJ
fcis-31417	34	27	the	the	DET
fcis-31417	34	28	chromosome	chromosome	NOUN
fcis-31417	34	29	instability	instability	NOUN
fcis-31417	34	30	(	(	PUNCT
fcis-31417	34	31	cin	cin	PROPN
fcis-31417	34	32	)	)	PUNCT
fcis-31417	34	33	score	score	NOUN
fcis-31417	34	34	of	of	ADP
fcis-31417	34	35	liquid	liquid	ADJ
fcis-31417	34	36	biopsy	biopsy	NOUN
fcis-31417	34	37	can	can	AUX
fcis-31417	34	38	reflect	reflect	VERB
fcis-31417	34	39	the	the	DET
fcis-31417	34	40	level	level	NOUN
fcis-31417	34	41	of	of	ADP
fcis-31417	34	42	genomic	genomic	ADJ
fcis-31417	34	43	variation	variation	NOUN
fcis-31417	35	1	[	[	X
fcis-31417	35	2	6	6	NUM
fcis-31417	35	3	]	]	PUNCT
fcis-31417	35	4	.	.	PUNCT
fcis-31417	36	1	the	the	DET
fcis-31417	36	2	joint	joint	ADJ
fcis-31417	36	3	analysis	analysis	NOUN
fcis-31417	36	4	of	of	ADP
fcis-31417	36	5	the	the	DET
fcis-31417	36	6	two	two	NUM
fcis-31417	36	7	can	can	AUX
fcis-31417	36	8	construct	construct	VERB
fcis-31417	36	9	a	a	DET
fcis-31417	36	10	"	"	PUNCT
fcis-31417	36	11	morphological	morphological	ADJ
fcis-31417	36	12	-	-	PUNCT
fcis-31417	36	13	molecular	molecular	ADJ
fcis-31417	36	14	"	"	PUNCT
fcis-31417	36	15	dualdimensional	dualdimensional	ADJ
fcis-31417	36	16	evaluation	evaluation	NOUN
fcis-31417	36	17	system	system	NOUN
fcis-31417	36	18	.	.	PUNCT
fcis-31417	37	1	previous	previous	ADJ
fcis-31417	37	2	exploratory	exploratory	ADJ
fcis-31417	37	3	studies	study	NOUN
fcis-31417	37	4	have	have	AUX
fcis-31417	37	5	shown	show	VERB
fcis-31417	37	6	that	that	SCONJ
fcis-31417	37	7	the	the	DET
fcis-31417	37	8	prediction	prediction	NOUN
fcis-31417	37	9	accuracy	accuracy	NOUN
fcis-31417	37	10	(	(	PUNCT
fcis-31417	37	11	c	c	NOUN
fcis-31417	37	12	-	-	PUNCT
fcis-31417	37	13	index	index	NOUN
fcis-31417	37	14	0.81	0.81	NUM
fcis-31417	37	15	)	)	PUNCT
fcis-31417	37	16	of	of	ADP
fcis-31417	37	17	the	the	DET
fcis-31417	37	18	model	model	NOUN
fcis-31417	37	19	integrating	integrate	VERB
fcis-31417	37	20	ct	ct	NUM
fcis-31417	37	21	imaging	imaging	NOUN
fcis-31417	37	22	genomics	genomic	NOUN
fcis-31417	37	23	and	and	CCONJ
fcis-31417	37	24	ctdna	ctdna	NOUN
fcis-31417	37	25	mutation	mutation	NOUN
fcis-31417	37	26	features	feature	NOUN
fcis-31417	37	27	is	be	AUX
fcis-31417	37	28	significantly	significantly	ADV
fcis-31417	37	29	higher	high	ADJ
fcis-31417	37	30	than	than	ADP
fcis-31417	37	31	that	that	PRON
fcis-31417	37	32	of	of	ADP
fcis-31417	37	33	a	a	DET
fcis-31417	37	34	single	single	ADJ
fcis-31417	37	35	imaging	imaging	NOUN
fcis-31417	37	36	model	model	NOUN
fcis-31417	37	37	(	(	PUNCT
fcis-31417	37	38	0.72	0.72	NUM
fcis-31417	37	39	)	)	PUNCT
fcis-31417	37	40	or	or	CCONJ
fcis-31417	37	41	a	a	DET
fcis-31417	37	42	single	single	ADJ
fcis-31417	37	43	molecular	molecular	ADJ
fcis-31417	37	44	model	model	NOUN
fcis-31417	37	45	(	(	PUNCT
fcis-31417	37	46	0.69	0.69	NUM
fcis-31417	37	47	)	)	PUNCT
fcis-31417	37	48	.	.	PUNCT
fcis-31417	38	1	this	this	DET
fcis-31417	38	2	study	study	NOUN
fcis-31417	38	3	will	will	AUX
fcis-31417	38	4	further	far	ADV
fcis-31417	38	5	optimize	optimize	VERB
fcis-31417	38	6	the	the	DET
fcis-31417	38	7	feature	feature	NOUN
fcis-31417	38	8	screening	screening	NOUN
fcis-31417	38	9	process	process	NOUN
fcis-31417	38	10	,	,	PUNCT
fcis-31417	38	11	use	use	VERB
fcis-31417	38	12	the	the	DET
fcis-31417	38	13	attention	attention	NOUN
fcis-31417	38	14	mechanism	mechanism	NOUN
fcis-31417	38	15	to	to	PART
fcis-31417	38	16	give	give	VERB
fcis-31417	38	17	dynamic	dynamic	ADJ
fcis-31417	38	18	weights	weight	NOUN
fcis-31417	38	19	to	to	ADP
fcis-31417	38	20	different	different	ADJ
fcis-31417	38	21	modal	modal	ADJ
fcis-31417	38	22	features	feature	NOUN
fcis-31417	38	23	,	,	PUNCT
fcis-31417	38	24	and	and	CCONJ
fcis-31417	38	25	verify	verify	VERB
fcis-31417	38	26	the	the	DET
fcis-31417	38	27	generalization	generalization	NOUN
fcis-31417	38	28	ability	ability	NOUN
fcis-31417	38	29	of	of	ADP
fcis-31417	38	30	the	the	DET
fcis-31417	38	31	model	model	NOUN
fcis-31417	38	32	through	through	ADP
fcis-31417	38	33	multi	multi	ADJ
fcis-31417	38	34	-	-	ADJ
fcis-31417	38	35	center	center	ADJ
fcis-31417	38	36	data	datum	NOUN
fcis-31417	38	37	,	,	PUNCT
fcis-31417	38	38	and	and	CCONJ
fcis-31417	38	39	ultimately	ultimately	ADV
fcis-31417	38	40	establish	establish	VERB
fcis-31417	38	41	a	a	DET
fcis-31417	38	42	clinically	clinically	ADV
fcis-31417	38	43	applicable	applicable	ADJ
fcis-31417	38	44	lung	lung	NOUN
fcis-31417	38	45	cancer	cancer	NOUN
fcis-31417	38	46	survival	survival	NOUN
fcis-31417	38	47	prediction	prediction	NOUN
fcis-31417	38	48	tool	tool	NOUN
fcis-31417	38	49	to	to	PART
fcis-31417	38	50	provide	provide	VERB
fcis-31417	38	51	an	an	DET
fcis-31417	38	52	objective	objective	ADJ
fcis-31417	38	53	basis	basis	NOUN
fcis-31417	38	54	for	for	ADP
fcis-31417	38	55	key	key	ADJ
fcis-31417	38	56	decisions	decision	NOUN
fcis-31417	38	57	such	such	ADJ
fcis-31417	38	58	as	as	ADP
fcis-31417	38	59	postoperative	postoperative	ADJ
fcis-31417	38	60	adjuvant	adjuvant	ADJ
fcis-31417	38	61	therapy	therapy	NOUN
fcis-31417	38	62	selection	selection	NOUN
fcis-31417	38	63	and	and	CCONJ
fcis-31417	38	64	the	the	DET
fcis-31417	38	65	timing	timing	NOUN
fcis-31417	38	66	of	of	ADP
fcis-31417	38	67	discontinuation	discontinuation	NOUN
fcis-31417	38	68	of	of	ADP
fcis-31417	38	69	targeted	target	VERB
fcis-31417	38	70	drugs	drug	NOUN
fcis-31417	38	71	.	.	PUNCT
fcis-31417	39	1	35	35	NUM
fcis-31417	39	2	2	2	NUM
fcis-31417	39	3	.	.	PUNCT
fcis-31417	39	4	materials	material	NOUN
fcis-31417	39	5	and	and	CCONJ
fcis-31417	39	6	methods	method	NOUN
fcis-31417	39	7	2.1	2.1	NUM
fcis-31417	39	8	.	.	PUNCT
fcis-31417	40	1	patient	patient	ADJ
fcis-31417	40	2	data	datum	NOUN
fcis-31417	40	3	collection	collection	NOUN
fcis-31417	40	4	this	this	DET
fcis-31417	40	5	study	study	NOUN
fcis-31417	40	6	included	include	VERB
fcis-31417	40	7	data	datum	NOUN
fcis-31417	40	8	on	on	ADP
fcis-31417	40	9	lung	lung	NOUN
fcis-31417	40	10	cancer	cancer	NOUN
fcis-31417	40	11	patients	patient	NOUN
fcis-31417	40	12	from	from	ADP
fcis-31417	40	13	three	three	NUM
fcis-31417	40	14	medical	medical	ADJ
fcis-31417	40	15	institutions	institution	NOUN
fcis-31417	40	16	from	from	ADP
fcis-31417	40	17	january	january	PROPN
fcis-31417	40	18	2019	2019	NUM
fcis-31417	40	19	to	to	ADP
fcis-31417	40	20	december	december	PROPN
fcis-31417	40	21	2022	2022	NUM
fcis-31417	40	22	,	,	PUNCT
fcis-31417	40	23	including	include	VERB
fcis-31417	40	24	the	the	DET
fcis-31417	40	25	first	first	ADJ
fcis-31417	40	26	affiliated	affiliate	VERB
fcis-31417	40	27	hospital	hospital	NOUN
fcis-31417	40	28	of	of	ADP
fcis-31417	40	29	xx	xx	NUM
fcis-31417	40	30	university	university	NOUN
fcis-31417	40	31	(	(	PUNCT
fcis-31417	40	32	n=326	n=326	NUM
fcis-31417	40	33	)	)	PUNCT
fcis-31417	40	34	,	,	PUNCT
fcis-31417	40	35	xx	xx	NUM
fcis-31417	40	36	provincial	provincial	ADJ
fcis-31417	40	37	cancer	cancer	NOUN
fcis-31417	40	38	hospital	hospital	NOUN
fcis-31417	40	39	(	(	PUNCT
fcis-31417	40	40	n=218	n=218	NOUN
fcis-31417	40	41	)	)	PUNCT
fcis-31417	40	42	and	and	CCONJ
fcis-31417	40	43	xx	xx	NUM
fcis-31417	40	44	city	city	NOUN
fcis-31417	40	45	chest	chest	PROPN
fcis-31417	40	46	hospital	hospital	NOUN
fcis-31417	40	47	(	(	PUNCT
fcis-31417	40	48	n=187	n=187	NUM
fcis-31417	40	49	)	)	PUNCT
fcis-31417	40	50	,	,	PUNCT
fcis-31417	40	51	totaling	total	VERB
fcis-31417	40	52	731	731	NUM
fcis-31417	40	53	cases	case	NOUN
fcis-31417	40	54	.	.	PUNCT
fcis-31417	41	1	inclusion	inclusion	NOUN
fcis-31417	41	2	criteria	criterion	NOUN
fcis-31417	41	3	:	:	PUNCT
fcis-31417	41	4	(	(	PUNCT
fcis-31417	41	5	1	1	X
fcis-31417	41	6	)	)	PUNCT
fcis-31417	41	7	primary	primary	ADJ
fcis-31417	41	8	lung	lung	NOUN
fcis-31417	41	9	cancer	cancer	NOUN
fcis-31417	41	10	confirmed	confirm	VERB
fcis-31417	41	11	by	by	ADP
fcis-31417	41	12	pathological	pathological	ADJ
fcis-31417	41	13	histology	histology	NOUN
fcis-31417	41	14	or	or	CCONJ
fcis-31417	41	15	cytology	cytology	NOUN
fcis-31417	41	16	;	;	PUNCT
fcis-31417	41	17	(	(	PUNCT
fcis-31417	41	18	2	2	X
fcis-31417	41	19	)	)	PUNCT
fcis-31417	41	20	no	no	DET
fcis-31417	41	21	anti	anti	ADJ
fcis-31417	41	22	-	-	ADJ
fcis-31417	41	23	tumor	tumor	ADJ
fcis-31417	41	24	treatment	treatment	NOUN
fcis-31417	41	25	at	at	ADP
fcis-31417	41	26	the	the	DET
fcis-31417	41	27	initial	initial	ADJ
fcis-31417	41	28	diagnosis	diagnosis	NOUN
fcis-31417	41	29	;	;	PUNCT
fcis-31417	41	30	(	(	PUNCT
fcis-31417	41	31	3	3	X
fcis-31417	41	32	)	)	PUNCT
fcis-31417	41	33	complete	complete	ADJ
fcis-31417	41	34	baseline	baseline	NOUN
fcis-31417	41	35	ct	ct	PROPN
fcis-31417	41	36	imaging	imaging	NOUN
fcis-31417	41	37	data	datum	NOUN
fcis-31417	41	38	;	;	PUNCT
fcis-31417	41	39	(	(	PUNCT
fcis-31417	41	40	4	4	X
fcis-31417	41	41	)	)	PUNCT
fcis-31417	41	42	retained	retain	VERB
fcis-31417	41	43	peripheral	peripheral	ADJ
fcis-31417	41	44	blood	blood	NOUN
fcis-31417	41	45	samples	sample	NOUN
fcis-31417	41	46	before	before	ADP
fcis-31417	41	47	treatment	treatment	NOUN
fcis-31417	41	48	;	;	PUNCT
fcis-31417	41	49	(	(	PUNCT
fcis-31417	41	50	5	5	X
fcis-31417	41	51	)	)	PUNCT
fcis-31417	41	52	complete	complete	ADJ
fcis-31417	41	53	clinical	clinical	ADJ
fcis-31417	41	54	follow	follow	NOUN
fcis-31417	41	55	-	-	PUNCT
fcis-31417	41	56	up	up	ADP
fcis-31417	41	57	data	datum	NOUN
fcis-31417	41	58	,	,	PUNCT
fcis-31417	41	59	and	and	CCONJ
fcis-31417	41	60	the	the	DET
fcis-31417	41	61	follow	follow	VERB
fcis-31417	41	62	-	-	PUNCT
fcis-31417	41	63	up	up	ADP
fcis-31417	41	64	deadline	deadline	NOUN
fcis-31417	41	65	is	be	AUX
fcis-31417	41	66	december	december	PROPN
fcis-31417	41	67	2023	2023	NUM
fcis-31417	41	68	.	.	PUNCT
fcis-31417	42	1	exclusion	exclusion	NOUN
fcis-31417	42	2	criteria	criterion	NOUN
fcis-31417	42	3	:	:	PUNCT
fcis-31417	42	4	(	(	PUNCT
fcis-31417	42	5	1	1	X
fcis-31417	42	6	)	)	PUNCT
fcis-31417	42	7	combined	combine	VERB
fcis-31417	42	8	with	with	ADP
fcis-31417	42	9	other	other	ADJ
fcis-31417	42	10	primary	primary	ADJ
fcis-31417	42	11	malignant	malignant	ADJ
fcis-31417	42	12	tumors	tumor	NOUN
fcis-31417	42	13	;	;	PUNCT
fcis-31417	42	14	(	(	PUNCT
fcis-31417	42	15	2	2	X
fcis-31417	42	16	)	)	PUNCT
fcis-31417	42	17	severe	severe	ADJ
fcis-31417	42	18	artifacts	artifact	NOUN
fcis-31417	42	19	or	or	CCONJ
fcis-31417	42	20	motion	motion	NOUN
fcis-31417	42	21	interference	interference	NOUN
fcis-31417	42	22	in	in	ADP
fcis-31417	42	23	ct	ct	NUM
fcis-31417	42	24	images	image	NOUN
fcis-31417	42	25	;	;	PUNCT
fcis-31417	42	26	(	(	PUNCT
fcis-31417	42	27	3	3	X
fcis-31417	42	28	)	)	PUNCT
fcis-31417	42	29	failure	failure	NOUN
fcis-31417	42	30	to	to	PART
fcis-31417	42	31	complete	complete	VERB
fcis-31417	42	32	the	the	DET
fcis-31417	42	33	test	test	NOUN
fcis-31417	42	34	within	within	ADP
fcis-31417	42	35	24	24	NUM
fcis-31417	42	36	hours	hour	NOUN
fcis-31417	42	37	after	after	ADP
fcis-31417	42	38	peripheral	peripheral	ADJ
fcis-31417	42	39	blood	blood	NOUN
fcis-31417	42	40	sample	sample	NOUN
fcis-31417	42	41	collection	collection	NOUN
fcis-31417	42	42	;	;	PUNCT
fcis-31417	42	43	(	(	PUNCT
fcis-31417	42	44	4	4	X
fcis-31417	42	45	)	)	PUNCT
fcis-31417	42	46	death	death	NOUN
fcis-31417	42	47	due	due	ADP
fcis-31417	42	48	to	to	ADP
fcis-31417	42	49	non	non	ADJ
fcis-31417	42	50	-	-	ADJ
fcis-31417	42	51	tumor	tumor	ADJ
fcis-31417	42	52	-	-	PUNCT
fcis-31417	42	53	related	relate	VERB
fcis-31417	42	54	factors	factor	NOUN
fcis-31417	42	55	during	during	ADP
fcis-31417	42	56	follow	follow	NOUN
fcis-31417	42	57	-	-	PUNCT
fcis-31417	42	58	up	up	NOUN
fcis-31417	42	59	.	.	PUNCT
fcis-31417	43	1	to	to	PART
fcis-31417	43	2	ensure	ensure	VERB
fcis-31417	43	3	the	the	DET
fcis-31417	43	4	representativeness	representativeness	NOUN
fcis-31417	43	5	of	of	ADP
fcis-31417	43	6	the	the	DET
fcis-31417	43	7	data	datum	NOUN
fcis-31417	43	8	,	,	PUNCT
fcis-31417	43	9	stratified	stratify	VERB
fcis-31417	43	10	sampling	sampling	NOUN
fcis-31417	43	11	was	be	AUX
fcis-31417	43	12	used	use	VERB
fcis-31417	43	13	to	to	PART
fcis-31417	43	14	match	match	VERB
fcis-31417	43	15	the	the	DET
fcis-31417	43	16	data	datum	NOUN
fcis-31417	43	17	according	accord	VERB
fcis-31417	43	18	to	to	ADP
fcis-31417	43	19	pathological	pathological	ADJ
fcis-31417	43	20	type	type	NOUN
fcis-31417	43	21	(	(	PUNCT
fcis-31417	43	22	adenocarcinoma	adenocarcinoma	NOUN
fcis-31417	43	23	42	42	NUM
fcis-31417	43	24	%	%	NOUN
fcis-31417	43	25	,	,	PUNCT
fcis-31417	43	26	squamous	squamous	ADJ
fcis-31417	43	27	cell	cell	NOUN
fcis-31417	43	28	carcinoma	carcinoma	NOUN
fcis-31417	43	29	31	31	NUM
fcis-31417	43	30	%	%	NOUN
fcis-31417	43	31	,	,	PUNCT
fcis-31417	43	32	small	small	ADJ
fcis-31417	43	33	cell	cell	NOUN
fcis-31417	43	34	carcinoma	carcinoma	NOUN
fcis-31417	43	35	18	18	NUM
fcis-31417	43	36	%	%	NOUN
fcis-31417	43	37	,	,	PUNCT
fcis-31417	43	38	and	and	CCONJ
fcis-31417	43	39	other	other	ADJ
fcis-31417	43	40	9	9	NUM
fcis-31417	43	41	%	%	NOUN
fcis-31417	43	42	)	)	PUNCT
fcis-31417	43	43	and	and	CCONJ
fcis-31417	43	44	tnm	tnm	NUM
fcis-31417	43	45	stage	stage	NOUN
fcis-31417	43	46	(	(	PUNCT
fcis-31417	43	47	stage	stage	NOUN
fcis-31417	43	48	i	i	PRON
fcis-31417	43	49	38	38	NUM
fcis-31417	43	50	%	%	NOUN
fcis-31417	43	51	,	,	PUNCT
fcis-31417	43	52	stage	stage	NOUN
fcis-31417	43	53	ii	ii	PROPN
fcis-31417	43	54	25	25	NUM
fcis-31417	43	55	%	%	NOUN
fcis-31417	43	56	,	,	PUNCT
fcis-31417	43	57	stage	stage	NOUN
fcis-31417	43	58	iii	iii	NUM
fcis-31417	43	59	22	22	NUM
fcis-31417	43	60	%	%	NOUN
fcis-31417	43	61	,	,	PUNCT
fcis-31417	43	62	and	and	CCONJ
fcis-31417	43	63	stage	stage	NOUN
fcis-31417	43	64	iv	iv	NUM
fcis-31417	43	65	15	15	NUM
fcis-31417	43	66	%	%	NOUN
fcis-31417	43	67	)	)	PUNCT
fcis-31417	43	68	.	.	PUNCT
fcis-31417	44	1	multiple	multiple	ADJ
fcis-31417	44	2	interpolation	interpolation	NOUN
fcis-31417	44	3	was	be	AUX
fcis-31417	44	4	used	use	VERB
fcis-31417	44	5	to	to	PART
fcis-31417	44	6	process	process	VERB
fcis-31417	44	7	missing	miss	VERB
fcis-31417	44	8	data	datum	NOUN
fcis-31417	44	9	.	.	PUNCT
fcis-31417	45	1	missing	miss	VERB
fcis-31417	45	2	values	value	NOUN
fcis-31417	45	3	≤5	≤5	VERB
fcis-31417	45	4	%	%	NOUN
fcis-31417	45	5	were	be	AUX
fcis-31417	45	6	filled	fill	VERB
fcis-31417	45	7	with	with	ADP
fcis-31417	45	8	the	the	DET
fcis-31417	45	9	mean	mean	NOUN
fcis-31417	45	10	of	of	ADP
fcis-31417	45	11	the	the	DET
fcis-31417	45	12	same	same	ADJ
fcis-31417	45	13	group	group	NOUN
fcis-31417	45	14	,	,	PUNCT
fcis-31417	45	15	and	and	CCONJ
fcis-31417	45	16	missing	miss	VERB
fcis-31417	45	17	indicators	indicator	NOUN
fcis-31417	45	18	>	>	PUNCT
fcis-31417	45	19	5	5	NUM
fcis-31417	45	20	%	%	NOUN
fcis-31417	45	21	(	(	PUNCT
fcis-31417	45	22	such	such	ADJ
fcis-31417	45	23	as	as	ADP
fcis-31417	45	24	some	some	DET
fcis-31417	45	25	tumor	tumor	NOUN
fcis-31417	45	26	markers	marker	NOUN
fcis-31417	45	27	)	)	PUNCT
fcis-31417	45	28	were	be	AUX
fcis-31417	45	29	predicted	predict	VERB
fcis-31417	45	30	and	and	CCONJ
fcis-31417	45	31	supplemented	supplement	VERB
fcis-31417	45	32	by	by	ADP
fcis-31417	45	33	the	the	DET
fcis-31417	45	34	random	random	ADJ
fcis-31417	45	35	forest	forest	NOUN
fcis-31417	45	36	algorithm	algorithm	NOUN
fcis-31417	45	37	.	.	PUNCT
fcis-31417	46	1	all	all	DET
fcis-31417	46	2	cases	case	NOUN
fcis-31417	46	3	signed	sign	VERB
fcis-31417	46	4	informed	informed	ADJ
fcis-31417	46	5	consent	consent	NOUN
fcis-31417	46	6	forms	form	NOUN
fcis-31417	46	7	,	,	PUNCT
fcis-31417	46	8	and	and	CCONJ
fcis-31417	46	9	the	the	DET
fcis-31417	46	10	research	research	NOUN
fcis-31417	46	11	plan	plan	NOUN
fcis-31417	46	12	was	be	AUX
fcis-31417	46	13	approved	approve	VERB
fcis-31417	46	14	by	by	ADP
fcis-31417	46	15	the	the	DET
fcis-31417	46	16	ethics	ethic	NOUN
fcis-31417	46	17	committees	committee	NOUN
fcis-31417	46	18	of	of	ADP
fcis-31417	46	19	the	the	DET
fcis-31417	46	20	three	three	NUM
fcis-31417	46	21	institutions	institution	NOUN
fcis-31417	46	22	(	(	PUNCT
fcis-31417	46	23	approval	approval	NOUN
fcis-31417	46	24	numbers	number	NOUN
fcis-31417	46	25	:	:	PUNCT
fcis-31417	46	26	2019032	2019032	NUM
fcis-31417	46	27	,	,	PUNCT
fcis-31417	46	28	2019	2019	NUM
fcis-31417	46	29	-	-	SYM
fcis-31417	46	30	056	056	NUM
fcis-31417	46	31	,	,	PUNCT
fcis-31417	46	32	and	and	CCONJ
fcis-31417	46	33	2019	2019	NUM
fcis-31417	46	34	-	-	SYM
fcis-31417	46	35	078	078	NUM
fcis-31417	46	36	)	)	PUNCT
fcis-31417	46	37	.	.	PUNCT
fcis-31417	47	1	2.2	2.2	NUM
fcis-31417	47	2	.	.	PUNCT
fcis-31417	48	1	ct	ct	NUM
fcis-31417	48	2	image	image	NOUN
fcis-31417	48	3	data	datum	NOUN
fcis-31417	48	4	processing	process	VERB
fcis-31417	48	5	ct	ct	NUM
fcis-31417	48	6	image	image	NOUN
fcis-31417	48	7	acquisition	acquisition	NOUN
fcis-31417	48	8	equipment	equipment	NOUN
fcis-31417	48	9	included	include	VERB
fcis-31417	48	10	ge	ge	PROPN
fcis-31417	48	11	revolution	revolution	PROPN
fcis-31417	48	12	ct	ct	PROPN
fcis-31417	48	13	(	(	PUNCT
fcis-31417	48	14	512	512	NUM
fcis-31417	48	15	cases	case	NOUN
fcis-31417	48	16	)	)	PUNCT
fcis-31417	48	17	,	,	PUNCT
fcis-31417	48	18	siemens	siemen	NOUN
fcis-31417	48	19	somatom	somatom	PROPN
fcis-31417	48	20	force	force	PROPN
fcis-31417	48	21	ct	ct	PROPN
fcis-31417	48	22	(	(	PUNCT
fcis-31417	48	23	157	157	NUM
fcis-31417	48	24	cases	case	NOUN
fcis-31417	48	25	)	)	PUNCT
fcis-31417	48	26	,	,	PUNCT
fcis-31417	48	27	and	and	CCONJ
fcis-31417	48	28	philips	philips	PROPN
fcis-31417	48	29	ingenuity	ingenuity	NOUN
fcis-31417	48	30	ct	ct	PROPN
fcis-31417	48	31	(	(	PUNCT
fcis-31417	48	32	62	62	NUM
fcis-31417	48	33	cases	case	NOUN
fcis-31417	48	34	)	)	PUNCT
fcis-31417	48	35	.	.	PUNCT
fcis-31417	49	1	the	the	DET
fcis-31417	49	2	scanning	scan	VERB
fcis-31417	49	3	parameters	parameter	NOUN
fcis-31417	49	4	were	be	AUX
fcis-31417	49	5	unified	unify	VERB
fcis-31417	49	6	as	as	SCONJ
fcis-31417	49	7	follows	follow	VERB
fcis-31417	49	8	:	:	PUNCT
fcis-31417	49	9	tube	tube	NOUN
fcis-31417	49	10	voltage	voltage	NOUN
fcis-31417	49	11	120	120	NUM
fcis-31417	49	12	kv	kv	PROPN
fcis-31417	49	13	,	,	PUNCT
fcis-31417	49	14	tube	tube	NOUN
fcis-31417	49	15	current	current	ADJ
fcis-31417	49	16	automatic	automatic	ADJ
fcis-31417	49	17	ma	ma	PROPN
fcis-31417	49	18	adjustment	adjustment	NOUN
fcis-31417	49	19	(	(	PUNCT
fcis-31417	49	20	range	range	NOUN
fcis-31417	49	21	100	100	NUM
fcis-31417	49	22	-	-	SYM
fcis-31417	49	23	300	300	NUM
fcis-31417	49	24	ma	ma	NOUN
fcis-31417	49	25	)	)	PUNCT
fcis-31417	49	26	,	,	PUNCT
fcis-31417	49	27	slice	slice	NOUN
fcis-31417	49	28	thickness	thickness	NOUN
fcis-31417	49	29	1	1	NUM
fcis-31417	49	30	mm	mm	NOUN
fcis-31417	49	31	,	,	PUNCT
fcis-31417	49	32	slice	slice	NOUN
fcis-31417	49	33	spacing	space	VERB
fcis-31417	49	34	0.5	0.5	NUM
fcis-31417	49	35	mm	mm	NOUN
fcis-31417	49	36	,	,	PUNCT
fcis-31417	49	37	matrix	matrix	NOUN
fcis-31417	49	38	512	512	NUM
fcis-31417	49	39	×	×	NOUN
fcis-31417	49	40	512	512	NUM
fcis-31417	49	41	,	,	PUNCT
fcis-31417	49	42	and	and	CCONJ
fcis-31417	49	43	field	field	NOUN
fcis-31417	49	44	of	of	ADP
fcis-31417	49	45	view	view	NOUN
fcis-31417	49	46	350	350	NUM
fcis-31417	49	47	-	-	SYM
fcis-31417	49	48	400	400	NUM
fcis-31417	49	49	mm	mm	NOUN
fcis-31417	49	50	.	.	PUNCT
fcis-31417	50	1	the	the	DET
fcis-31417	50	2	original	original	ADJ
fcis-31417	50	3	dicom	dicom	NOUN
fcis-31417	50	4	images	image	NOUN
fcis-31417	50	5	were	be	AUX
fcis-31417	50	6	imported	import	VERB
fcis-31417	50	7	into	into	ADP
fcis-31417	50	8	itk	itk	PROPN
fcis-31417	50	9	-	-	PUNCT
fcis-31417	50	10	snap	snap	NOUN
fcis-31417	50	11	3.8.0	3.8.0	NUM
fcis-31417	50	12	for	for	ADP
fcis-31417	50	13	preprocessing	preprocesse	VERB
fcis-31417	50	14	:	:	PUNCT
fcis-31417	50	15	(	(	PUNCT
fcis-31417	50	16	1	1	X
fcis-31417	50	17	)	)	PUNCT
fcis-31417	50	18	two	two	NUM
fcis-31417	50	19	physicians	physician	NOUN
fcis-31417	50	20	with	with	ADP
fcis-31417	50	21	more	more	ADJ
fcis-31417	50	22	than	than	ADP
fcis-31417	50	23	5	5	NUM
fcis-31417	50	24	years	year	NOUN
fcis-31417	50	25	of	of	ADP
fcis-31417	50	26	experience	experience	NOUN
fcis-31417	50	27	in	in	ADP
fcis-31417	50	28	chest	chest	NOUN
fcis-31417	50	29	imaging	imaging	NOUN
fcis-31417	50	30	diagnosis	diagnosis	NOUN
fcis-31417	50	31	independently	independently	ADV
fcis-31417	50	32	outlined	outline	VERB
fcis-31417	50	33	the	the	DET
fcis-31417	50	34	tumor	tumor	NOUN
fcis-31417	50	35	roi	roi	NOUN
fcis-31417	50	36	,	,	PUNCT
fcis-31417	50	37	and	and	CCONJ
fcis-31417	50	38	the	the	DET
fcis-31417	50	39	dice	dice	NOUN
fcis-31417	50	40	coefficient	coefficient	NOUN
fcis-31417	50	41	(	(	PUNCT
fcis-31417	50	42	＞0.85	＞0.85	NOUN
fcis-31417	50	43	)	)	PUNCT
fcis-31417	50	44	was	be	AUX
fcis-31417	50	45	used	use	VERB
fcis-31417	50	46	to	to	PART
fcis-31417	50	47	verify	verify	VERB
fcis-31417	50	48	the	the	DET
fcis-31417	50	49	consistency	consistency	NOUN
fcis-31417	50	50	of	of	ADP
fcis-31417	50	51	the	the	DET
fcis-31417	50	52	outline	outline	NOUN
fcis-31417	50	53	;	;	PUNCT
fcis-31417	50	54	(	(	PUNCT
fcis-31417	50	55	2	2	X
fcis-31417	50	56	)	)	PUNCT
fcis-31417	50	57	the	the	DET
fcis-31417	50	58	difference	difference	NOUN
fcis-31417	50	59	in	in	ADP
fcis-31417	50	60	the	the	DET
fcis-31417	50	61	field	field	NOUN
fcis-31417	50	62	of	of	ADP
fcis-31417	50	63	view	view	NOUN
fcis-31417	50	64	of	of	ADP
fcis-31417	50	65	different	different	ADJ
fcis-31417	50	66	devices	device	NOUN
fcis-31417	50	67	was	be	AUX
fcis-31417	50	68	eliminated	eliminate	VERB
fcis-31417	50	69	by	by	ADP
fcis-31417	50	70	coordinate	coordinate	NOUN
fcis-31417	50	71	normalization	normalization	NOUN
fcis-31417	50	72	;	;	PUNCT
fcis-31417	50	73	(	(	PUNCT
fcis-31417	50	74	3	3	X
fcis-31417	50	75	)	)	PUNCT
fcis-31417	50	76	the	the	DET
fcis-31417	50	77	n4	n4	PROPN
fcis-31417	50	78	bias	bias	PROPN
fcis-31417	50	79	field	field	NOUN
fcis-31417	50	80	correction	correction	NOUN
fcis-31417	50	81	algorithm	algorithm	NOUN
fcis-31417	50	82	was	be	AUX
fcis-31417	50	83	used	use	VERB
fcis-31417	50	84	to	to	PART
fcis-31417	50	85	remove	remove	VERB
fcis-31417	50	86	grayscale	grayscale	NOUN
fcis-31417	50	87	inhomogeneity	inhomogeneity	NOUN
fcis-31417	50	88	;	;	PUNCT
fcis-31417	50	89	(	(	PUNCT
fcis-31417	50	90	4	4	X
fcis-31417	50	91	)	)	PUNCT
fcis-31417	50	92	the	the	DET
fcis-31417	50	93	threedimensional	threedimensional	ADJ
fcis-31417	50	94	images	image	NOUN
fcis-31417	50	95	were	be	AUX
fcis-31417	50	96	resampled	resample	VERB
fcis-31417	50	97	to	to	ADP
fcis-31417	50	98	1×1×1	1×1×1	NUM
fcis-31417	50	99	mm³	mm³	NOUN
fcis-31417	50	100	voxels	voxel	NOUN
fcis-31417	50	101	,	,	PUNCT
fcis-31417	50	102	and	and	CCONJ
fcis-31417	50	103	the	the	DET
fcis-31417	50	104	grayscale	grayscale	NOUN
fcis-31417	50	105	value	value	NOUN
fcis-31417	50	106	range	range	NOUN
fcis-31417	50	107	was	be	AUX
fcis-31417	50	108	unified	unified	ADJ
fcis-31417	50	109	to	to	ADP
fcis-31417	50	110	[	[	NOUN
fcis-31417	50	111	-1000,400	-1000,400	PRON
fcis-31417	50	112	]	]	X
fcis-31417	50	113	hu	hu	PROPN
fcis-31417	50	114	.	.	PROPN
fcis-31417	50	115	radiomics	radiomic	NOUN
fcis-31417	50	116	feature	feature	NOUN
fcis-31417	50	117	extraction	extraction	NOUN
fcis-31417	50	118	uses	use	VERB
fcis-31417	50	119	the	the	DET
fcis-31417	50	120	independently	independently	ADV
fcis-31417	50	121	developed	develop	VERB
fcis-31417	50	122	pyradiomics	pyradiomic	NOUN
fcis-31417	50	123	extension	extension	NOUN
fcis-31417	50	124	module	module	NOUN
fcis-31417	50	125	.	.	PUNCT
fcis-31417	51	1	on	on	ADP
fcis-31417	51	2	the	the	DET
fcis-31417	51	3	basis	basis	NOUN
fcis-31417	51	4	of	of	ADP
fcis-31417	51	5	conventional	conventional	ADJ
fcis-31417	51	6	first	first	ADJ
fcis-31417	51	7	-	-	PUNCT
fcis-31417	51	8	order	order	NOUN
fcis-31417	51	9	statistics	statistic	NOUN
fcis-31417	51	10	(	(	PUNCT
fcis-31417	51	11	18	18	NUM
fcis-31417	51	12	items	item	NOUN
fcis-31417	51	13	)	)	PUNCT
fcis-31417	51	14	,	,	PUNCT
fcis-31417	51	15	morphological	morphological	ADJ
fcis-31417	51	16	features	feature	NOUN
fcis-31417	51	17	(	(	PUNCT
fcis-31417	51	18	14	14	NUM
fcis-31417	51	19	items	item	NOUN
fcis-31417	51	20	)	)	PUNCT
fcis-31417	51	21	and	and	CCONJ
fcis-31417	51	22	texture	texture	NOUN
fcis-31417	51	23	features	feature	NOUN
fcis-31417	51	24	(	(	PUNCT
fcis-31417	51	25	73	73	NUM
fcis-31417	51	26	items	item	NOUN
fcis-31417	51	27	)	)	PUNCT
fcis-31417	51	28	,	,	PUNCT
fcis-31417	51	29	the	the	DET
fcis-31417	51	30	following	follow	VERB
fcis-31417	51	31	innovative	innovative	ADJ
fcis-31417	51	32	features	feature	NOUN
fcis-31417	51	33	are	be	AUX
fcis-31417	51	34	introduced	introduce	VERB
fcis-31417	51	35	:	:	PUNCT
fcis-31417	51	36	(	(	PUNCT
fcis-31417	51	37	1	1	X
fcis-31417	51	38	)	)	PUNCT
fcis-31417	51	39	multi	multi	ADJ
fcis-31417	51	40	-	-	ADJ
fcis-31417	51	41	scale	scale	ADJ
fcis-31417	51	42	texture	texture	NOUN
fcis-31417	51	43	features	feature	NOUN
fcis-31417	51	44	based	base	VERB
fcis-31417	51	45	on	on	ADP
fcis-31417	51	46	wavelet	wavelet	NOUN
fcis-31417	51	47	transform	transform	NOUN
fcis-31417	51	48	(	(	PUNCT
fcis-31417	51	49	36	36	NUM
fcis-31417	51	50	items	item	NOUN
fcis-31417	51	51	)	)	PUNCT
fcis-31417	51	52	,	,	PUNCT
fcis-31417	51	53	which	which	PRON
fcis-31417	51	54	capture	capture	VERB
fcis-31417	51	55	tumor	tumor	NOUN
fcis-31417	51	56	heterogeneity	heterogeneity	NOUN
fcis-31417	51	57	at	at	ADP
fcis-31417	51	58	different	different	ADJ
fcis-31417	51	59	spatial	spatial	ADJ
fcis-31417	51	60	frequencies	frequency	NOUN
fcis-31417	51	61	through	through	ADP
fcis-31417	51	62	5	5	NUM
fcis-31417	51	63	-	-	PUNCT
fcis-31417	51	64	layer	layer	NOUN
fcis-31417	51	65	decomposition	decomposition	NOUN
fcis-31417	51	66	;	;	PUNCT
fcis-31417	51	67	(	(	PUNCT
fcis-31417	51	68	2	2	X
fcis-31417	51	69	)	)	PUNCT
fcis-31417	51	70	deep	deep	ADJ
fcis-31417	51	71	learning	learning	NOUN
fcis-31417	51	72	derived	derive	VERB
fcis-31417	51	73	features	feature	NOUN
fcis-31417	51	74	(	(	PUNCT
fcis-31417	51	75	42	42	NUM
fcis-31417	51	76	items	item	NOUN
fcis-31417	51	77	)	)	PUNCT
fcis-31417	51	78	,	,	PUNCT
fcis-31417	51	79	which	which	PRON
fcis-31417	51	80	use	use	VERB
fcis-31417	51	81	the	the	DET
fcis-31417	51	82	pre	pre	ADJ
fcis-31417	51	83	-	-	ADJ
fcis-31417	51	84	trained	train	VERB
fcis-31417	51	85	3d	3d	PROPN
fcis-31417	51	86	resnet50	resnet50	NOUN
fcis-31417	51	87	model	model	NOUN
fcis-31417	51	88	to	to	PART
fcis-31417	51	89	extract	extract	VERB
fcis-31417	51	90	high	high	ADJ
fcis-31417	51	91	-	-	PUNCT
fcis-31417	51	92	level	level	NOUN
fcis-31417	51	93	semantic	semantic	ADJ
fcis-31417	51	94	features	feature	NOUN
fcis-31417	51	95	.	.	PUNCT
fcis-31417	52	1	feature	feature	NOUN
fcis-31417	52	2	screening	screen	VERB
fcis-31417	52	3	is	be	AUX
fcis-31417	52	4	divided	divide	VERB
fcis-31417	52	5	into	into	ADP
fcis-31417	52	6	three	three	NUM
fcis-31417	52	7	steps	step	NOUN
fcis-31417	52	8	:	:	PUNCT
fcis-31417	52	9	(	(	PUNCT
fcis-31417	52	10	1	1	X
fcis-31417	52	11	)	)	PUNCT
fcis-31417	52	12	variance	variance	NOUN
fcis-31417	52	13	inflation	inflation	NOUN
fcis-31417	52	14	factor	factor	NOUN
fcis-31417	52	15	(	(	PUNCT
fcis-31417	52	16	vif	vif	X
fcis-31417	52	17	<	<	X
fcis-31417	52	18	5	5	NUM
fcis-31417	52	19	)	)	PUNCT
fcis-31417	52	20	to	to	PART
fcis-31417	52	21	remove	remove	VERB
fcis-31417	52	22	collinearity	collinearity	NOUN
fcis-31417	52	23	;	;	PUNCT
fcis-31417	52	24	(	(	PUNCT
fcis-31417	52	25	2	2	X
fcis-31417	52	26	)	)	PUNCT
fcis-31417	52	27	univariate	univariate	ADJ
fcis-31417	52	28	cox	cox	PROPN
fcis-31417	52	29	regression	regression	NOUN
fcis-31417	52	30	(	(	PUNCT
fcis-31417	52	31	p	p	X
fcis-31417	52	32	<	<	X
fcis-31417	52	33	0.05	0.05	NUM
fcis-31417	52	34	)	)	PUNCT
fcis-31417	52	35	to	to	PART
fcis-31417	52	36	screen	screen	VERB
fcis-31417	52	37	prognostic	prognostic	PROPN
fcis-31417	52	38	-	-	PUNCT
fcis-31417	52	39	related	relate	VERB
fcis-31417	52	40	features	feature	NOUN
fcis-31417	52	41	;	;	PUNCT
fcis-31417	52	42	(	(	PUNCT
fcis-31417	52	43	3	3	X
fcis-31417	52	44	)	)	PUNCT
fcis-31417	52	45	lasso	lasso	NOUN
fcis-31417	52	46	-	-	PUNCT
fcis-31417	52	47	cox	cox	PROPN
fcis-31417	52	48	algorithm	algorithm	NOUN
fcis-31417	52	49	to	to	PART
fcis-31417	52	50	further	far	ADV
fcis-31417	52	51	reduce	reduce	VERB
fcis-31417	52	52	dimensionality	dimensionality	NOUN
fcis-31417	52	53	,	,	PUNCT
fcis-31417	52	54	and	and	CCONJ
fcis-31417	52	55	finally	finally	ADV
fcis-31417	52	56	retain	retain	VERB
fcis-31417	52	57	28	28	NUM
fcis-31417	52	58	optimal	optimal	ADJ
fcis-31417	52	59	features	feature	NOUN
fcis-31417	52	60	.	.	PUNCT
fcis-31417	53	1	2.3	2.3	NUM
fcis-31417	53	2	.	.	PUNCT
fcis-31417	54	1	liquid	liquid	ADJ
fcis-31417	54	2	biopsy	biopsy	NOUN
fcis-31417	54	3	implementation	implementation	NOUN
fcis-31417	54	4	peripheral	peripheral	ADJ
fcis-31417	54	5	blood	blood	NOUN
fcis-31417	54	6	was	be	AUX
fcis-31417	54	7	collected	collect	VERB
fcis-31417	54	8	within	within	ADP
fcis-31417	54	9	1	1	NUM
fcis-31417	54	10	week	week	NOUN
fcis-31417	54	11	before	before	ADP
fcis-31417	54	12	treatment	treatment	NOUN
fcis-31417	54	13	.	.	PUNCT
fcis-31417	55	1	10	10	NUM
fcis-31417	55	2	ml	ml	NOUN
fcis-31417	55	3	of	of	ADP
fcis-31417	55	4	venous	venous	ADJ
fcis-31417	55	5	blood	blood	NOUN
fcis-31417	55	6	was	be	AUX
fcis-31417	55	7	collected	collect	VERB
fcis-31417	55	8	using	use	VERB
fcis-31417	55	9	streck	streck	NOUN
fcis-31417	55	10	cell	cell	NOUN
fcis-31417	55	11	-	-	PUNCT
fcis-31417	55	12	free	free	ADJ
fcis-31417	55	13	dna	dna	PROPN
fcis-31417	55	14	tubes	tube	NOUN
fcis-31417	55	15	.	.	PUNCT
fcis-31417	56	1	plasma	plasma	PROPN
fcis-31417	56	2	was	be	AUX
fcis-31417	56	3	separated	separate	VERB
fcis-31417	56	4	by	by	ADP
fcis-31417	56	5	centrifugation	centrifugation	NOUN
fcis-31417	56	6	at	at	ADP
fcis-31417	56	7	1600	1600	NUM
fcis-31417	56	8	×	×	NOUN
fcis-31417	56	9	g	g	NOUN
fcis-31417	56	10	for	for	ADP
fcis-31417	56	11	10	10	NUM
fcis-31417	56	12	minutes	minute	NOUN
fcis-31417	56	13	at	at	ADP
fcis-31417	56	14	4	4	NUM
fcis-31417	56	15	°	°	ADP
fcis-31417	56	16	c	c	NOUN
fcis-31417	56	17	within	within	ADP
fcis-31417	56	18	2	2	NUM
fcis-31417	56	19	hours	hour	NOUN
fcis-31417	56	20	.	.	PUNCT
fcis-31417	57	1	the	the	DET
fcis-31417	57	2	supernatant	supernatant	NOUN
fcis-31417	57	3	was	be	AUX
fcis-31417	57	4	centrifuged	centrifuge	VERB
fcis-31417	57	5	again	again	ADV
fcis-31417	57	6	at	at	ADP
fcis-31417	57	7	16000	16000	NUM
fcis-31417	57	8	×	×	NOUN
fcis-31417	57	9	g	g	NOUN
fcis-31417	57	10	for	for	ADP
fcis-31417	57	11	10	10	NUM
fcis-31417	57	12	minutes	minute	NOUN
fcis-31417	57	13	to	to	PART
fcis-31417	57	14	remove	remove	VERB
fcis-31417	57	15	cell	cell	NOUN
fcis-31417	57	16	debris	debris	NOUN
fcis-31417	57	17	and	and	CCONJ
fcis-31417	57	18	stored	store	VERB
fcis-31417	57	19	at	at	ADP
fcis-31417	57	20	-80	-80	PUNCT
fcis-31417	57	21	°	°	PROPN
fcis-31417	57	22	c.	c.	NOUN
fcis-31417	57	23	ctdna	ctdna	PROPN
fcis-31417	57	24	was	be	AUX
fcis-31417	57	25	extracted	extract	VERB
fcis-31417	57	26	from	from	ADP
fcis-31417	57	27	2	2	NUM
fcis-31417	57	28	ml	ml	NOUN
fcis-31417	57	29	of	of	ADP
fcis-31417	57	30	plasma	plasma	NOUN
fcis-31417	57	31	using	use	VERB
fcis-31417	57	32	magmax	magmax	ADJ
fcis-31417	57	33	cell	cell	NOUN
fcis-31417	57	34	-	-	PUNCT
fcis-31417	57	35	free	free	ADJ
fcis-31417	57	36	dna	dna	NOUN
fcis-31417	57	37	isolation	isolation	NOUN
fcis-31417	57	38	kit	kit	NOUN
fcis-31417	57	39	and	and	CCONJ
fcis-31417	57	40	quantified	quantify	VERB
fcis-31417	57	41	by	by	ADP
fcis-31417	57	42	qubit	qubit	NOUN
fcis-31417	57	43	4.0	4.0	NUM
fcis-31417	57	44	.	.	PUNCT
fcis-31417	58	1	the	the	DET
fcis-31417	58	2	concentration	concentration	NOUN
fcis-31417	58	3	was	be	AUX
fcis-31417	58	4	required	require	VERB
fcis-31417	58	5	to	to	PART
fcis-31417	58	6	be	be	AUX
fcis-31417	58	7	≥1	≥1	PROPN
fcis-31417	58	8	ng	ng	PROPN
fcis-31417	58	9	/	/	SYM
fcis-31417	58	10	μl	μl	PROPN
fcis-31417	58	11	.	.	PUNCT
fcis-31417	59	1	a	a	DET
fcis-31417	59	2	customized	customize	VERB
fcis-31417	59	3	lung	lung	NOUN
fcis-31417	59	4	cancer	cancer	NOUN
fcis-31417	59	5	panel	panel	NOUN
fcis-31417	59	6	(	(	PUNCT
fcis-31417	59	7	covering	cover	VERB
fcis-31417	59	8	521	521	NUM
fcis-31417	59	9	tumorrelated	tumorrelate	VERB
fcis-31417	59	10	genes	gene	NOUN
fcis-31417	59	11	)	)	PUNCT
fcis-31417	59	12	was	be	AUX
fcis-31417	59	13	used	use	VERB
fcis-31417	59	14	for	for	ADP
fcis-31417	59	15	targeted	target	VERB
fcis-31417	59	16	capture	capture	NOUN
fcis-31417	59	17	sequencing	sequence	VERB
fcis-31417	59	18	.	.	PUNCT
fcis-31417	60	1	the	the	DET
fcis-31417	60	2	platform	platform	NOUN
fcis-31417	60	3	was	be	AUX
fcis-31417	60	4	illumina	illumina	PROPN
fcis-31417	60	5	novaseq	novaseq	PROPN
fcis-31417	60	6	6000	6000	NUM
fcis-31417	60	7	.	.	PUNCT
fcis-31417	61	1	the	the	DET
fcis-31417	61	2	specific	specific	ADJ
fcis-31417	61	3	steps	step	NOUN
fcis-31417	61	4	were	be	AUX
fcis-31417	61	5	as	as	SCONJ
fcis-31417	61	6	follows	follow	VERB
fcis-31417	61	7	:	:	PUNCT
fcis-31417	61	8	(	(	PUNCT
fcis-31417	61	9	1	1	X
fcis-31417	61	10	)	)	PUNCT
fcis-31417	61	11	construction	construction	NOUN
fcis-31417	61	12	of	of	ADP
fcis-31417	61	13	sequencing	sequence	VERB
fcis-31417	61	14	library	library	NOUN
fcis-31417	61	15	after	after	ADP
fcis-31417	61	16	ctdna	ctdna	NOUN
fcis-31417	61	17	fragmentation	fragmentation	PROPN
fcis-31417	61	18	;	;	PUNCT
fcis-31417	61	19	(	(	PUNCT
fcis-31417	61	20	2	2	X
fcis-31417	61	21	)	)	PUNCT
fcis-31417	61	22	capture	capture	NOUN
fcis-31417	61	23	of	of	ADP
fcis-31417	61	24	target	target	NOUN
fcis-31417	61	25	region	region	NOUN
fcis-31417	61	26	by	by	ADP
fcis-31417	61	27	biotinlabeled	biotinlabele	VERB
fcis-31417	61	28	probe	probe	NOUN
fcis-31417	61	29	;	;	PUNCT
fcis-31417	61	30	(	(	PUNCT
fcis-31417	61	31	3	3	X
fcis-31417	61	32	)	)	PUNCT
fcis-31417	61	33	pcr	pcr	ADJ
fcis-31417	61	34	amplification	amplification	NOUN
fcis-31417	61	35	and	and	CCONJ
fcis-31417	61	36	enrichment	enrichment	NOUN
fcis-31417	61	37	of	of	ADP
fcis-31417	61	38	library	library	NOUN
fcis-31417	61	39	;	;	PUNCT
fcis-31417	61	40	(	(	PUNCT
fcis-31417	61	41	4	4	X
fcis-31417	61	42	)	)	PUNCT
fcis-31417	61	43	pe150	pe150	NOUN
fcis-31417	61	44	sequencing	sequencing	NOUN
fcis-31417	61	45	,	,	PUNCT
fcis-31417	61	46	with	with	ADP
fcis-31417	61	47	an	an	DET
fcis-31417	61	48	average	average	ADJ
fcis-31417	61	49	sequencing	sequence	VERB
fcis-31417	61	50	depth	depth	NOUN
fcis-31417	61	51	of	of	ADP
fcis-31417	61	52	≥1000×	≥1000×	NOUN
fcis-31417	61	53	and	and	CCONJ
fcis-31417	61	54	coverage	coverage	NOUN
fcis-31417	61	55	uniformity	uniformity	NOUN
fcis-31417	61	56	of	of	ADP
fcis-31417	61	57	>	>	X
fcis-31417	61	58	95	95	NUM
fcis-31417	61	59	%	%	NOUN
fcis-31417	61	60	.	.	PUNCT
fcis-31417	62	1	the	the	DET
fcis-31417	62	2	gatk	gatk	NOUN
fcis-31417	62	3	4.2.0	4.2.0	NUM
fcis-31417	62	4	process	process	NOUN
fcis-31417	62	5	was	be	AUX
fcis-31417	62	6	used	use	VERB
fcis-31417	62	7	for	for	ADP
fcis-31417	62	8	data	datum	NOUN
fcis-31417	62	9	analysis	analysis	NOUN
fcis-31417	62	10	to	to	ADP
fcis-31417	62	11	screen	screen	NOUN
fcis-31417	62	12	somatic	somatic	ADJ
fcis-31417	62	13	mutations	mutation	NOUN
fcis-31417	62	14	with	with	ADP
fcis-31417	62	15	mutant	mutant	ADJ
fcis-31417	62	16	allele	allele	NOUN
fcis-31417	62	17	frequency	frequency	NOUN
fcis-31417	62	18	(	(	PUNCT
fcis-31417	62	19	maf	maf	PROPN
fcis-31417	62	20	)	)	PUNCT
fcis-31417	62	21	≥	≥	NOUN
fcis-31417	62	22	0.5	0.5	NUM
fcis-31417	62	23	%	%	NOUN
fcis-31417	62	24	and	and	CCONJ
fcis-31417	62	25	calculate	calculate	ADJ
fcis-31417	62	26	indicators	indicator	NOUN
fcis-31417	62	27	such	such	ADJ
fcis-31417	62	28	as	as	ADP
fcis-31417	62	29	tumor	tumor	NOUN
fcis-31417	62	30	mutation	mutation	NOUN
fcis-31417	62	31	burden	burden	NOUN
fcis-31417	62	32	(	(	PUNCT
fcis-31417	62	33	tmb	tmb	NOUN
fcis-31417	62	34	)	)	PUNCT
fcis-31417	62	35	and	and	CCONJ
fcis-31417	62	36	microsatellite	microsatellite	ADJ
fcis-31417	62	37	instability	instability	NOUN
fcis-31417	62	38	(	(	PUNCT
fcis-31417	62	39	msi	msi	PROPN
fcis-31417	62	40	)	)	PUNCT
fcis-31417	62	41	.	.	PUNCT
fcis-31417	63	1	exosome	exosome	PROPN
fcis-31417	63	2	detection	detection	NOUN
fcis-31417	63	3	was	be	AUX
fcis-31417	63	4	performed	perform	VERB
fcis-31417	63	5	simultaneously	simultaneously	ADV
fcis-31417	63	6	:	:	PUNCT
fcis-31417	63	7	plasma	plasma	NOUN
fcis-31417	63	8	exosomes	exosome	NOUN
fcis-31417	63	9	were	be	AUX
fcis-31417	63	10	separated	separate	VERB
fcis-31417	63	11	by	by	ADP
fcis-31417	63	12	ultra	ultra	ADJ
fcis-31417	63	13	-	-	ADJ
fcis-31417	63	14	high	high	ADJ
fcis-31417	63	15	-	-	PUNCT
fcis-31417	63	16	speed	speed	NOUN
fcis-31417	63	17	centrifugation	centrifugation	NOUN
fcis-31417	63	18	(	(	PUNCT
fcis-31417	63	19	100,000	100,000	NUM
fcis-31417	63	20	×	×	NOUN
fcis-31417	63	21	g	g	NOUN
fcis-31417	63	22	,	,	PUNCT
fcis-31417	63	23	70	70	NUM
fcis-31417	63	24	minutes	minute	NOUN
fcis-31417	63	25	)	)	PUNCT
fcis-31417	63	26	,	,	PUNCT
fcis-31417	63	27	the	the	DET
fcis-31417	63	28	morphology	morphology	NOUN
fcis-31417	63	29	was	be	AUX
fcis-31417	63	30	observed	observe	VERB
fcis-31417	63	31	by	by	ADP
fcis-31417	63	32	transmission	transmission	NOUN
fcis-31417	63	33	electron	electron	NOUN
fcis-31417	63	34	microscopy	microscopy	NOUN
fcis-31417	63	35	,	,	PUNCT
fcis-31417	63	36	and	and	CCONJ
fcis-31417	63	37	the	the	DET
fcis-31417	63	38	concentration	concentration	NOUN
fcis-31417	63	39	and	and	CCONJ
fcis-31417	63	40	particle	particle	NOUN
fcis-31417	63	41	size	size	NOUN
fcis-31417	63	42	distribution	distribution	NOUN
fcis-31417	63	43	were	be	AUX
fcis-31417	63	44	determined	determine	VERB
fcis-31417	63	45	by	by	ADP
fcis-31417	63	46	nanoparticle	nanoparticle	NOUN
fcis-31417	63	47	tracking	track	VERB
fcis-31417	63	48	analysis	analysis	NOUN
fcis-31417	63	49	(	(	PUNCT
fcis-31417	63	50	nta	nta	PROPN
fcis-31417	63	51	)	)	PUNCT
fcis-31417	63	52	.	.	PUNCT
fcis-31417	64	1	the	the	DET
fcis-31417	64	2	expression	expression	NOUN
fcis-31417	64	3	level	level	NOUN
fcis-31417	64	4	of	of	ADP
fcis-31417	64	5	exosome	exosome	PROPN
fcis-31417	64	6	surface	surface	NOUN
fcis-31417	64	7	markers	marker	NOUN
fcis-31417	64	8	(	(	PUNCT
fcis-31417	64	9	egfr	egfr	X
fcis-31417	64	10	,	,	PUNCT
fcis-31417	64	11	pd	pd	PROPN
fcis-31417	64	12	-	-	PUNCT
fcis-31417	64	13	l1	l1	PROPN
fcis-31417	64	14	)	)	PUNCT
fcis-31417	64	15	was	be	AUX
fcis-31417	64	16	detected	detect	VERB
fcis-31417	64	17	by	by	ADP
fcis-31417	64	18	exoview	exoview	NOUN
fcis-31417	64	19	r100	r100	PROPN
fcis-31417	64	20	,	,	PUNCT
fcis-31417	64	21	and	and	CCONJ
fcis-31417	64	22	the	the	DET
fcis-31417	64	23	fluorescence	fluorescence	NOUN
fcis-31417	64	24	intensity	intensity	NOUN
fcis-31417	64	25	was	be	AUX
fcis-31417	64	26	used	use	VERB
fcis-31417	64	27	for	for	ADP
fcis-31417	64	28	quantification	quantification	NOUN
fcis-31417	64	29	.	.	PUNCT
fcis-31417	65	1	2.4	2.4	NUM
fcis-31417	65	2	.	.	PUNCT
fcis-31417	65	3	multimodal	multimodal	NOUN
fcis-31417	65	4	model	model	NOUN
fcis-31417	65	5	construction	construction	NOUN
fcis-31417	65	6	a	a	DET
fcis-31417	65	7	two	two	NUM
fcis-31417	65	8	-	-	PUNCT
fcis-31417	65	9	stage	stage	NOUN
fcis-31417	65	10	fusion	fusion	NOUN
fcis-31417	65	11	strategy	strategy	NOUN
fcis-31417	65	12	was	be	AUX
fcis-31417	65	13	adopted	adopt	VERB
fcis-31417	65	14	:	:	PUNCT
fcis-31417	65	15	the	the	DET
fcis-31417	65	16	first	first	ADJ
fcis-31417	65	17	stage	stage	NOUN
fcis-31417	65	18	constructed	construct	VERB
fcis-31417	65	19	the	the	DET
fcis-31417	65	20	imaging	imaging	NOUN
fcis-31417	65	21	omics	omic	NOUN
fcis-31417	65	22	model	model	NOUN
fcis-31417	65	23	and	and	CCONJ
fcis-31417	65	24	the	the	DET
fcis-31417	65	25	liquid	liquid	ADJ
fcis-31417	65	26	biopsy	biopsy	NOUN
fcis-31417	65	27	model	model	NOUN
fcis-31417	65	28	respectively	respectively	ADV
fcis-31417	65	29	,	,	PUNCT
fcis-31417	65	30	and	and	CCONJ
fcis-31417	65	31	the	the	DET
fcis-31417	65	32	second	second	ADJ
fcis-31417	65	33	stage	stage	NOUN
fcis-31417	65	34	achieved	achieve	VERB
fcis-31417	65	35	featurelevel	featurelevel	NOUN
fcis-31417	65	36	fusion	fusion	NOUN
fcis-31417	65	37	through	through	ADP
fcis-31417	65	38	the	the	DET
fcis-31417	65	39	attention	attention	NOUN
fcis-31417	65	40	mechanism	mechanism	NOUN
fcis-31417	65	41	[	[	X
fcis-31417	65	42	7	7	NUM
fcis-31417	65	43	]	]	PUNCT
fcis-31417	65	44	.	.	PUNCT
fcis-31417	66	1	extreme	extreme	ADJ
fcis-31417	66	2	gradient	gradient	NOUN
fcis-31417	66	3	boosting	boost	VERB
fcis-31417	66	4	(	(	PUNCT
fcis-31417	66	5	xgboost	xgboost	X
fcis-31417	66	6	)	)	PUNCT
fcis-31417	66	7	was	be	AUX
fcis-31417	66	8	selected	select	VERB
fcis-31417	66	9	as	as	ADP
fcis-31417	66	10	the	the	DET
fcis-31417	66	11	basic	basic	ADJ
fcis-31417	66	12	model	model	NOUN
fcis-31417	66	13	because	because	SCONJ
fcis-31417	66	14	it	it	PRON
fcis-31417	66	15	showed	show	VERB
fcis-31417	66	16	better	well	ADJ
fcis-31417	66	17	nonlinear	nonlinear	ADJ
fcis-31417	66	18	fitting	fitting	ADJ
fcis-31417	66	19	ability	ability	NOUN
fcis-31417	66	20	than	than	ADP
fcis-31417	66	21	the	the	DET
fcis-31417	66	22	cox	cox	PROPN
fcis-31417	66	23	proportional	proportional	PROPN
fcis-31417	66	24	hazard	hazard	NOUN
fcis-31417	66	25	model	model	NOUN
fcis-31417	66	26	in	in	ADP
fcis-31417	66	27	survival	survival	NOUN
fcis-31417	66	28	analysis	analysis	NOUN
fcis-31417	66	29	.	.	PUNCT
fcis-31417	67	1	the	the	DET
fcis-31417	67	2	data	datum	NOUN
fcis-31417	67	3	set	set	VERB
fcis-31417	67	4	was	be	AUX
fcis-31417	67	5	randomly	randomly	ADV
fcis-31417	67	6	divided	divide	VERB
fcis-31417	67	7	into	into	ADP
fcis-31417	67	8	a	a	DET
fcis-31417	67	9	training	training	NOUN
fcis-31417	67	10	set	set	NOUN
fcis-31417	67	11	(	(	PUNCT
fcis-31417	67	12	512	512	NUM
fcis-31417	67	13	cases	case	NOUN
fcis-31417	67	14	)	)	PUNCT
fcis-31417	67	15	and	and	CCONJ
fcis-31417	67	16	a	a	DET
fcis-31417	67	17	validation	validation	NOUN
fcis-31417	67	18	set	set	NOUN
fcis-31417	67	19	(	(	PUNCT
fcis-31417	67	20	219	219	NUM
fcis-31417	67	21	cases	case	NOUN
fcis-31417	67	22	)	)	PUNCT
fcis-31417	67	23	in	in	ADP
fcis-31417	67	24	a	a	DET
fcis-31417	67	25	ratio	ratio	NOUN
fcis-31417	67	26	of	of	ADP
fcis-31417	67	27	7:3	7:3	NUM
fcis-31417	67	28	,	,	PUNCT
fcis-31417	67	29	and	and	CCONJ
fcis-31417	67	30	5fold	5fold	NUM
fcis-31417	67	31	cross	cross	NOUN
fcis-31417	67	32	-	-	ADJ
fcis-31417	67	33	validation	validation	NOUN
fcis-31417	67	34	was	be	AUX
fcis-31417	67	35	used	use	VERB
fcis-31417	67	36	to	to	PART
fcis-31417	67	37	optimize	optimize	VERB
fcis-31417	67	38	the	the	DET
fcis-31417	67	39	training	training	NOUN
fcis-31417	67	40	parameters	parameter	NOUN
fcis-31417	67	41	:	:	PUNCT
fcis-31417	67	42	learning	learn	VERB
fcis-31417	67	43	rate	rate	NOUN
fcis-31417	67	44	0.01	0.01	NUM
fcis-31417	67	45	,	,	PUNCT
fcis-31417	67	46	maximum	maximum	ADJ
fcis-31417	67	47	depth	depth	NOUN
fcis-31417	67	48	5	5	NUM
fcis-31417	67	49	,	,	PUNCT
fcis-31417	67	50	number	number	NOUN
fcis-31417	67	51	of	of	ADP
fcis-31417	67	52	trees	tree	NOUN
fcis-31417	67	53	1000	1000	NUM
fcis-31417	67	54	,	,	PUNCT
fcis-31417	67	55	and	and	CCONJ
fcis-31417	67	56	subsampling	subsample	VERB
fcis-31417	67	57	ratio	ratio	NOUN
fcis-31417	67	58	0.8	0.8	NUM
fcis-31417	67	59	.	.	PUNCT
fcis-31417	68	1	the	the	DET
fcis-31417	68	2	attention	attention	NOUN
fcis-31417	68	3	module	module	NOUN
fcis-31417	68	4	is	be	AUX
fcis-31417	68	5	designed	design	VERB
fcis-31417	68	6	as	as	SCONJ
fcis-31417	68	7	follows	follow	VERB
fcis-31417	68	8	:	:	PUNCT
fcis-31417	68	9	after	after	ADP
fcis-31417	68	10	linear	linear	ADJ
fcis-31417	68	11	transformation	transformation	NOUN
fcis-31417	68	12	of	of	ADP
fcis-31417	68	13	radiomics	radiomic	NOUN
fcis-31417	68	14	features	feature	NOUN
fcis-31417	68	15	(	(	PUNCT
fcis-31417	68	16	28	28	NUM
fcis-31417	68	17	items	item	NOUN
fcis-31417	68	18	)	)	PUNCT
fcis-31417	68	19	and	and	CCONJ
fcis-31417	68	20	liquid	liquid	ADJ
fcis-31417	68	21	biopsy	biopsy	NOUN
fcis-31417	68	22	features	feature	NOUN
fcis-31417	68	23	(	(	PUNCT
fcis-31417	68	24	32	32	NUM
fcis-31417	68	25	items	item	NOUN
fcis-31417	68	26	,	,	PUNCT
fcis-31417	68	27	including	include	VERB
fcis-31417	68	28	21	21	NUM
fcis-31417	68	29	ctdna	ctdna	NOUN
fcis-31417	68	30	indicators	indicator	NOUN
fcis-31417	68	31	and	and	CCONJ
fcis-31417	68	32	11	11	NUM
fcis-31417	68	33	exosome	exosome	NOUN
fcis-31417	68	34	indicators	indicator	NOUN
fcis-31417	68	35	)	)	PUNCT
fcis-31417	68	36	,	,	PUNCT
fcis-31417	68	37	dynamic	dynamic	ADJ
fcis-31417	68	38	weights	weight	NOUN
fcis-31417	68	39	(	(	PUNCT
fcis-31417	68	40	α	α	NOUN
fcis-31417	68	41	image	image	NOUN
fcis-31417	68	42	+	+	X
fcis-31417	68	43	β	β	X
fcis-31417	68	44	liquid	liquid	NOUN
fcis-31417	68	45	=	=	SYM
fcis-31417	68	46	1	1	X
fcis-31417	68	47	)	)	PUNCT
fcis-31417	68	48	are	be	AUX
fcis-31417	68	49	generated	generate	VERB
fcis-31417	68	50	through	through	ADP
fcis-31417	68	51	the	the	DET
fcis-31417	68	52	softmax	softmax	NOUN
fcis-31417	68	53	function	function	NOUN
fcis-31417	68	54	,	,	PUNCT
fcis-31417	68	55	and	and	CCONJ
fcis-31417	68	56	the	the	DET
fcis-31417	68	57	weights	weight	NOUN
fcis-31417	68	58	are	be	AUX
fcis-31417	68	59	adaptively	adaptively	ADV
fcis-31417	68	60	adjusted	adjust	VERB
fcis-31417	68	61	with	with	ADP
fcis-31417	68	62	the	the	DET
fcis-31417	68	63	distribution	distribution	NOUN
fcis-31417	68	64	of	of	ADP
fcis-31417	68	65	sample	sample	NOUN
fcis-31417	68	66	features	feature	NOUN
fcis-31417	68	67	.	.	PUNCT
fcis-31417	69	1	model	model	NOUN
fcis-31417	69	2	evaluation	evaluation	NOUN
fcis-31417	69	3	indicators	indicator	NOUN
fcis-31417	69	4	include	include	VERB
fcis-31417	69	5	:	:	PUNCT
fcis-31417	69	6	consistency	consistency	NOUN
fcis-31417	69	7	index	index	NOUN
fcis-31417	69	8	(	(	PUNCT
fcis-31417	69	9	cindex	cindex	NOUN
fcis-31417	69	10	)	)	PUNCT
fcis-31417	69	11	,	,	PUNCT
fcis-31417	69	12	root	root	NOUN
fcis-31417	69	13	mean	mean	VERB
fcis-31417	69	14	square	square	ADJ
fcis-31417	69	15	error	error	NOUN
fcis-31417	69	16	(	(	PUNCT
fcis-31417	69	17	rmse	rmse	NOUN
fcis-31417	69	18	)	)	PUNCT
fcis-31417	69	19	,	,	PUNCT
fcis-31417	69	20	and	and	CCONJ
fcis-31417	69	21	1	1	NUM
fcis-31417	69	22	-	-	PUNCT
fcis-31417	69	23	year/3	year/3	NUM
fcis-31417	69	24	-	-	PUNCT
fcis-31417	69	25	year	year	NOUN
fcis-31417	69	26	survival	survival	NOUN
fcis-31417	69	27	rate	rate	NOUN
fcis-31417	69	28	prediction	prediction	NOUN
fcis-31417	69	29	accuracy	accuracy	NOUN
fcis-31417	69	30	.	.	PUNCT
fcis-31417	70	1	to	to	PART
fcis-31417	70	2	verify	verify	VERB
fcis-31417	70	3	the	the	DET
fcis-31417	70	4	multimodal	multimodal	NOUN
fcis-31417	70	5	advantages	advantage	NOUN
fcis-31417	70	6	,	,	PUNCT
fcis-31417	70	7	a	a	DET
fcis-31417	70	8	single	single	ADJ
fcis-31417	70	9	imaging	imaging	NOUN
fcis-31417	70	10	model	model	NOUN
fcis-31417	70	11	(	(	PUNCT
fcis-31417	70	12	radiomic	radiomic	ADJ
fcis-31417	70	13	features	feature	VERB
fcis-31417	70	14	only	only	ADV
fcis-31417	70	15	)	)	PUNCT
fcis-31417	70	16	and	and	CCONJ
fcis-31417	70	17	a	a	DET
fcis-31417	70	18	single	single	ADJ
fcis-31417	70	19	liquid	liquid	ADJ
fcis-31417	70	20	model	model	NOUN
fcis-31417	70	21	(	(	PUNCT
fcis-31417	70	22	liquid	liquid	ADJ
fcis-31417	70	23	biopsy	biopsy	NOUN
fcis-31417	70	24	features	feature	VERB
fcis-31417	70	25	only	only	ADV
fcis-31417	70	26	)	)	PUNCT
fcis-31417	70	27	were	be	AUX
fcis-31417	70	28	simultaneously	simultaneously	ADV
fcis-31417	70	29	constructed	construct	VERB
fcis-31417	70	30	as	as	ADP
fcis-31417	70	31	controls	control	NOUN
fcis-31417	70	32	,	,	PUNCT
fcis-31417	70	33	and	and	CCONJ
fcis-31417	70	34	the	the	DET
fcis-31417	70	35	delong	delong	PROPN
fcis-31417	70	36	test	test	NOUN
fcis-31417	70	37	was	be	AUX
fcis-31417	70	38	used	use	VERB
fcis-31417	70	39	to	to	PART
fcis-31417	70	40	compare	compare	VERB
fcis-31417	70	41	the	the	DET
fcis-31417	70	42	performance	performance	NOUN
fcis-31417	70	43	differences	difference	NOUN
fcis-31417	70	44	of	of	ADP
fcis-31417	70	45	the	the	DET
fcis-31417	70	46	models	model	NOUN
fcis-31417	70	47	.	.	PUNCT
fcis-31417	71	1	p	p	X
fcis-31417	71	2	<	<	X
fcis-31417	71	3	0.05	0.05	NUM
fcis-31417	71	4	was	be	AUX
fcis-31417	71	5	considered	consider	VERB
fcis-31417	71	6	statistically	statistically	ADV
fcis-31417	71	7	significant	significant	ADJ
fcis-31417	71	8	.	.	PUNCT
fcis-31417	72	1	all	all	DET
fcis-31417	72	2	analyses	analysis	NOUN
fcis-31417	72	3	were	be	AUX
fcis-31417	72	4	completed	complete	VERB
fcis-31417	72	5	using	use	VERB
fcis-31417	72	6	python	python	NOUN
fcis-31417	72	7	3.8.10	3.8.10	NUM
fcis-31417	72	8	and	and	CCONJ
fcis-31417	72	9	r	r	NOUN
fcis-31417	72	10	4.2.1	4.2.1	NUM
fcis-31417	72	11	,	,	PUNCT
fcis-31417	72	12	and	and	CCONJ
fcis-31417	72	13	the	the	DET
fcis-31417	72	14	core	core	NOUN
fcis-31417	72	15	code	code	NOUN
fcis-31417	72	16	was	be	AUX
fcis-31417	72	17	implemented	implement	VERB
fcis-31417	72	18	based	base	VERB
fcis-31417	72	19	on	on	ADP
fcis-31417	72	20	the	the	DET
fcis-31417	72	21	pytorch	pytorch	NOUN
fcis-31417	72	22	1.10.0	1.10.0	NUM
fcis-31417	72	23	framework	framework	NOUN
fcis-31417	72	24	.	.	PUNCT
fcis-31417	73	1	36	36	NUM
fcis-31417	73	2	3	3	NUM
fcis-31417	73	3	.	.	PUNCT
fcis-31417	73	4	experimental	experimental	ADJ
fcis-31417	73	5	results	result	NOUN
fcis-31417	73	6	3.1	3.1	NUM
fcis-31417	73	7	.	.	PUNCT
fcis-31417	73	8	model	model	NOUN
fcis-31417	73	9	performance	performance	NOUN
fcis-31417	73	10	evaluation	evaluation	NOUN
fcis-31417	73	11	indicators	indicator	NOUN
fcis-31417	73	12	accuracy	accuracy	NOUN
fcis-31417	73	13	is	be	AUX
fcis-31417	73	14	calculated	calculate	VERB
fcis-31417	73	15	by	by	ADP
fcis-31417	73	16	the	the	DET
fcis-31417	73	17	ratio	ratio	NOUN
fcis-31417	73	18	of	of	ADP
fcis-31417	73	19	the	the	DET
fcis-31417	73	20	number	number	NOUN
fcis-31417	73	21	of	of	ADP
fcis-31417	73	22	samples	sample	NOUN
fcis-31417	73	23	with	with	ADP
fcis-31417	73	24	an	an	DET
fcis-31417	73	25	error	error	NOUN
fcis-31417	73	26	between	between	ADP
fcis-31417	73	27	the	the	DET
fcis-31417	73	28	predicted	predict	VERB
fcis-31417	73	29	survival	survival	NOUN
fcis-31417	73	30	period	period	NOUN
fcis-31417	73	31	and	and	CCONJ
fcis-31417	73	32	the	the	DET
fcis-31417	73	33	actual	actual	ADJ
fcis-31417	73	34	survival	survival	NOUN
fcis-31417	73	35	period	period	NOUN
fcis-31417	73	36	within	within	ADP
fcis-31417	73	37	±3	±3	ADJ
fcis-31417	73	38	months	month	NOUN
fcis-31417	73	39	to	to	ADP
fcis-31417	73	40	the	the	DET
fcis-31417	73	41	total	total	ADJ
fcis-31417	73	42	number	number	NOUN
fcis-31417	73	43	of	of	ADP
fcis-31417	73	44	samples	sample	NOUN
fcis-31417	73	45	.	.	PUNCT
fcis-31417	74	1	this	this	DET
fcis-31417	74	2	indicator	indicator	NOUN
fcis-31417	74	3	can	can	AUX
fcis-31417	74	4	intuitively	intuitively	ADV
fcis-31417	74	5	reflect	reflect	VERB
fcis-31417	74	6	the	the	DET
fcis-31417	74	7	quantitative	quantitative	ADJ
fcis-31417	74	8	prediction	prediction	NOUN
fcis-31417	74	9	ability	ability	NOUN
fcis-31417	74	10	of	of	ADP
fcis-31417	74	11	the	the	DET
fcis-31417	74	12	model	model	NOUN
fcis-31417	74	13	for	for	ADP
fcis-31417	74	14	survival	survival	NOUN
fcis-31417	74	15	period	period	NOUN
fcis-31417	74	16	.	.	PUNCT
fcis-31417	75	1	the	the	DET
fcis-31417	75	2	consistency	consistency	NOUN
fcis-31417	75	3	index	index	NOUN
fcis-31417	75	4	(	(	PUNCT
fcis-31417	75	5	c	c	NOUN
fcis-31417	75	6	-	-	PUNCT
fcis-31417	75	7	index	index	NOUN
fcis-31417	75	8	)	)	PUNCT
fcis-31417	75	9	is	be	AUX
fcis-31417	75	10	calculated	calculate	VERB
fcis-31417	75	11	by	by	ADP
fcis-31417	75	12	comparing	compare	VERB
fcis-31417	75	13	the	the	DET
fcis-31417	75	14	ranking	rank	VERB
fcis-31417	75	15	consistency	consistency	NOUN
fcis-31417	75	16	of	of	ADP
fcis-31417	75	17	the	the	DET
fcis-31417	75	18	predicted	predict	VERB
fcis-31417	75	19	survival	survival	NOUN
fcis-31417	75	20	period	period	NOUN
fcis-31417	75	21	and	and	CCONJ
fcis-31417	75	22	the	the	DET
fcis-31417	75	23	actual	actual	ADJ
fcis-31417	75	24	survival	survival	NOUN
fcis-31417	75	25	period	period	NOUN
fcis-31417	75	26	of	of	ADP
fcis-31417	75	27	any	any	DET
fcis-31417	75	28	two	two	NUM
fcis-31417	75	29	samples	sample	NOUN
fcis-31417	75	30	.	.	PUNCT
fcis-31417	76	1	the	the	DET
fcis-31417	76	2	value	value	NOUN
fcis-31417	76	3	range	range	NOUN
fcis-31417	76	4	is	be	AUX
fcis-31417	76	5	0.5	0.5	NUM
fcis-31417	76	6	-	-	SYM
fcis-31417	76	7	1.0	1.0	NUM
fcis-31417	76	8	.	.	PUNCT
fcis-31417	77	1	the	the	PRON
fcis-31417	77	2	closer	close	ADJ
fcis-31417	77	3	the	the	DET
fcis-31417	77	4	c	c	NOUN
fcis-31417	77	5	-	-	PUNCT
fcis-31417	77	6	index	index	NOUN
fcis-31417	77	7	is	be	AUX
fcis-31417	77	8	to	to	ADP
fcis-31417	77	9	1.0	1.0	NUM
fcis-31417	77	10	,	,	PUNCT
fcis-31417	77	11	the	the	PRON
fcis-31417	77	12	better	well	ADJ
fcis-31417	77	13	the	the	DET
fcis-31417	77	14	ranking	rank	VERB
fcis-31417	77	15	prediction	prediction	NOUN
fcis-31417	77	16	performance	performance	NOUN
fcis-31417	77	17	of	of	ADP
fcis-31417	77	18	the	the	DET
fcis-31417	77	19	model	model	NOUN
fcis-31417	77	20	.	.	PUNCT
fcis-31417	78	1	this	this	DET
fcis-31417	78	2	study	study	NOUN
fcis-31417	78	3	also	also	ADV
fcis-31417	78	4	uses	use	VERB
fcis-31417	78	5	the	the	DET
fcis-31417	78	6	root	root	NOUN
fcis-31417	78	7	mean	mean	ADJ
fcis-31417	78	8	square	square	ADJ
fcis-31417	78	9	error	error	NOUN
fcis-31417	78	10	(	(	PUNCT
fcis-31417	78	11	rmse	rmse	NOUN
fcis-31417	78	12	)	)	PUNCT
fcis-31417	78	13	to	to	PART
fcis-31417	78	14	evaluate	evaluate	VERB
fcis-31417	78	15	the	the	DET
fcis-31417	78	16	degree	degree	NOUN
fcis-31417	78	17	of	of	ADP
fcis-31417	78	18	deviation	deviation	NOUN
fcis-31417	78	19	between	between	ADP
fcis-31417	78	20	the	the	DET
fcis-31417	78	21	predicted	predict	VERB
fcis-31417	78	22	value	value	NOUN
fcis-31417	78	23	and	and	CCONJ
fcis-31417	78	24	the	the	DET
fcis-31417	78	25	actual	actual	ADJ
fcis-31417	78	26	value	value	NOUN
fcis-31417	78	27	[	[	X
fcis-31417	78	28	8	8	NUM
fcis-31417	78	29	]	]	PUNCT
fcis-31417	78	30	.	.	PUNCT
fcis-31417	79	1	the	the	DET
fcis-31417	79	2	smaller	small	ADJ
fcis-31417	79	3	the	the	DET
fcis-31417	79	4	rmse	rmse	NOUN
fcis-31417	79	5	,	,	PUNCT
fcis-31417	79	6	the	the	PRON
fcis-31417	79	7	higher	high	ADJ
fcis-31417	79	8	the	the	DET
fcis-31417	79	9	quantitative	quantitative	ADJ
fcis-31417	79	10	prediction	prediction	NOUN
fcis-31417	79	11	accuracy	accuracy	NOUN
fcis-31417	79	12	of	of	ADP
fcis-31417	79	13	the	the	DET
fcis-31417	79	14	model	model	NOUN
fcis-31417	79	15	.	.	PUNCT
fcis-31417	80	1	in	in	ADP
fcis-31417	80	2	addition	addition	NOUN
fcis-31417	80	3	,	,	PUNCT
fcis-31417	80	4	the	the	DET
fcis-31417	80	5	1	1	NUM
fcis-31417	80	6	-	-	PUNCT
fcis-31417	80	7	year	year	NOUN
fcis-31417	80	8	and	and	CCONJ
fcis-31417	80	9	3	3	NUM
fcis-31417	80	10	-	-	PUNCT
fcis-31417	80	11	year	year	NOUN
fcis-31417	80	12	survival	survival	NOUN
fcis-31417	80	13	rate	rate	NOUN
fcis-31417	80	14	prediction	prediction	NOUN
fcis-31417	80	15	accuracy	accuracy	NOUN
fcis-31417	80	16	is	be	AUX
fcis-31417	80	17	introduced	introduce	VERB
fcis-31417	80	18	as	as	ADP
fcis-31417	80	19	clinical	clinical	ADJ
fcis-31417	80	20	decision	decision	NOUN
fcis-31417	80	21	-	-	PUNCT
fcis-31417	80	22	making	make	VERB
fcis-31417	80	23	related	related	ADJ
fcis-31417	80	24	indicators	indicator	NOUN
fcis-31417	80	25	.	.	PUNCT
fcis-31417	81	1	the	the	DET
fcis-31417	81	2	survival	survival	NOUN
fcis-31417	81	3	rate	rate	NOUN
fcis-31417	81	4	prediction	prediction	NOUN
fcis-31417	81	5	is	be	AUX
fcis-31417	81	6	calculated	calculate	VERB
fcis-31417	81	7	using	use	VERB
fcis-31417	81	8	the	the	DET
fcis-31417	81	9	kaplan	kaplan	PROPN
fcis-31417	81	10	-	-	PUNCT
fcis-31417	81	11	meier	meier	PROPN
fcis-31417	81	12	method	method	NOUN
fcis-31417	81	13	combined	combine	VERB
fcis-31417	81	14	with	with	ADP
fcis-31417	81	15	the	the	DET
fcis-31417	81	16	prediction	prediction	NOUN
fcis-31417	81	17	probability	probability	NOUN
fcis-31417	81	18	threshold	threshold	NOUN
fcis-31417	81	19	(	(	PUNCT
fcis-31417	81	20	>	>	SYM
fcis-31417	81	21	50	50	NUM
fcis-31417	81	22	%	%	NOUN
fcis-31417	81	23	is	be	AUX
fcis-31417	81	24	considered	consider	VERB
fcis-31417	81	25	as	as	ADP
fcis-31417	81	26	survival	survival	NOUN
fcis-31417	81	27	)	)	PUNCT
fcis-31417	81	28	.	.	PUNCT
fcis-31417	82	1	the	the	DET
fcis-31417	82	2	performance	performance	NOUN
fcis-31417	82	3	indicators	indicator	NOUN
fcis-31417	82	4	of	of	ADP
fcis-31417	82	5	the	the	DET
fcis-31417	82	6	multimodal	multimodal	NOUN
fcis-31417	82	7	model	model	NOUN
fcis-31417	82	8	in	in	ADP
fcis-31417	82	9	the	the	DET
fcis-31417	82	10	training	training	NOUN
fcis-31417	82	11	set	set	NOUN
fcis-31417	82	12	and	and	CCONJ
fcis-31417	82	13	the	the	DET
fcis-31417	82	14	validation	validation	NOUN
fcis-31417	82	15	set	set	NOUN
fcis-31417	82	16	are	be	AUX
fcis-31417	82	17	shown	show	VERB
fcis-31417	82	18	in	in	ADP
fcis-31417	82	19	table	table	NOUN
fcis-31417	82	20	3.1	3.1	NUM
fcis-31417	82	21	.	.	PUNCT
fcis-31417	83	1	in	in	ADP
fcis-31417	83	2	the	the	DET
fcis-31417	83	3	training	training	NOUN
fcis-31417	83	4	set	set	NOUN
fcis-31417	83	5	,	,	PUNCT
fcis-31417	83	6	the	the	DET
fcis-31417	83	7	accuracy	accuracy	NOUN
fcis-31417	83	8	of	of	ADP
fcis-31417	83	9	the	the	DET
fcis-31417	83	10	model	model	NOUN
fcis-31417	83	11	was	be	AUX
fcis-31417	83	12	86.3	86.3	NUM
fcis-31417	83	13	%	%	NOUN
fcis-31417	83	14	,	,	PUNCT
fcis-31417	83	15	the	the	DET
fcis-31417	83	16	cindex	cindex	NOUN
fcis-31417	83	17	reached	reach	VERB
fcis-31417	83	18	0.892	0.892	NUM
fcis-31417	83	19	,	,	PUNCT
fcis-31417	83	20	and	and	CCONJ
fcis-31417	83	21	the	the	DET
fcis-31417	83	22	rmse	rmse	NOUN
fcis-31417	83	23	was	be	AUX
fcis-31417	83	24	5.2	5.2	NUM
fcis-31417	83	25	months	month	NOUN
fcis-31417	83	26	;	;	PUNCT
fcis-31417	83	27	in	in	ADP
fcis-31417	83	28	the	the	DET
fcis-31417	83	29	validation	validation	NOUN
fcis-31417	83	30	set	set	NOUN
fcis-31417	83	31	,	,	PUNCT
fcis-31417	83	32	the	the	DET
fcis-31417	83	33	accuracy	accuracy	NOUN
fcis-31417	83	34	was	be	AUX
fcis-31417	83	35	81.7	81.7	NUM
fcis-31417	83	36	%	%	NOUN
fcis-31417	83	37	,	,	PUNCT
fcis-31417	83	38	the	the	DET
fcis-31417	83	39	c	c	NOUN
fcis-31417	83	40	-	-	PUNCT
fcis-31417	83	41	index	index	NOUN
fcis-31417	83	42	was	be	AUX
fcis-31417	83	43	0.856	0.856	NUM
fcis-31417	83	44	,	,	PUNCT
fcis-31417	83	45	and	and	CCONJ
fcis-31417	83	46	the	the	DET
fcis-31417	83	47	rmse	rmse	NOUN
fcis-31417	83	48	was	be	AUX
fcis-31417	83	49	6.1	6.1	NUM
fcis-31417	83	50	months	month	NOUN
fcis-31417	83	51	.	.	PUNCT
fcis-31417	84	1	the	the	DET
fcis-31417	84	2	difference	difference	NOUN
fcis-31417	84	3	between	between	ADP
fcis-31417	84	4	the	the	DET
fcis-31417	84	5	two	two	NUM
fcis-31417	84	6	was	be	AUX
fcis-31417	84	7	small	small	ADJ
fcis-31417	84	8	(	(	PUNCT
fcis-31417	84	9	δc	δc	NOUN
fcis-31417	84	10	-	-	PUNCT
fcis-31417	84	11	index=0.036	index=0.036	NOUN
fcis-31417	84	12	)	)	PUNCT
fcis-31417	84	13	,	,	PUNCT
fcis-31417	84	14	indicating	indicate	VERB
fcis-31417	84	15	that	that	SCONJ
fcis-31417	84	16	the	the	DET
fcis-31417	84	17	model	model	NOUN
fcis-31417	84	18	did	do	AUX
fcis-31417	84	19	not	not	PART
fcis-31417	84	20	overfit	overfit	VERB
fcis-31417	84	21	[	[	X
fcis-31417	84	22	9	9	NUM
fcis-31417	84	23	]	]	PUNCT
fcis-31417	84	24	.	.	PUNCT
fcis-31417	85	1	in	in	ADP
fcis-31417	85	2	the	the	DET
fcis-31417	85	3	single	single	ADJ
fcis-31417	85	4	-	-	PUNCT
fcis-31417	85	5	modality	modality	NOUN
fcis-31417	85	6	model	model	NOUN
fcis-31417	85	7	,	,	PUNCT
fcis-31417	85	8	the	the	DET
fcis-31417	85	9	validation	validation	NOUN
fcis-31417	85	10	set	set	VERB
fcis-31417	85	11	c	c	NOUN
fcis-31417	85	12	-	-	PUNCT
fcis-31417	85	13	index	index	NOUN
fcis-31417	85	14	of	of	ADP
fcis-31417	85	15	the	the	DET
fcis-31417	85	16	imaging	imaging	NOUN
fcis-31417	85	17	omics	omics	PROPN
fcis-31417	85	18	model	model	NOUN
fcis-31417	85	19	was	be	AUX
fcis-31417	85	20	0.783	0.783	NUM
fcis-31417	85	21	,	,	PUNCT
fcis-31417	85	22	and	and	CCONJ
fcis-31417	85	23	that	that	PRON
fcis-31417	85	24	of	of	ADP
fcis-31417	85	25	the	the	DET
fcis-31417	85	26	liquid	liquid	ADJ
fcis-31417	85	27	biopsy	biopsy	NOUN
fcis-31417	85	28	model	model	NOUN
fcis-31417	85	29	was	be	AUX
fcis-31417	85	30	0.756	0.756	NUM
fcis-31417	85	31	,	,	PUNCT
fcis-31417	85	32	both	both	PRON
fcis-31417	85	33	significantly	significantly	ADV
fcis-31417	85	34	lower	low	ADJ
fcis-31417	85	35	than	than	ADP
fcis-31417	85	36	that	that	PRON
fcis-31417	85	37	of	of	ADP
fcis-31417	85	38	the	the	DET
fcis-31417	85	39	multimodal	multimodal	NOUN
fcis-31417	85	40	model	model	NOUN
fcis-31417	85	41	(	(	PUNCT
fcis-31417	85	42	p<0.01	p<0.01	PROPN
fcis-31417	85	43	)	)	PUNCT
fcis-31417	85	44	.	.	PUNCT
fcis-31417	86	1	it	it	PRON
fcis-31417	86	2	is	be	AUX
fcis-31417	86	3	worth	worth	ADJ
fcis-31417	86	4	noting	note	VERB
fcis-31417	86	5	that	that	SCONJ
fcis-31417	86	6	although	although	SCONJ
fcis-31417	86	7	the	the	DET
fcis-31417	86	8	performance	performance	NOUN
fcis-31417	86	9	of	of	ADP
fcis-31417	86	10	the	the	DET
fcis-31417	86	11	imaging	imaging	NOUN
fcis-31417	86	12	omics	omic	NOUN
fcis-31417	86	13	+	+	CCONJ
fcis-31417	86	14	clinical	clinical	ADJ
fcis-31417	86	15	model	model	NOUN
fcis-31417	86	16	(	(	PUNCT
fcis-31417	86	17	c	c	NOUN
fcis-31417	86	18	-	-	PUNCT
fcis-31417	86	19	index=0.801	index=0.801	NOUN
fcis-31417	86	20	)	)	PUNCT
fcis-31417	86	21	and	and	CCONJ
fcis-31417	86	22	the	the	DET
fcis-31417	86	23	liquid	liquid	ADJ
fcis-31417	86	24	biopsy	biopsy	NOUN
fcis-31417	86	25	+	+	CCONJ
fcis-31417	86	26	clinical	clinical	ADJ
fcis-31417	86	27	model	model	NOUN
fcis-31417	86	28	(	(	PUNCT
fcis-31417	86	29	c	c	NOUN
fcis-31417	86	30	-	-	PUNCT
fcis-31417	86	31	index=0.779	index=0.779	NOUN
fcis-31417	86	32	)	)	PUNCT
fcis-31417	86	33	was	be	AUX
fcis-31417	86	34	better	well	ADJ
fcis-31417	86	35	than	than	ADP
fcis-31417	86	36	that	that	PRON
fcis-31417	86	37	of	of	ADP
fcis-31417	86	38	the	the	DET
fcis-31417	86	39	single	single	ADJ
fcis-31417	86	40	clinical	clinical	ADJ
fcis-31417	86	41	model	model	NOUN
fcis-31417	86	42	(	(	PUNCT
fcis-31417	86	43	c	c	NOUN
fcis-31417	86	44	-	-	NOUN
fcis-31417	86	45	index=0.712	index=0.712	NOUN
fcis-31417	86	46	)	)	PUNCT
fcis-31417	86	47	,	,	PUNCT
fcis-31417	86	48	it	it	PRON
fcis-31417	86	49	was	be	AUX
fcis-31417	86	50	still	still	ADV
fcis-31417	86	51	inferior	inferior	ADJ
fcis-31417	86	52	to	to	ADP
fcis-31417	86	53	the	the	DET
fcis-31417	86	54	multimodal	multimodal	NOUN
fcis-31417	86	55	model	model	NOUN
fcis-31417	86	56	,	,	PUNCT
fcis-31417	86	57	suggesting	suggest	VERB
fcis-31417	86	58	that	that	SCONJ
fcis-31417	86	59	simply	simply	ADV
fcis-31417	86	60	superimposing	superimpose	VERB
fcis-31417	86	61	clinical	clinical	ADJ
fcis-31417	86	62	features	feature	NOUN
fcis-31417	86	63	can	can	AUX
fcis-31417	86	64	not	not	PART
fcis-31417	86	65	replace	replace	VERB
fcis-31417	86	66	the	the	DET
fcis-31417	86	67	complementary	complementary	ADJ
fcis-31417	86	68	role	role	NOUN
fcis-31417	86	69	of	of	ADP
fcis-31417	86	70	multimodal	multimodal	NOUN
fcis-31417	86	71	features	feature	NOUN
fcis-31417	86	72	.	.	PUNCT
fcis-31417	87	1	table	table	NOUN
fcis-31417	87	2	1	1	NUM
fcis-31417	87	3	.	.	PUNCT
fcis-31417	87	4	comparison	comparison	NOUN
fcis-31417	87	5	of	of	ADP
fcis-31417	87	6	performance	performance	NOUN
fcis-31417	87	7	indicators	indicator	NOUN
fcis-31417	87	8	of	of	ADP
fcis-31417	87	9	different	different	ADJ
fcis-31417	87	10	models	model	NOUN
fcis-31417	87	11	model	model	NOUN
fcis-31417	87	12	type	type	NOUN
fcis-31417	87	13	dataset	dataset	NOUN
fcis-31417	87	14	accuracy	accuracy	NOUN
fcis-31417	87	15	(	(	PUNCT
fcis-31417	87	16	%	%	INTJ
fcis-31417	87	17	)	)	PUNCT
fcis-31417	87	18	cindex	cindex	NOUN
fcis-31417	87	19	rmse	rmse	NOUN
fcis-31417	87	20	(	(	PUNCT
fcis-31417	87	21	moon	moon	NOUN
fcis-31417	87	22	)	)	PUNCT
fcis-31417	87	23	1	1	NUM
fcis-31417	87	24	-	-	PUNCT
fcis-31417	87	25	year	year	NOUN
fcis-31417	87	26	survival	survival	NOUN
fcis-31417	87	27	rate	rate	NOUN
fcis-31417	87	28	prediction	prediction	NOUN
fcis-31417	87	29	accuracy	accuracy	NOUN
fcis-31417	87	30	(	(	PUNCT
fcis-31417	87	31	%	%	NOUN
fcis-31417	87	32	)	)	PUNCT
fcis-31417	87	33	3	3	NUM
fcis-31417	87	34	-	-	PUNCT
fcis-31417	87	35	year	year	NOUN
fcis-31417	87	36	survival	survival	NOUN
fcis-31417	87	37	rate	rate	NOUN
fcis-31417	87	38	prediction	prediction	NOUN
fcis-31417	87	39	accuracy	accuracy	NOUN
fcis-31417	87	40	(	(	PUNCT
fcis-31417	87	41	%	%	INTJ
fcis-31417	87	42	)	)	PUNCT
fcis-31417	87	43	delong	delong	PROPN
fcis-31417	87	44	test	test	NOUN
fcis-31417	87	45	p	p	PROPN
fcis-31417	87	46	value	value	NOUN
fcis-31417	87	47	(	(	PUNCT
fcis-31417	87	48	vs	vs	ADP
fcis-31417	87	49	multimodal	multimodal	NOUN
fcis-31417	87	50	)	)	PUNCT
fcis-31417	87	51	multimodal	multimodal	NOUN
fcis-31417	87	52	model	model	NOUN
fcis-31417	87	53	training	training	NOUN
fcis-31417	87	54	set	set	VERB
fcis-31417	87	55	86.3	86.3	NUM
fcis-31417	87	56	0.892	0.892	NUM
fcis-31417	87	57	5.2	5.2	NUM
fcis-31417	87	58	88.7	88.7	NUM
fcis-31417	87	59	84.5	84.5	NUM
fcis-31417	87	60	validation	validation	NOUN
fcis-31417	87	61	set	set	VERB
fcis-31417	87	62	81.7	81.7	NUM
fcis-31417	87	63	0.856	0.856	NUM
fcis-31417	87	64	6.1	6.1	NUM
fcis-31417	87	65	83.5	83.5	NUM
fcis-31417	87	66	79.8	79.8	NUM
fcis-31417	87	67	radiomic	radiomic	ADJ
fcis-31417	87	68	model	model	NOUN
fcis-31417	87	69	validation	validation	NOUN
fcis-31417	87	70	set	set	VERB
fcis-31417	87	71	72.6	72.6	NUM
fcis-31417	87	72	0.783	0.783	NUM
fcis-31417	87	73	8.4	8.4	NUM
fcis-31417	87	74	76.2	76.2	NUM
fcis-31417	87	75	71.3	71.3	NUM
fcis-31417	87	76	<	<	NOUN
fcis-31417	87	77	0.001	0.001	NUM
fcis-31417	87	78	liquid	liquid	ADJ
fcis-31417	87	79	biopsy	biopsy	NOUN
fcis-31417	87	80	model	model	NOUN
fcis-31417	87	81	validation	validation	NOUN
fcis-31417	87	82	set	set	VERB
fcis-31417	87	83	69.4	69.4	NUM
fcis-31417	87	84	0.756	0.756	NUM
fcis-31417	87	85	9.2	9.2	NUM
fcis-31417	87	86	73.1	73.1	NUM
fcis-31417	87	87	68.5	68.5	NUM
fcis-31417	87	88	<	<	NOUN
fcis-31417	87	89	0.001	0.001	NUM
fcis-31417	87	90	radiomic	radiomic	ADJ
fcis-31417	87	91	+	+	CCONJ
fcis-31417	87	92	clinical	clinical	ADJ
fcis-31417	87	93	model	model	NOUN
fcis-31417	87	94	validation	validation	NOUN
fcis-31417	87	95	set	set	VERB
fcis-31417	87	96	75.2	75.2	NUM
fcis-31417	87	97	0.801	0.801	NUM
fcis-31417	87	98	7.8	7.8	NUM
fcis-31417	87	99	78.5	78.5	NUM
fcis-31417	87	100	73.6	73.6	NUM
fcis-31417	87	101	0.003	0.003	NUM
fcis-31417	87	102	liquid	liquid	ADJ
fcis-31417	87	103	biopsy	biopsy	NOUN
fcis-31417	87	104	+	+	CCONJ
fcis-31417	87	105	clinical	clinical	ADJ
fcis-31417	87	106	model	model	NOUN
fcis-31417	87	107	validation	validation	NOUN
fcis-31417	87	108	set	set	VERB
fcis-31417	87	109	73.5	73.5	NUM
fcis-31417	87	110	0.779	0.779	NUM
fcis-31417	87	111	8.6	8.6	NUM
fcis-31417	87	112	75.3	75.3	NUM
fcis-31417	87	113	70.2	70.2	NUM
fcis-31417	87	114	<	<	NOUN
fcis-31417	87	115	0.001	0.001	NUM
fcis-31417	87	116	clinical	clinical	ADJ
fcis-31417	87	117	model	model	NOUN
fcis-31417	87	118	dataset	dataset	VERB
fcis-31417	87	119	65.3	65.3	NUM
fcis-31417	87	120	0.712	0.712	NUM
fcis-31417	87	121	10.5	10.5	NUM
fcis-31417	87	122	69.8	69.8	NUM
fcis-31417	87	123	63.7	63.7	NUM
fcis-31417	87	124	<	<	NOUN
fcis-31417	87	125	0.001	0.001	NUM
fcis-31417	87	126	3.2	3.2	NUM
fcis-31417	87	127	.	.	PUNCT
fcis-31417	88	1	analysis	analysis	NOUN
fcis-31417	88	2	of	of	ADP
fcis-31417	88	3	prediction	prediction	NOUN
fcis-31417	88	4	results	result	VERB
fcis-31417	88	5	the	the	DET
fcis-31417	88	6	model	model	NOUN
fcis-31417	88	7	prediction	prediction	NOUN
fcis-31417	88	8	performance	performance	NOUN
fcis-31417	88	9	of	of	ADP
fcis-31417	88	10	lung	lung	NOUN
fcis-31417	88	11	cancer	cancer	NOUN
fcis-31417	88	12	patients	patient	NOUN
fcis-31417	88	13	with	with	ADP
fcis-31417	88	14	different	different	ADJ
fcis-31417	88	15	tnm	tnm	PROPN
fcis-31417	88	16	stages	stage	NOUN
fcis-31417	88	17	is	be	AUX
fcis-31417	88	18	shown	show	VERB
fcis-31417	88	19	in	in	ADP
fcis-31417	88	20	table	table	NOUN
fcis-31417	88	21	2	2	NUM
fcis-31417	88	22	.	.	PUNCT
fcis-31417	89	1	in	in	ADP
fcis-31417	89	2	stage	stage	NOUN
fcis-31417	89	3	i	i	PRON
fcis-31417	89	4	patients	patient	VERB
fcis-31417	89	5	,	,	PUNCT
fcis-31417	89	6	the	the	DET
fcis-31417	89	7	accuracy	accuracy	NOUN
fcis-31417	89	8	of	of	ADP
fcis-31417	89	9	the	the	DET
fcis-31417	89	10	multimodal	multimodal	NOUN
fcis-31417	89	11	model	model	NOUN
fcis-31417	89	12	was	be	AUX
fcis-31417	89	13	85.2	85.2	NUM
fcis-31417	89	14	%	%	NOUN
fcis-31417	89	15	and	and	CCONJ
fcis-31417	89	16	the	the	DET
fcis-31417	89	17	c	c	NOUN
fcis-31417	89	18	-	-	PUNCT
fcis-31417	89	19	index	index	NOUN
fcis-31417	89	20	was	be	AUX
fcis-31417	89	21	0.871	0.871	NUM
fcis-31417	89	22	;	;	PUNCT
fcis-31417	89	23	in	in	ADP
fcis-31417	89	24	stage	stage	NOUN
fcis-31417	89	25	ii	ii	NOUN
fcis-31417	89	26	patients	patient	NOUN
fcis-31417	89	27	,	,	PUNCT
fcis-31417	89	28	the	the	DET
fcis-31417	89	29	accuracy	accuracy	NOUN
fcis-31417	89	30	was	be	AUX
fcis-31417	89	31	82.6	82.6	NUM
fcis-31417	89	32	%	%	NOUN
fcis-31417	89	33	and	and	CCONJ
fcis-31417	89	34	the	the	DET
fcis-31417	89	35	c	c	NOUN
fcis-31417	89	36	-	-	PUNCT
fcis-31417	89	37	index	index	NOUN
fcis-31417	89	38	was	be	AUX
fcis-31417	89	39	0.863	0.863	NUM
fcis-31417	89	40	;	;	PUNCT
fcis-31417	89	41	in	in	ADP
fcis-31417	89	42	stage	stage	NOUN
fcis-31417	89	43	iii	iii	NUM
fcis-31417	89	44	patients	patient	NOUN
fcis-31417	89	45	,	,	PUNCT
fcis-31417	89	46	the	the	DET
fcis-31417	89	47	accuracy	accuracy	NOUN
fcis-31417	89	48	was	be	AUX
fcis-31417	89	49	79.3	79.3	NUM
fcis-31417	89	50	%	%	NOUN
fcis-31417	89	51	and	and	CCONJ
fcis-31417	89	52	the	the	DET
fcis-31417	89	53	c	c	NOUN
fcis-31417	89	54	-	-	PUNCT
fcis-31417	89	55	index	index	NOUN
fcis-31417	89	56	was	be	AUX
fcis-31417	89	57	0.845	0.845	NUM
fcis-31417	89	58	;	;	PUNCT
fcis-31417	89	59	in	in	ADP
fcis-31417	89	60	stage	stage	NOUN
fcis-31417	89	61	iv	iv	NUM
fcis-31417	89	62	patients	patient	NOUN
fcis-31417	89	63	,	,	PUNCT
fcis-31417	89	64	the	the	DET
fcis-31417	89	65	accuracy	accuracy	NOUN
fcis-31417	89	66	was	be	AUX
fcis-31417	89	67	76.8	76.8	NUM
fcis-31417	89	68	%	%	NOUN
fcis-31417	89	69	and	and	CCONJ
fcis-31417	89	70	the	the	DET
fcis-31417	89	71	c	c	NOUN
fcis-31417	89	72	-	-	PUNCT
fcis-31417	89	73	index	index	NOUN
fcis-31417	89	74	was	be	AUX
fcis-31417	89	75	0.827	0.827	NUM
fcis-31417	89	76	.	.	PUNCT
fcis-31417	90	1	as	as	SCONJ
fcis-31417	90	2	the	the	DET
fcis-31417	90	3	stage	stage	NOUN
fcis-31417	90	4	increased	increase	VERB
fcis-31417	90	5	,	,	PUNCT
fcis-31417	90	6	the	the	DET
fcis-31417	90	7	model	model	NOUN
fcis-31417	90	8	performance	performance	NOUN
fcis-31417	90	9	decreased	decrease	VERB
fcis-31417	90	10	gradually	gradually	ADV
fcis-31417	90	11	(	(	PUNCT
fcis-31417	90	12	the	the	DET
fcis-31417	90	13	c	c	NOUN
fcis-31417	90	14	-	-	PUNCT
fcis-31417	90	15	index	index	NOUN
fcis-31417	90	16	decreased	decrease	VERB
fcis-31417	90	17	by	by	ADP
fcis-31417	90	18	0.016	0.016	NUM
fcis-31417	90	19	on	on	ADP
fcis-31417	90	20	average	average	NOUN
fcis-31417	90	21	for	for	ADP
fcis-31417	90	22	each	each	DET
fcis-31417	90	23	stage	stage	NOUN
fcis-31417	90	24	)	)	PUNCT
fcis-31417	90	25	,	,	PUNCT
fcis-31417	90	26	but	but	CCONJ
fcis-31417	90	27	the	the	DET
fcis-31417	90	28	c	c	NOUN
fcis-31417	90	29	-	-	PUNCT
fcis-31417	90	30	index	index	NOUN
fcis-31417	90	31	of	of	ADP
fcis-31417	90	32	each	each	DET
fcis-31417	90	33	stage	stage	NOUN
fcis-31417	90	34	was	be	AUX
fcis-31417	90	35	higher	high	ADJ
fcis-31417	90	36	than	than	ADP
fcis-31417	90	37	0.82	0.82	NUM
fcis-31417	90	38	,	,	PUNCT
fcis-31417	90	39	indicating	indicate	VERB
fcis-31417	90	40	that	that	SCONJ
fcis-31417	90	41	the	the	DET
fcis-31417	90	42	model	model	NOUN
fcis-31417	90	43	maintained	maintain	VERB
fcis-31417	90	44	stable	stable	ADJ
fcis-31417	90	45	prediction	prediction	NOUN
fcis-31417	90	46	ability	ability	NOUN
fcis-31417	90	47	in	in	ADP
fcis-31417	90	48	lung	lung	NOUN
fcis-31417	90	49	cancer	cancer	NOUN
fcis-31417	90	50	at	at	ADP
fcis-31417	90	51	different	different	ADJ
fcis-31417	90	52	stages	stage	NOUN
fcis-31417	90	53	of	of	ADP
fcis-31417	90	54	progression	progression	NOUN
fcis-31417	90	55	.	.	PUNCT
fcis-31417	91	1	in	in	ADP
fcis-31417	91	2	the	the	DET
fcis-31417	91	3	prediction	prediction	NOUN
fcis-31417	91	4	of	of	ADP
fcis-31417	91	5	1	1	NUM
fcis-31417	91	6	-	-	PUNCT
fcis-31417	91	7	year	year	NOUN
fcis-31417	91	8	survival	survival	NOUN
fcis-31417	91	9	rate	rate	NOUN
fcis-31417	91	10	,	,	PUNCT
fcis-31417	91	11	the	the	DET
fcis-31417	91	12	accuracy	accuracy	NOUN
fcis-31417	91	13	of	of	ADP
fcis-31417	91	14	stage	stage	NOUN
fcis-31417	91	15	i	i	PRON
fcis-31417	91	16	patients	patient	NOUN
fcis-31417	91	17	reached	reach	VERB
fcis-31417	91	18	91.2	91.2	NUM
fcis-31417	91	19	%	%	NOUN
fcis-31417	91	20	,	,	PUNCT
fcis-31417	91	21	which	which	PRON
fcis-31417	91	22	was	be	AUX
fcis-31417	91	23	significantly	significantly	ADV
fcis-31417	91	24	higher	high	ADJ
fcis-31417	91	25	than	than	ADP
fcis-31417	91	26	75.6	75.6	NUM
fcis-31417	91	27	%	%	NOUN
fcis-31417	91	28	of	of	ADP
fcis-31417	91	29	stage	stage	NOUN
fcis-31417	91	30	iv	iv	NUM
fcis-31417	91	31	(	(	PUNCT
fcis-31417	91	32	p=0.002	p=0.002	NOUN
fcis-31417	91	33	)	)	PUNCT
fcis-31417	91	34	,	,	PUNCT
fcis-31417	91	35	indicating	indicate	VERB
fcis-31417	91	36	that	that	SCONJ
fcis-31417	91	37	the	the	DET
fcis-31417	91	38	model	model	NOUN
fcis-31417	91	39	is	be	AUX
fcis-31417	91	40	more	more	ADV
fcis-31417	91	41	accurate	accurate	ADJ
fcis-31417	91	42	in	in	ADP
fcis-31417	91	43	predicting	predict	VERB
fcis-31417	91	44	the	the	DET
fcis-31417	91	45	short	short	ADJ
fcis-31417	91	46	-	-	PUNCT
fcis-31417	91	47	term	term	NOUN
fcis-31417	91	48	prognosis	prognosis	NOUN
fcis-31417	91	49	of	of	ADP
fcis-31417	91	50	early	early	ADJ
fcis-31417	91	51	-	-	PUNCT
fcis-31417	91	52	stage	stage	NOUN
fcis-31417	91	53	patients	patient	NOUN
fcis-31417	91	54	.	.	PUNCT
fcis-31417	92	1	table	table	NOUN
fcis-31417	92	2	2	2	NUM
fcis-31417	92	3	.	.	PUNCT
fcis-31417	92	4	model	model	NOUN
fcis-31417	92	5	prediction	prediction	NOUN
fcis-31417	92	6	performance	performance	NOUN
fcis-31417	92	7	of	of	ADP
fcis-31417	92	8	patients	patient	NOUN
fcis-31417	92	9	with	with	ADP
fcis-31417	92	10	different	different	ADJ
fcis-31417	92	11	tnm	tnm	PROPN
fcis-31417	92	12	stages	stage	NOUN
fcis-31417	92	13	tnm	tnm	PROPN
fcis-31417	92	14	staging	stage	VERB
fcis-31417	92	15	sample	sample	NOUN
fcis-31417	92	16	size	size	NOUN
fcis-31417	92	17	accuracy(%	accuracy(%	ADJ
fcis-31417	92	18	)	)	PUNCT
fcis-31417	92	19	c	c	NOUN
fcis-31417	92	20	-	-	PUNCT
fcis-31417	92	21	index	index	NOUN
fcis-31417	92	22	rmse	rmse	NOUN
fcis-31417	92	23	(	(	PUNCT
fcis-31417	92	24	moon	moon	NOUN
fcis-31417	92	25	)	)	PUNCT
fcis-31417	92	26	1	1	NUM
fcis-31417	92	27	-	-	PUNCT
fcis-31417	92	28	year	year	NOUN
fcis-31417	92	29	survival	survival	NOUN
fcis-31417	92	30	rate	rate	NOUN
fcis-31417	92	31	prediction	prediction	NOUN
fcis-31417	92	32	accuracy	accuracy	NOUN
fcis-31417	92	33	(	(	PUNCT
fcis-31417	92	34	%	%	NOUN
fcis-31417	92	35	)	)	PUNCT
fcis-31417	92	36	3	3	NUM
fcis-31417	92	37	-	-	PUNCT
fcis-31417	92	38	year	year	NOUN
fcis-31417	92	39	survival	survival	NOUN
fcis-31417	92	40	rate	rate	NOUN
fcis-31417	92	41	prediction	prediction	NOUN
fcis-31417	92	42	accuracy	accuracy	NOUN
fcis-31417	92	43	(	(	PUNCT
fcis-31417	92	44	%	%	INTJ
fcis-31417	92	45	)	)	PUNCT
fcis-31417	92	46	radiomics	radiomic	NOUN
fcis-31417	92	47	model	model	PROPN
fcis-31417	92	48	δcindex	δcindex	PROPN
fcis-31417	92	49	liquid	liquid	PROPN
fcis-31417	92	50	biopsy	biopsy	NOUN
fcis-31417	92	51	model	model	NOUN
fcis-31417	92	52	δcindex	δcindex	NOUN
fcis-31417	92	53	stage	stage	NOUN
fcis-31417	92	54	i	i	PRON
fcis-31417	92	55	168	168	NUM
fcis-31417	93	1	85.2	85.2	NUM
fcis-31417	93	2	0.871	0.871	NUM
fcis-31417	93	3	4.8	4.8	NUM
fcis-31417	93	4	91.2	91.2	NUM
fcis-31417	93	5	88.7	88.7	NUM
fcis-31417	93	6	0.082	0.082	NUM
fcis-31417	93	7	0.097	0.097	NUM
fcis-31417	93	8	stage	stage	NOUN
fcis-31417	93	9	ii	ii	NOUN
fcis-31417	93	10	124	124	NUM
fcis-31417	93	11	82.6	82.6	NUM
fcis-31417	93	12	0.863	0.863	NUM
fcis-31417	93	13	5.3	5.3	NUM
fcis-31417	93	14	87.1	87.1	NUM
fcis-31417	93	15	83.9	83.9	NUM
fcis-31417	93	16	0.076	0.076	NUM
fcis-31417	93	17	0.091	0.091	NUM
fcis-31417	93	18	stage	stage	NOUN
fcis-31417	93	19	iii	iii	NUM
fcis-31417	93	20	112	112	NUM
fcis-31417	93	21	79.3	79.3	NUM
fcis-31417	93	22	0.845	0.845	NUM
fcis-31417	93	23	6.2	6.2	NUM
fcis-31417	93	24	82.1	82.1	NUM
fcis-31417	93	25	77.6	77.6	NUM
fcis-31417	93	26	0.069	0.069	NUM
fcis-31417	93	27	0.083	0.083	NUM
fcis-31417	93	28	stage	stage	NOUN
fcis-31417	93	29	iv	iv	NUM
fcis-31417	93	30	86	86	NUM
fcis-31417	93	31	76.8	76.8	NUM
fcis-31417	93	32	0.827	0.827	NUM
fcis-31417	93	33	7.5	7.5	NUM
fcis-31417	93	34	75.6	75.6	NUM
fcis-31417	93	35	69.8	69.8	NUM
fcis-31417	93	36	0.065	0.065	NUM
fcis-31417	93	37	0.078	0.078	NUM
fcis-31417	93	38	figure	figure	NOUN
fcis-31417	93	39	1	1	NUM
fcis-31417	93	40	shows	show	VERB
fcis-31417	93	41	the	the	DET
fcis-31417	93	42	c	c	NOUN
fcis-31417	93	43	-	-	PUNCT
fcis-31417	93	44	index	index	NOUN
fcis-31417	93	45	comparison	comparison	NOUN
fcis-31417	93	46	between	between	ADP
fcis-31417	93	47	the	the	DET
fcis-31417	93	48	multimodal	multimodal	NOUN
fcis-31417	93	49	model	model	NOUN
fcis-31417	93	50	and	and	CCONJ
fcis-31417	93	51	the	the	DET
fcis-31417	93	52	single	single	ADJ
fcis-31417	93	53	-	-	PUNCT
fcis-31417	93	54	modal	modal	NOUN
fcis-31417	93	55	model	model	NOUN
fcis-31417	93	56	in	in	ADP
fcis-31417	93	57	different	different	ADJ
fcis-31417	93	58	stages	stage	NOUN
fcis-31417	93	59	,	,	PUNCT
fcis-31417	93	60	with	with	ADP
fcis-31417	93	61	the	the	DET
fcis-31417	93	62	horizontal	horizontal	ADJ
fcis-31417	93	63	axis	axis	NOUN
fcis-31417	93	64	being	be	AUX
fcis-31417	93	65	the	the	DET
fcis-31417	93	66	tnm	tnm	PROPN
fcis-31417	93	67	stage	stage	NOUN
fcis-31417	93	68	(	(	PUNCT
fcis-31417	93	69	stage	stage	NOUN
fcis-31417	93	70	iiv	iiv	NOUN
fcis-31417	93	71	)	)	PUNCT
fcis-31417	93	72	and	and	CCONJ
fcis-31417	93	73	the	the	DET
fcis-31417	93	74	vertical	vertical	ADJ
fcis-31417	93	75	axis	axis	NOUN
fcis-31417	93	76	being	be	AUX
fcis-31417	93	77	the	the	DET
fcis-31417	93	78	c	c	NOUN
fcis-31417	93	79	-	-	PUNCT
fcis-31417	93	80	index	index	NOUN
fcis-31417	93	81	value	value	NOUN
fcis-31417	93	82	(	(	PUNCT
fcis-31417	93	83	range	range	NOUN
fcis-31417	93	84	0.750.90	0.750.90	NUM
fcis-31417	93	85	)	)	PUNCT
fcis-31417	93	86	.	.	PUNCT
fcis-31417	94	1	it	it	PRON
fcis-31417	94	2	can	can	AUX
fcis-31417	94	3	be	be	AUX
fcis-31417	94	4	observed	observe	VERB
fcis-31417	94	5	that	that	SCONJ
fcis-31417	94	6	the	the	DET
fcis-31417	94	7	c	c	NOUN
fcis-31417	94	8	-	-	PUNCT
fcis-31417	94	9	index	index	NOUN
fcis-31417	94	10	of	of	ADP
fcis-31417	94	11	the	the	DET
fcis-31417	94	12	multimodal	multimodal	NOUN
fcis-31417	94	13	model	model	NOUN
fcis-31417	94	14	is	be	AUX
fcis-31417	94	15	higher	high	ADJ
fcis-31417	94	16	than	than	ADP
fcis-31417	94	17	that	that	PRON
fcis-31417	94	18	of	of	ADP
fcis-31417	94	19	the	the	DET
fcis-31417	94	20	single	single	ADJ
fcis-31417	94	21	-	-	PUNCT
fcis-31417	94	22	modal	modal	NOUN
fcis-31417	94	23	model	model	NOUN
fcis-31417	94	24	in	in	ADP
fcis-31417	94	25	each	each	DET
fcis-31417	94	26	37	37	NUM
fcis-31417	94	27	stage	stage	NOUN
fcis-31417	94	28	,	,	PUNCT
fcis-31417	94	29	with	with	ADP
fcis-31417	94	30	the	the	DET
fcis-31417	94	31	largest	large	ADJ
fcis-31417	94	32	difference	difference	NOUN
fcis-31417	94	33	in	in	ADP
fcis-31417	94	34	stage	stage	NOUN
fcis-31417	94	35	i	i	PRON
fcis-31417	94	36	(	(	PUNCT
fcis-31417	94	37	0.082	0.082	NUM
fcis-31417	94	38	higher	high	ADJ
fcis-31417	94	39	than	than	ADP
fcis-31417	94	40	the	the	DET
fcis-31417	94	41	imaging	imaging	NOUN
fcis-31417	94	42	omics	omic	NOUN
fcis-31417	94	43	model	model	NOUN
fcis-31417	94	44	and	and	CCONJ
fcis-31417	94	45	0.097	0.097	NUM
fcis-31417	94	46	higher	high	ADJ
fcis-31417	94	47	than	than	ADP
fcis-31417	94	48	the	the	DET
fcis-31417	94	49	liquid	liquid	ADJ
fcis-31417	94	50	biopsy	biopsy	NOUN
fcis-31417	94	51	model	model	NOUN
fcis-31417	94	52	)	)	PUNCT
fcis-31417	94	53	,	,	PUNCT
fcis-31417	94	54	and	and	CCONJ
fcis-31417	94	55	the	the	DET
fcis-31417	94	56	smallest	small	ADJ
fcis-31417	94	57	difference	difference	NOUN
fcis-31417	94	58	in	in	ADP
fcis-31417	94	59	stage	stage	NOUN
fcis-31417	94	60	iv	iv	NUM
fcis-31417	94	61	(	(	PUNCT
fcis-31417	94	62	0.065	0.065	NUM
fcis-31417	94	63	higher	high	ADJ
fcis-31417	94	64	than	than	ADP
fcis-31417	94	65	the	the	DET
fcis-31417	94	66	imaging	imaging	NOUN
fcis-31417	94	67	omics	omic	NOUN
fcis-31417	94	68	model	model	NOUN
fcis-31417	94	69	and	and	CCONJ
fcis-31417	94	70	0.078	0.078	NUM
fcis-31417	94	71	higher	high	ADJ
fcis-31417	94	72	than	than	ADP
fcis-31417	94	73	the	the	DET
fcis-31417	94	74	liquid	liquid	ADJ
fcis-31417	94	75	biopsy	biopsy	NOUN
fcis-31417	94	76	model	model	NOUN
fcis-31417	94	77	)	)	PUNCT
fcis-31417	94	78	,	,	PUNCT
fcis-31417	94	79	indicating	indicate	VERB
fcis-31417	94	80	that	that	SCONJ
fcis-31417	94	81	multimodal	multimodal	NOUN
fcis-31417	94	82	fusion	fusion	NOUN
fcis-31417	94	83	has	have	VERB
fcis-31417	94	84	a	a	DET
fcis-31417	94	85	more	more	ADV
fcis-31417	94	86	significant	significant	ADJ
fcis-31417	94	87	improvement	improvement	NOUN
fcis-31417	94	88	in	in	ADP
fcis-31417	94	89	the	the	DET
fcis-31417	94	90	prediction	prediction	NOUN
fcis-31417	94	91	of	of	ADP
fcis-31417	94	92	early	early	ADJ
fcis-31417	94	93	lung	lung	NOUN
fcis-31417	94	94	cancer	cancer	NOUN
fcis-31417	95	1	[	[	X
fcis-31417	95	2	10	10	NUM
fcis-31417	95	3	]	]	PUNCT
fcis-31417	95	4	.	.	PUNCT
fcis-31417	96	1	this	this	DET
fcis-31417	96	2	difference	difference	NOUN
fcis-31417	96	3	may	may	AUX
fcis-31417	96	4	be	be	AUX
fcis-31417	96	5	related	relate	VERB
fcis-31417	96	6	to	to	ADP
fcis-31417	96	7	the	the	DET
fcis-31417	96	8	more	more	ADV
fcis-31417	96	9	stable	stable	ADJ
fcis-31417	96	10	molecular	molecular	ADJ
fcis-31417	96	11	characteristics	characteristic	NOUN
fcis-31417	96	12	and	and	CCONJ
fcis-31417	96	13	more	more	ADV
fcis-31417	96	14	typical	typical	ADJ
fcis-31417	96	15	imaging	imaging	ADJ
fcis-31417	96	16	characteristics	characteristic	NOUN
fcis-31417	96	17	of	of	ADP
fcis-31417	96	18	early	early	ADJ
fcis-31417	96	19	lung	lung	NOUN
fcis-31417	96	20	cancer	cancer	NOUN
fcis-31417	96	21	,	,	PUNCT
fcis-31417	96	22	while	while	SCONJ
fcis-31417	96	23	the	the	DET
fcis-31417	96	24	increased	increase	VERB
fcis-31417	96	25	heterogeneity	heterogeneity	NOUN
fcis-31417	96	26	of	of	ADP
fcis-31417	96	27	late	late	ADJ
fcis-31417	96	28	-	-	PUNCT
fcis-31417	96	29	stage	stage	NOUN
fcis-31417	96	30	lung	lung	NOUN
fcis-31417	96	31	cancer	cancer	NOUN
fcis-31417	96	32	weakens	weaken	VERB
fcis-31417	96	33	the	the	DET
fcis-31417	96	34	fusion	fusion	NOUN
fcis-31417	96	35	gain	gain	NOUN
fcis-31417	96	36	.	.	PUNCT
fcis-31417	97	1	fig	fig	NOUN
fcis-31417	97	2	1	1	NUM
fcis-31417	97	3	.	.	PUNCT
fcis-31417	97	4	comparison	comparison	NOUN
fcis-31417	97	5	of	of	ADP
fcis-31417	97	6	c	c	NOUN
fcis-31417	97	7	-	-	PUNCT
fcis-31417	97	8	index	index	NOUN
fcis-31417	97	9	between	between	ADP
fcis-31417	97	10	multimodal	multimodal	NOUN
fcis-31417	97	11	model	model	NOUN
fcis-31417	97	12	and	and	CCONJ
fcis-31417	97	13	unimodal	unimodal	ADJ
fcis-31417	97	14	model	model	NOUN
fcis-31417	97	15	in	in	ADP
fcis-31417	97	16	different	different	ADJ
fcis-31417	97	17	stages	stage	NOUN
fcis-31417	97	18	figure	figure	NOUN
fcis-31417	97	19	2	2	NUM
fcis-31417	97	20	shows	show	VERB
fcis-31417	97	21	the	the	DET
fcis-31417	97	22	scatter	scatter	NOUN
fcis-31417	97	23	distribution	distribution	NOUN
fcis-31417	97	24	of	of	ADP
fcis-31417	97	25	the	the	DET
fcis-31417	97	26	predicted	predict	VERB
fcis-31417	97	27	survival	survival	NOUN
fcis-31417	97	28	time	time	NOUN
fcis-31417	97	29	of	of	ADP
fcis-31417	97	30	the	the	DET
fcis-31417	97	31	multimodal	multimodal	NOUN
fcis-31417	97	32	model	model	NOUN
fcis-31417	97	33	and	and	CCONJ
fcis-31417	97	34	the	the	DET
fcis-31417	97	35	actual	actual	ADJ
fcis-31417	97	36	survival	survival	NOUN
fcis-31417	97	37	time	time	NOUN
fcis-31417	97	38	.	.	PUNCT
fcis-31417	98	1	the	the	DET
fcis-31417	98	2	horizontal	horizontal	ADJ
fcis-31417	98	3	axis	axis	NOUN
fcis-31417	98	4	is	be	AUX
fcis-31417	98	5	the	the	DET
fcis-31417	98	6	actual	actual	ADJ
fcis-31417	98	7	survival	survival	NOUN
fcis-31417	98	8	time	time	NOUN
fcis-31417	98	9	(	(	PUNCT
fcis-31417	98	10	months	month	NOUN
fcis-31417	98	11	,	,	PUNCT
fcis-31417	98	12	range	range	NOUN
fcis-31417	98	13	0	0	NUM
fcis-31417	98	14	-	-	SYM
fcis-31417	98	15	60	60	NUM
fcis-31417	98	16	)	)	PUNCT
fcis-31417	98	17	,	,	PUNCT
fcis-31417	98	18	and	and	CCONJ
fcis-31417	98	19	the	the	DET
fcis-31417	98	20	vertical	vertical	ADJ
fcis-31417	98	21	axis	axis	NOUN
fcis-31417	98	22	is	be	AUX
fcis-31417	98	23	the	the	DET
fcis-31417	98	24	predicted	predict	VERB
fcis-31417	98	25	survival	survival	NOUN
fcis-31417	98	26	time	time	NOUN
fcis-31417	98	27	(	(	PUNCT
fcis-31417	98	28	months	month	NOUN
fcis-31417	98	29	,	,	PUNCT
fcis-31417	98	30	range	range	NOUN
fcis-31417	98	31	0	0	NUM
fcis-31417	98	32	-	-	SYM
fcis-31417	98	33	60	60	NUM
fcis-31417	98	34	)	)	PUNCT
fcis-31417	98	35	.	.	PUNCT
fcis-31417	99	1	the	the	DET
fcis-31417	99	2	diagonal	diagonal	ADJ
fcis-31417	99	3	line	line	NOUN
fcis-31417	99	4	in	in	ADP
fcis-31417	99	5	the	the	DET
fcis-31417	99	6	figure	figure	NOUN
fcis-31417	99	7	is	be	AUX
fcis-31417	99	8	the	the	DET
fcis-31417	99	9	ideal	ideal	ADJ
fcis-31417	99	10	prediction	prediction	NOUN
fcis-31417	99	11	line	line	NOUN
fcis-31417	99	12	,	,	PUNCT
fcis-31417	99	13	and	and	CCONJ
fcis-31417	99	14	the	the	DET
fcis-31417	99	15	dotted	dotted	ADJ
fcis-31417	99	16	line	line	NOUN
fcis-31417	99	17	is	be	AUX
fcis-31417	99	18	the	the	DET
fcis-31417	99	19	±6	±6	NOUN
fcis-31417	99	20	-	-	PUNCT
fcis-31417	99	21	month	month	NOUN
fcis-31417	99	22	error	error	NOUN
fcis-31417	99	23	range	range	NOUN
fcis-31417	99	24	.	.	PUNCT
fcis-31417	100	1	most	most	ADJ
fcis-31417	100	2	of	of	ADP
fcis-31417	100	3	the	the	DET
fcis-31417	100	4	sample	sample	NOUN
fcis-31417	100	5	points	point	NOUN
fcis-31417	100	6	(	(	PUNCT
fcis-31417	100	7	89.2	89.2	NUM
fcis-31417	100	8	%	%	NOUN
fcis-31417	100	9	)	)	PUNCT
fcis-31417	100	10	are	be	AUX
fcis-31417	100	11	distributed	distribute	VERB
fcis-31417	100	12	within	within	ADP
fcis-31417	100	13	the	the	DET
fcis-31417	100	14	±6	±6	NOUN
fcis-31417	100	15	-	-	PUNCT
fcis-31417	100	16	month	month	NOUN
fcis-31417	100	17	error	error	NOUN
fcis-31417	100	18	range	range	NOUN
fcis-31417	100	19	,	,	PUNCT
fcis-31417	100	20	of	of	ADP
fcis-31417	100	21	which	which	PRON
fcis-31417	100	22	the	the	DET
fcis-31417	100	23	samples	sample	NOUN
fcis-31417	100	24	with	with	ADP
fcis-31417	100	25	an	an	DET
fcis-31417	100	26	error	error	NOUN
fcis-31417	100	27	of	of	ADP
fcis-31417	100	28	≤3	≤3	ADJ
fcis-31417	100	29	months	month	NOUN
fcis-31417	100	30	account	account	VERB
fcis-31417	100	31	for	for	ADP
fcis-31417	100	32	68.7	68.7	NUM
fcis-31417	100	33	%	%	NOUN
fcis-31417	100	34	,	,	PUNCT
fcis-31417	100	35	indicating	indicate	VERB
fcis-31417	100	36	that	that	SCONJ
fcis-31417	100	37	the	the	DET
fcis-31417	100	38	quantitative	quantitative	ADJ
fcis-31417	100	39	prediction	prediction	NOUN
fcis-31417	100	40	accuracy	accuracy	NOUN
fcis-31417	100	41	of	of	ADP
fcis-31417	100	42	the	the	DET
fcis-31417	100	43	model	model	NOUN
fcis-31417	100	44	is	be	AUX
fcis-31417	100	45	high	high	ADJ
fcis-31417	100	46	[	[	X
fcis-31417	100	47	11	11	NUM
fcis-31417	100	48	]	]	PUNCT
fcis-31417	100	49	.	.	PUNCT
fcis-31417	101	1	through	through	ADP
fcis-31417	101	2	the	the	DET
fcis-31417	101	3	local	local	ADJ
fcis-31417	101	4	weighted	weight	VERB
fcis-31417	101	5	regression	regression	NOUN
fcis-31417	101	6	curve	curve	NOUN
fcis-31417	101	7	(	(	PUNCT
fcis-31417	101	8	lowess	lowess	NOUN
fcis-31417	101	9	)	)	PUNCT
fcis-31417	101	10	analysis	analysis	NOUN
fcis-31417	101	11	,	,	PUNCT
fcis-31417	101	12	it	it	PRON
fcis-31417	101	13	was	be	AUX
fcis-31417	101	14	found	find	VERB
fcis-31417	101	15	that	that	SCONJ
fcis-31417	101	16	the	the	DET
fcis-31417	101	17	prediction	prediction	NOUN
fcis-31417	101	18	deviation	deviation	NOUN
fcis-31417	101	19	of	of	ADP
fcis-31417	101	20	samples	sample	NOUN
fcis-31417	101	21	with	with	ADP
fcis-31417	101	22	a	a	DET
fcis-31417	101	23	survival	survival	NOUN
fcis-31417	101	24	period	period	NOUN
fcis-31417	101	25	of	of	ADP
fcis-31417	101	26	12	12	NUM
fcis-31417	101	27	-	-	SYM
fcis-31417	101	28	36	36	NUM
fcis-31417	101	29	months	month	NOUN
fcis-31417	101	30	was	be	AUX
fcis-31417	101	31	the	the	DET
fcis-31417	101	32	smallest	small	ADJ
fcis-31417	101	33	(	(	PUNCT
fcis-31417	101	34	average	average	ADJ
fcis-31417	101	35	error	error	NOUN
fcis-31417	101	36	2.3	2.3	NUM
fcis-31417	101	37	months	month	NOUN
fcis-31417	101	38	)	)	PUNCT
fcis-31417	101	39	,	,	PUNCT
fcis-31417	101	40	while	while	SCONJ
fcis-31417	101	41	the	the	DET
fcis-31417	101	42	error	error	NOUN
fcis-31417	101	43	of	of	ADP
fcis-31417	101	44	samples	sample	NOUN
fcis-31417	101	45	with	with	ADP
fcis-31417	101	46	a	a	DET
fcis-31417	101	47	survival	survival	NOUN
fcis-31417	101	48	period	period	NOUN
fcis-31417	101	49	of	of	ADP
fcis-31417	101	50	<	<	X
fcis-31417	101	51	12	12	NUM
fcis-31417	101	52	months	month	NOUN
fcis-31417	101	53	or	or	CCONJ
fcis-31417	101	54	>	>	SYM
fcis-31417	101	55	36	36	NUM
fcis-31417	101	56	months	month	NOUN
fcis-31417	101	57	was	be	AUX
fcis-31417	101	58	slightly	slightly	ADV
fcis-31417	101	59	larger	large	ADJ
fcis-31417	101	60	(	(	PUNCT
fcis-31417	101	61	average	average	ADJ
fcis-31417	101	62	error	error	NOUN
fcis-31417	101	63	4.7	4.7	NUM
fcis-31417	101	64	months	month	NOUN
fcis-31417	101	65	)	)	PUNCT
fcis-31417	101	66	,	,	PUNCT
fcis-31417	101	67	which	which	PRON
fcis-31417	101	68	may	may	AUX
fcis-31417	101	69	be	be	AUX
fcis-31417	101	70	related	relate	VERB
fcis-31417	101	71	to	to	ADP
fcis-31417	101	72	the	the	DET
fcis-31417	101	73	rapid	rapid	ADJ
fcis-31417	101	74	progression	progression	NOUN
fcis-31417	101	75	of	of	ADP
fcis-31417	101	76	the	the	DET
fcis-31417	101	77	disease	disease	NOUN
fcis-31417	101	78	and	and	CCONJ
fcis-31417	101	79	large	large	ADJ
fcis-31417	101	80	individual	individual	ADJ
fcis-31417	101	81	differences	difference	NOUN
fcis-31417	101	82	in	in	ADP
fcis-31417	101	83	advanced	advanced	ADJ
fcis-31417	101	84	patients	patient	NOUN
fcis-31417	101	85	.	.	PUNCT
fcis-31417	102	1	subgroup	subgroup	NOUN
fcis-31417	102	2	analysis	analysis	NOUN
fcis-31417	102	3	showed	show	VERB
fcis-31417	102	4	that	that	SCONJ
fcis-31417	102	5	the	the	DET
fcis-31417	102	6	prediction	prediction	NOUN
fcis-31417	102	7	error	error	NOUN
fcis-31417	102	8	of	of	ADP
fcis-31417	102	9	patients	patient	NOUN
fcis-31417	102	10	with	with	ADP
fcis-31417	102	11	adenocarcinoma	adenocarcinoma	NOUN
fcis-31417	102	12	(	(	PUNCT
fcis-31417	102	13	rmse=5.6	rmse=5.6	PROPN
fcis-31417	102	14	months	month	NOUN
fcis-31417	102	15	)	)	PUNCT
fcis-31417	102	16	was	be	AUX
fcis-31417	102	17	smaller	small	ADJ
fcis-31417	102	18	than	than	ADP
fcis-31417	102	19	that	that	PRON
fcis-31417	102	20	of	of	ADP
fcis-31417	102	21	patients	patient	NOUN
fcis-31417	102	22	with	with	ADP
fcis-31417	102	23	squamous	squamous	ADJ
fcis-31417	102	24	cell	cell	NOUN
fcis-31417	102	25	carcinoma	carcinoma	NOUN
fcis-31417	102	26	(	(	PUNCT
fcis-31417	102	27	rmse=6.8	rmse=6.8	NOUN
fcis-31417	102	28	months	month	NOUN
fcis-31417	102	29	,	,	PUNCT
fcis-31417	102	30	p=0.032	p=0.032	NUM
fcis-31417	102	31	)	)	PUNCT
fcis-31417	102	32	,	,	PUNCT
fcis-31417	102	33	suggesting	suggest	VERB
fcis-31417	102	34	that	that	SCONJ
fcis-31417	102	35	the	the	DET
fcis-31417	102	36	prediction	prediction	NOUN
fcis-31417	102	37	accuracy	accuracy	NOUN
fcis-31417	102	38	of	of	ADP
fcis-31417	102	39	the	the	DET
fcis-31417	102	40	model	model	NOUN
fcis-31417	102	41	for	for	ADP
fcis-31417	102	42	different	different	ADJ
fcis-31417	102	43	pathological	pathological	ADJ
fcis-31417	102	44	types	type	NOUN
fcis-31417	102	45	was	be	AUX
fcis-31417	102	46	different	different	ADJ
fcis-31417	102	47	.	.	PUNCT
fcis-31417	103	1	fig	fig	NOUN
fcis-31417	103	2	2	2	NUM
fcis-31417	103	3	.	.	PUNCT
fcis-31417	103	4	scatter	scatter	NOUN
fcis-31417	103	5	distribution	distribution	NOUN
fcis-31417	103	6	of	of	ADP
fcis-31417	103	7	the	the	DET
fcis-31417	103	8	predicted	predict	VERB
fcis-31417	103	9	survival	survival	NOUN
fcis-31417	103	10	period	period	NOUN
fcis-31417	103	11	and	and	CCONJ
fcis-31417	103	12	the	the	DET
fcis-31417	103	13	actual	actual	ADJ
fcis-31417	103	14	survival	survival	NOUN
fcis-31417	103	15	period	period	NOUN
fcis-31417	103	16	of	of	ADP
fcis-31417	103	17	the	the	DET
fcis-31417	103	18	multimodal	multimodal	NOUN
fcis-31417	103	19	model	model	NOUN
fcis-31417	103	20	compared	compare	VERB
fcis-31417	103	21	with	with	ADP
fcis-31417	103	22	the	the	DET
fcis-31417	103	23	single	single	ADJ
fcis-31417	103	24	-	-	PUNCT
fcis-31417	103	25	modal	modal	NOUN
fcis-31417	103	26	model	model	NOUN
fcis-31417	103	27	,	,	PUNCT
fcis-31417	103	28	the	the	DET
fcis-31417	103	29	accuracy	accuracy	NOUN
fcis-31417	103	30	of	of	ADP
fcis-31417	103	31	the	the	DET
fcis-31417	103	32	multimodal	multimodal	NOUN
fcis-31417	103	33	model	model	NOUN
fcis-31417	103	34	in	in	ADP
fcis-31417	103	35	each	each	DET
fcis-31417	103	36	stage	stage	NOUN
fcis-31417	103	37	increased	increase	VERB
fcis-31417	103	38	by	by	ADP
fcis-31417	103	39	an	an	DET
fcis-31417	103	40	average	average	ADJ
fcis-31417	103	41	38	38	NUM
fcis-31417	103	42	of	of	ADP
fcis-31417	103	43	9.4	9.4	NUM
fcis-31417	103	44	%	%	NOUN
fcis-31417	103	45	,	,	PUNCT
fcis-31417	103	46	including	include	VERB
fcis-31417	103	47	11.3	11.3	NUM
fcis-31417	103	48	%	%	NOUN
fcis-31417	103	49	in	in	ADP
fcis-31417	103	50	stage	stage	NOUN
fcis-31417	103	51	i	i	PRON
fcis-31417	103	52	,	,	PUNCT
fcis-31417	103	53	9.7	9.7	NUM
fcis-31417	103	54	%	%	NOUN
fcis-31417	103	55	in	in	ADP
fcis-31417	103	56	stage	stage	PROPN
fcis-31417	103	57	ii	ii	PROPN
fcis-31417	103	58	,	,	PUNCT
fcis-31417	103	59	8.5	8.5	NUM
fcis-31417	103	60	%	%	NOUN
fcis-31417	103	61	in	in	ADP
fcis-31417	103	62	stage	stage	NOUN
fcis-31417	103	63	iii	iii	NOUN
fcis-31417	103	64	,	,	PUNCT
fcis-31417	103	65	and	and	CCONJ
fcis-31417	103	66	7.1	7.1	NUM
fcis-31417	103	67	%	%	NOUN
fcis-31417	103	68	in	in	ADP
fcis-31417	103	69	stage	stage	NOUN
fcis-31417	103	70	iv	iv	X
fcis-31417	103	71	.	.	PUNCT
fcis-31417	104	1	in	in	ADP
fcis-31417	104	2	the	the	DET
fcis-31417	104	3	prediction	prediction	NOUN
fcis-31417	104	4	of	of	ADP
fcis-31417	104	5	1	1	NUM
fcis-31417	104	6	-	-	PUNCT
fcis-31417	104	7	year	year	NOUN
fcis-31417	104	8	survival	survival	NOUN
fcis-31417	104	9	rate	rate	NOUN
fcis-31417	104	10	,	,	PUNCT
fcis-31417	104	11	the	the	DET
fcis-31417	104	12	accuracy	accuracy	NOUN
fcis-31417	104	13	of	of	ADP
fcis-31417	104	14	the	the	DET
fcis-31417	104	15	multimodal	multimodal	NOUN
fcis-31417	104	16	model	model	NOUN
fcis-31417	104	17	was	be	AUX
fcis-31417	104	18	83.5	83.5	NUM
fcis-31417	104	19	%	%	NOUN
fcis-31417	104	20	,	,	PUNCT
fcis-31417	104	21	7.3	7.3	NUM
fcis-31417	104	22	%	%	NOUN
fcis-31417	104	23	higher	high	ADJ
fcis-31417	104	24	than	than	ADP
fcis-31417	104	25	the	the	DET
fcis-31417	104	26	imaging	imaging	NOUN
fcis-31417	104	27	omics	omic	NOUN
fcis-31417	104	28	model	model	NOUN
fcis-31417	104	29	and	and	CCONJ
fcis-31417	104	30	10.4	10.4	NUM
fcis-31417	104	31	%	%	NOUN
fcis-31417	104	32	higher	high	ADJ
fcis-31417	104	33	than	than	ADP
fcis-31417	104	34	the	the	DET
fcis-31417	104	35	liquid	liquid	ADJ
fcis-31417	104	36	biopsy	biopsy	NOUN
fcis-31417	104	37	model	model	NOUN
fcis-31417	104	38	;	;	PUNCT
fcis-31417	104	39	in	in	ADP
fcis-31417	104	40	the	the	DET
fcis-31417	104	41	prediction	prediction	NOUN
fcis-31417	104	42	of	of	ADP
fcis-31417	104	43	3year	3year	NUM
fcis-31417	104	44	survival	survival	NOUN
fcis-31417	104	45	rate	rate	NOUN
fcis-31417	104	46	,	,	PUNCT
fcis-31417	104	47	the	the	DET
fcis-31417	104	48	accuracy	accuracy	NOUN
fcis-31417	104	49	was	be	AUX
fcis-31417	104	50	79.8	79.8	NUM
fcis-31417	104	51	%	%	NOUN
fcis-31417	104	52	,	,	PUNCT
fcis-31417	104	53	8.5	8.5	NUM
fcis-31417	104	54	%	%	NOUN
fcis-31417	104	55	higher	high	ADJ
fcis-31417	104	56	than	than	ADP
fcis-31417	104	57	the	the	DET
fcis-31417	104	58	imaging	imaging	NOUN
fcis-31417	104	59	omics	omic	NOUN
fcis-31417	104	60	model	model	NOUN
fcis-31417	104	61	and	and	CCONJ
fcis-31417	104	62	11.3	11.3	NUM
fcis-31417	104	63	%	%	NOUN
fcis-31417	104	64	higher	high	ADJ
fcis-31417	104	65	than	than	ADP
fcis-31417	104	66	the	the	DET
fcis-31417	104	67	liquid	liquid	ADJ
fcis-31417	104	68	biopsy	biopsy	NOUN
fcis-31417	104	69	model	model	NOUN
fcis-31417	104	70	,	,	PUNCT
fcis-31417	104	71	further	far	ADV
fcis-31417	104	72	verifying	verify	VERB
fcis-31417	104	73	the	the	DET
fcis-31417	104	74	advantages	advantage	NOUN
fcis-31417	104	75	of	of	ADP
fcis-31417	104	76	the	the	DET
fcis-31417	104	77	multimodal	multimodal	NOUN
fcis-31417	104	78	model	model	NOUN
fcis-31417	104	79	in	in	ADP
fcis-31417	104	80	the	the	DET
fcis-31417	104	81	prediction	prediction	NOUN
fcis-31417	104	82	of	of	ADP
fcis-31417	104	83	survival	survival	NOUN
fcis-31417	104	84	probability	probability	NOUN
fcis-31417	104	85	[	[	X
fcis-31417	104	86	12	12	NUM
fcis-31417	104	87	]	]	PUNCT
fcis-31417	104	88	.	.	PUNCT
fcis-31417	105	1	stratified	stratify	VERB
fcis-31417	105	2	analysis	analysis	NOUN
fcis-31417	105	3	showed	show	VERB
fcis-31417	105	4	that	that	SCONJ
fcis-31417	105	5	in	in	ADP
fcis-31417	105	6	patients	patient	NOUN
fcis-31417	105	7	with	with	ADP
fcis-31417	105	8	egfr	egfr	ADJ
fcis-31417	105	9	mutations	mutation	NOUN
fcis-31417	105	10	,	,	PUNCT
fcis-31417	105	11	the	the	DET
fcis-31417	105	12	c	c	NOUN
fcis-31417	105	13	-	-	PUNCT
fcis-31417	105	14	index	index	NOUN
fcis-31417	105	15	of	of	ADP
fcis-31417	105	16	the	the	DET
fcis-31417	105	17	multimodal	multimodal	NOUN
fcis-31417	105	18	model	model	NOUN
fcis-31417	105	19	(	(	PUNCT
fcis-31417	105	20	0.873	0.873	NUM
fcis-31417	105	21	)	)	PUNCT
fcis-31417	105	22	was	be	AUX
fcis-31417	105	23	higher	high	ADJ
fcis-31417	105	24	than	than	ADP
fcis-31417	105	25	that	that	PRON
fcis-31417	105	26	of	of	ADP
fcis-31417	105	27	wild	wild	ADJ
fcis-31417	105	28	-	-	PUNCT
fcis-31417	105	29	type	type	NOUN
fcis-31417	105	30	patients	patient	NOUN
fcis-31417	105	31	(	(	PUNCT
fcis-31417	105	32	0.831	0.831	NUM
fcis-31417	105	33	,	,	PUNCT
fcis-31417	105	34	p=0.041	p=0.041	NOUN
fcis-31417	105	35	)	)	PUNCT
fcis-31417	105	36	,	,	PUNCT
fcis-31417	105	37	suggesting	suggest	VERB
fcis-31417	105	38	that	that	SCONJ
fcis-31417	105	39	the	the	DET
fcis-31417	105	40	model	model	NOUN
fcis-31417	105	41	is	be	AUX
fcis-31417	105	42	more	more	ADV
fcis-31417	105	43	accurate	accurate	ADJ
fcis-31417	105	44	in	in	ADP
fcis-31417	105	45	predicting	predict	VERB
fcis-31417	105	46	patients	patient	NOUN
fcis-31417	105	47	with	with	ADP
fcis-31417	105	48	driver	driver	NOUN
fcis-31417	105	49	gene	gene	NOUN
fcis-31417	105	50	mutations	mutation	NOUN
fcis-31417	105	51	,	,	PUNCT
fcis-31417	105	52	which	which	PRON
fcis-31417	105	53	may	may	AUX
fcis-31417	105	54	be	be	AUX
fcis-31417	105	55	related	relate	VERB
fcis-31417	105	56	to	to	ADP
fcis-31417	105	57	the	the	DET
fcis-31417	105	58	fact	fact	NOUN
fcis-31417	105	59	that	that	SCONJ
fcis-31417	105	60	mutation	mutation	NOUN
fcis-31417	105	61	status	status	NOUN
fcis-31417	105	62	affects	affect	VERB
fcis-31417	105	63	both	both	DET
fcis-31417	105	64	imaging	imaging	NOUN
fcis-31417	105	65	features	feature	NOUN
fcis-31417	105	66	and	and	CCONJ
fcis-31417	105	67	liquid	liquid	ADJ
fcis-31417	105	68	biopsy	biopsy	NOUN
fcis-31417	105	69	indicators	indicator	NOUN
fcis-31417	105	70	.	.	PUNCT
fcis-31417	106	1	4	4	X
fcis-31417	106	2	.	.	X
fcis-31417	106	3	discussion	discussion	NOUN
fcis-31417	106	4	4.1	4.1	NUM
fcis-31417	106	5	.	.	PUNCT
fcis-31417	107	1	discussion	discussion	NOUN
fcis-31417	107	2	on	on	ADP
fcis-31417	107	3	the	the	DET
fcis-31417	107	4	advantages	advantage	NOUN
fcis-31417	107	5	of	of	ADP
fcis-31417	107	6	the	the	DET
fcis-31417	107	7	multimodal	multimodal	NOUN
fcis-31417	107	8	model	model	NOUN
fcis-31417	107	9	the	the	DET
fcis-31417	107	10	complementarity	complementarity	NOUN
fcis-31417	107	11	of	of	ADP
fcis-31417	107	12	ct	ct	NUM
fcis-31417	107	13	imaging	imaging	NOUN
fcis-31417	107	14	and	and	CCONJ
fcis-31417	107	15	liquid	liquid	ADJ
fcis-31417	107	16	biopsy	biopsy	NOUN
fcis-31417	107	17	data	datum	NOUN
fcis-31417	107	18	is	be	AUX
fcis-31417	107	19	the	the	DET
fcis-31417	107	20	core	core	ADJ
fcis-31417	107	21	mechanism	mechanism	NOUN
fcis-31417	107	22	for	for	ADP
fcis-31417	107	23	improving	improve	VERB
fcis-31417	107	24	prediction	prediction	NOUN
fcis-31417	107	25	performance	performance	NOUN
fcis-31417	107	26	[	[	X
fcis-31417	107	27	13	13	NUM
fcis-31417	107	28	]	]	PUNCT
fcis-31417	107	29	.	.	PUNCT
fcis-31417	108	1	ct	ct	NUM
fcis-31417	108	2	images	image	NOUN
fcis-31417	108	3	intuitively	intuitively	ADV
fcis-31417	108	4	reflect	reflect	VERB
fcis-31417	108	5	the	the	DET
fcis-31417	108	6	spatial	spatial	ADJ
fcis-31417	108	7	invasiveness	invasiveness	NOUN
fcis-31417	108	8	of	of	ADP
fcis-31417	108	9	tumors	tumor	NOUN
fcis-31417	108	10	through	through	ADP
fcis-31417	108	11	three	three	NUM
fcis-31417	108	12	-	-	PUNCT
fcis-31417	108	13	dimensional	dimensional	ADJ
fcis-31417	108	14	anatomical	anatomical	ADJ
fcis-31417	108	15	features	feature	NOUN
fcis-31417	108	16	(	(	PUNCT
fcis-31417	108	17	such	such	ADJ
fcis-31417	108	18	as	as	ADP
fcis-31417	108	19	tumor	tumor	NOUN
fcis-31417	108	20	volume	volume	NOUN
fcis-31417	108	21	,	,	PUNCT
fcis-31417	108	22	pleural	pleural	ADJ
fcis-31417	108	23	invasion	invasion	NOUN
fcis-31417	108	24	range	range	NOUN
fcis-31417	108	25	,	,	PUNCT
fcis-31417	108	26	and	and	CCONJ
fcis-31417	108	27	spicule	spicule	VERB
fcis-31417	108	28	distribution	distribution	NOUN
fcis-31417	108	29	)	)	PUNCT
fcis-31417	108	30	.	.	PUNCT
fcis-31417	109	1	for	for	ADP
fcis-31417	109	2	example	example	NOUN
fcis-31417	109	3	,	,	PUNCT
fcis-31417	109	4	the	the	DET
fcis-31417	109	5	degree	degree	NOUN
fcis-31417	109	6	of	of	ADP
fcis-31417	109	7	lobulation	lobulation	NOUN
fcis-31417	109	8	of	of	ADP
fcis-31417	109	9	lung	lung	NOUN
fcis-31417	109	10	cancer	cancer	NOUN
fcis-31417	109	11	is	be	AUX
fcis-31417	109	12	positively	positively	ADV
fcis-31417	109	13	correlated	correlate	VERB
fcis-31417	109	14	with	with	ADP
fcis-31417	109	15	microvascular	microvascular	ADJ
fcis-31417	109	16	invasion	invasion	NOUN
fcis-31417	109	17	(	(	PUNCT
fcis-31417	109	18	r=0.68	r=0.68	NOUN
fcis-31417	109	19	)	)	PUNCT
fcis-31417	109	20	(	(	PUNCT
fcis-31417	109	21	figure	figure	NOUN
fcis-31417	109	22	3	3	NUM
fcis-31417	109	23	)	)	PUNCT
fcis-31417	109	24	,	,	PUNCT
fcis-31417	109	25	while	while	SCONJ
fcis-31417	109	26	the	the	DET
fcis-31417	109	27	ctdna	ctdna	NOUN
fcis-31417	109	28	mutation	mutation	NOUN
fcis-31417	109	29	spectrum	spectrum	NOUN
fcis-31417	109	30	(	(	PUNCT
fcis-31417	109	31	such	such	ADJ
fcis-31417	109	32	as	as	ADP
fcis-31417	109	33	egfr	egfr	ADJ
fcis-31417	109	34	l858r	l858r	NOUN
fcis-31417	109	35	mutation	mutation	NOUN
fcis-31417	109	36	abundance	abundance	PROPN
fcis-31417	109	37	)	)	PUNCT
fcis-31417	109	38	and	and	CCONJ
fcis-31417	109	39	exosome	exosome	PROPN
fcis-31417	109	40	markers	marker	NOUN
fcis-31417	109	41	(	(	PUNCT
fcis-31417	109	42	such	such	ADJ
fcis-31417	109	43	as	as	ADP
fcis-31417	109	44	pd	pd	PROPN
fcis-31417	109	45	-	-	PROPN
fcis-31417	109	46	l1	l1	PROPN
fcis-31417	109	47	fluorescence	fluorescence	NOUN
fcis-31417	109	48	intensity	intensity	NOUN
fcis-31417	109	49	)	)	PUNCT
fcis-31417	109	50	in	in	ADP
fcis-31417	109	51	liquid	liquid	ADJ
fcis-31417	109	52	biopsy	biopsy	NOUN
fcis-31417	109	53	reveal	reveal	VERB
fcis-31417	109	54	the	the	DET
fcis-31417	109	55	molecular	molecular	ADJ
fcis-31417	109	56	heterogeneity	heterogeneity	NOUN
fcis-31417	109	57	of	of	ADP
fcis-31417	109	58	tumors	tumor	NOUN
fcis-31417	109	59	(	(	PUNCT
fcis-31417	109	60	figure	figure	VERB
fcis-31417	109	61	4	4	NUM
fcis-31417	109	62	)	)	PUNCT
fcis-31417	109	63	.	.	PUNCT
fcis-31417	110	1	this	this	DET
fcis-31417	110	2	"	"	PUNCT
fcis-31417	110	3	morphology	morphology	NOUN
fcis-31417	110	4	-	-	PUNCT
fcis-31417	110	5	molecule	molecule	NOUN
fcis-31417	110	6	"	"	PUNCT
fcis-31417	110	7	dual	dual	ADJ
fcis-31417	110	8	-	-	PUNCT
fcis-31417	110	9	dimensional	dimensional	ADJ
fcis-31417	110	10	information	information	NOUN
fcis-31417	110	11	fusion	fusion	NOUN
fcis-31417	110	12	shows	show	VERB
fcis-31417	110	13	unique	unique	ADJ
fcis-31417	110	14	value	value	NOUN
fcis-31417	110	15	in	in	ADP
fcis-31417	110	16	key	key	ADJ
fcis-31417	110	17	clinical	clinical	ADJ
fcis-31417	110	18	scenarios	scenario	NOUN
fcis-31417	110	19	:	:	PUNCT
fcis-31417	110	20	for	for	ADP
fcis-31417	110	21	early	early	ADJ
fcis-31417	110	22	peripheral	peripheral	ADJ
fcis-31417	110	23	lung	lung	NOUN
fcis-31417	110	24	adenocarcinoma	adenocarcinoma	NOUN
fcis-31417	110	25	shown	show	VERB
fcis-31417	110	26	on	on	ADP
fcis-31417	110	27	ct	ct	NUM
fcis-31417	110	28	images	image	NOUN
fcis-31417	110	29	,	,	PUNCT
fcis-31417	110	30	if	if	SCONJ
fcis-31417	110	31	the	the	DET
fcis-31417	110	32	tumor	tumor	NOUN
fcis-31417	110	33	diameter	diameter	NOUN
fcis-31417	110	34	is	be	AUX
fcis-31417	110	35	<	<	X
fcis-31417	110	36	2	2	NUM
fcis-31417	110	37	cm	cm	NOUN
fcis-31417	110	38	and	and	CCONJ
fcis-31417	110	39	there	there	PRON
fcis-31417	110	40	is	be	VERB
fcis-31417	110	41	no	no	DET
fcis-31417	110	42	pleural	pleural	ADJ
fcis-31417	110	43	traction	traction	NOUN
fcis-31417	110	44	,	,	PUNCT
fcis-31417	110	45	a	a	DET
fcis-31417	110	46	single	single	ADJ
fcis-31417	110	47	imaging	imaging	NOUN
fcis-31417	110	48	model	model	NOUN
fcis-31417	110	49	may	may	AUX
fcis-31417	110	50	classify	classify	VERB
fcis-31417	110	51	it	it	PRON
fcis-31417	110	52	as	as	ADP
fcis-31417	110	53	a	a	DET
fcis-31417	110	54	low	low	ADJ
fcis-31417	110	55	-	-	PUNCT
fcis-31417	110	56	risk	risk	NOUN
fcis-31417	110	57	group	group	NOUN
fcis-31417	110	58	(	(	PUNCT
fcis-31417	110	59	3	3	NUM
fcis-31417	110	60	-	-	PUNCT
fcis-31417	110	61	year	year	NOUN
fcis-31417	110	62	survival	survival	NOUN
fcis-31417	110	63	rate	rate	NOUN
fcis-31417	110	64	prediction	prediction	NOUN
fcis-31417	110	65	of	of	ADP
fcis-31417	110	66	85	85	NUM
fcis-31417	110	67	%	%	NOUN
fcis-31417	110	68	)	)	PUNCT
fcis-31417	110	69	,	,	PUNCT
fcis-31417	110	70	but	but	CCONJ
fcis-31417	110	71	the	the	DET
fcis-31417	110	72	multimodal	multimodal	NOUN
fcis-31417	110	73	model	model	NOUN
fcis-31417	110	74	combined	combine	VERB
fcis-31417	110	75	with	with	ADP
fcis-31417	110	76	tp53	tp53	PROPN
fcis-31417	110	77	co	co	NOUN
fcis-31417	110	78	-	-	NOUN
fcis-31417	110	79	mutation	mutation	NOUN
fcis-31417	110	80	detected	detect	VERB
fcis-31417	110	81	by	by	ADP
fcis-31417	110	82	liquid	liquid	ADJ
fcis-31417	110	83	biopsy	biopsy	NOUN
fcis-31417	110	84	(	(	PUNCT
fcis-31417	110	85	mutation	mutation	NOUN
fcis-31417	110	86	abundance	abundance	PROPN
fcis-31417	110	87	>	>	X
fcis-31417	110	88	3	3	NUM
fcis-31417	110	89	%	%	NOUN
fcis-31417	110	90	)	)	PUNCT
fcis-31417	110	91	can	can	AUX
fcis-31417	110	92	accurately	accurately	ADV
fcis-31417	110	93	identify	identify	VERB
fcis-31417	110	94	its	its	PRON
fcis-31417	110	95	high	high	ADJ
fcis-31417	110	96	risk	risk	NOUN
fcis-31417	110	97	of	of	ADP
fcis-31417	110	98	recurrence	recurrence	NOUN
fcis-31417	110	99	(	(	PUNCT
fcis-31417	110	100	the	the	DET
fcis-31417	110	101	actual	actual	ADJ
fcis-31417	110	102	3year	3year	NUM
fcis-31417	110	103	survival	survival	NOUN
fcis-31417	110	104	rate	rate	NOUN
fcis-31417	110	105	is	be	AUX
fcis-31417	110	106	only	only	ADV
fcis-31417	110	107	52	52	NUM
fcis-31417	110	108	%	%	NOUN
fcis-31417	110	109	,	,	PUNCT
fcis-31417	110	110	and	and	CCONJ
fcis-31417	110	111	the	the	DET
fcis-31417	110	112	prediction	prediction	NOUN
fcis-31417	110	113	error	error	NOUN
fcis-31417	110	114	is	be	AUX
fcis-31417	110	115	<	<	X
fcis-31417	110	116	2	2	NUM
fcis-31417	110	117	months	month	NOUN
fcis-31417	110	118	)	)	PUNCT
fcis-31417	110	119	.	.	PUNCT
fcis-31417	111	1	in	in	ADP
fcis-31417	111	2	advanced	advanced	ADJ
fcis-31417	111	3	lung	lung	NOUN
fcis-31417	111	4	cancer	cancer	NOUN
fcis-31417	111	5	,	,	PUNCT
fcis-31417	111	6	when	when	SCONJ
fcis-31417	111	7	ct	ct	NOUN
fcis-31417	111	8	images	image	NOUN
fcis-31417	111	9	show	show	VERB
fcis-31417	111	10	multiple	multiple	ADJ
fcis-31417	111	11	metastases	metastasis	NOUN
fcis-31417	111	12	,	,	PUNCT
fcis-31417	111	13	if	if	SCONJ
fcis-31417	111	14	the	the	DET
fcis-31417	111	15	liquid	liquid	ADJ
fcis-31417	111	16	biopsy	biopsy	NOUN
fcis-31417	111	17	indicates	indicate	VERB
fcis-31417	111	18	alk	alk	NOUN
fcis-31417	111	19	fusion	fusion	NOUN
fcis-31417	111	20	and	and	CCONJ
fcis-31417	111	21	ctdna	ctdna	NOUN
fcis-31417	111	22	clearance	clearance	NOUN
fcis-31417	111	23	rate	rate	NOUN
fcis-31417	111	24	>	>	X
fcis-31417	111	25	70	70	NUM
fcis-31417	111	26	%	%	NOUN
fcis-31417	111	27	,	,	PUNCT
fcis-31417	111	28	the	the	DET
fcis-31417	111	29	model	model	NOUN
fcis-31417	111	30	can	can	AUX
fcis-31417	111	31	predict	predict	VERB
fcis-31417	111	32	the	the	DET
fcis-31417	111	33	long	long	ADJ
fcis-31417	111	34	-	-	PUNCT
fcis-31417	111	35	term	term	NOUN
fcis-31417	111	36	benefit	benefit	NOUN
fcis-31417	111	37	of	of	ADP
fcis-31417	111	38	targeted	target	VERB
fcis-31417	111	39	therapy	therapy	NOUN
fcis-31417	111	40	(	(	PUNCT
fcis-31417	111	41	median	median	ADJ
fcis-31417	111	42	survival	survival	NOUN
fcis-31417	111	43	predicted	predict	VERB
fcis-31417	111	44	32	32	NUM
fcis-31417	111	45	months	month	NOUN
fcis-31417	111	46	,	,	PUNCT
fcis-31417	111	47	actual	actual	ADJ
fcis-31417	111	48	31	31	NUM
fcis-31417	111	49	months	month	NOUN
fcis-31417	111	50	)	)	PUNCT
fcis-31417	111	51	,	,	PUNCT
fcis-31417	111	52	while	while	SCONJ
fcis-31417	111	53	the	the	DET
fcis-31417	111	54	single	single	ADJ
fcis-31417	111	55	liquid	liquid	ADJ
fcis-31417	111	56	model	model	NOUN
fcis-31417	111	57	may	may	AUX
fcis-31417	111	58	misjudge	misjudge	VERB
fcis-31417	111	59	it	it	PRON
fcis-31417	111	60	as	as	ADP
fcis-31417	111	61	a	a	DET
fcis-31417	111	62	short	short	ADJ
fcis-31417	111	63	-	-	PUNCT
fcis-31417	111	64	term	term	NOUN
fcis-31417	111	65	response	response	NOUN
fcis-31417	111	66	due	due	ADP
fcis-31417	111	67	to	to	ADP
fcis-31417	111	68	the	the	DET
fcis-31417	111	69	metastatic	metastatic	ADJ
fcis-31417	111	70	burden	burden	NOUN
fcis-31417	111	71	.	.	PUNCT
fcis-31417	112	1	fig	fig	NOUN
fcis-31417	112	2	3	3	NUM
fcis-31417	112	3	.	.	PUNCT
fcis-31417	113	1	ct	ct	NOUN
fcis-31417	113	2	images	image	NOUN
fcis-31417	113	3	of	of	ADP
fcis-31417	113	4	lung	lung	NOUN
fcis-31417	113	5	cancer	cancer	NOUN
fcis-31417	113	6	lobulation	lobulation	NOUN
fcis-31417	113	7	and	and	CCONJ
fcis-31417	113	8	microvascular	microvascular	ADJ
fcis-31417	113	9	invasion	invasion	NOUN
fcis-31417	113	10	fig	fig	NOUN
fcis-31417	113	11	4	4	NUM
fcis-31417	113	12	.	.	PUNCT
fcis-31417	113	13	ctdna	ctdna	NOUN
fcis-31417	113	14	mutation	mutation	PROPN
fcis-31417	113	15	spectrum	spectrum	VERB
fcis-31417	113	16	39	39	NUM
fcis-31417	113	17	in	in	ADP
fcis-31417	113	18	clinical	clinical	ADJ
fcis-31417	113	19	practice	practice	NOUN
fcis-31417	113	20	,	,	PUNCT
fcis-31417	113	21	the	the	DET
fcis-31417	113	22	application	application	NOUN
fcis-31417	113	23	potential	potential	NOUN
fcis-31417	113	24	of	of	ADP
fcis-31417	113	25	this	this	DET
fcis-31417	113	26	model	model	NOUN
fcis-31417	113	27	is	be	AUX
fcis-31417	113	28	reflected	reflect	VERB
fcis-31417	113	29	in	in	ADP
fcis-31417	113	30	three	three	NUM
fcis-31417	113	31	aspects	aspect	NOUN
fcis-31417	113	32	:	:	PUNCT
fcis-31417	113	33	first	first	ADV
fcis-31417	113	34	,	,	PUNCT
fcis-31417	113	35	assisting	assist	VERB
fcis-31417	113	36	postoperative	postoperative	ADJ
fcis-31417	113	37	treatment	treatment	NOUN
fcis-31417	113	38	decisions	decision	NOUN
fcis-31417	113	39	.	.	PUNCT
fcis-31417	114	1	for	for	ADP
fcis-31417	114	2	stage	stage	NOUN
fcis-31417	114	3	ib	ib	NOUN
fcis-31417	114	4	patients	patient	NOUN
fcis-31417	114	5	with	with	ADP
fcis-31417	114	6	a	a	DET
fcis-31417	114	7	1	1	NUM
fcis-31417	114	8	-	-	PUNCT
fcis-31417	114	9	year	year	NOUN
fcis-31417	114	10	recurrence	recurrence	NOUN
fcis-31417	114	11	risk	risk	NOUN
fcis-31417	114	12	>	>	X
fcis-31417	114	13	30	30	NUM
fcis-31417	114	14	%	%	NOUN
fcis-31417	114	15	predicted	predict	VERB
fcis-31417	114	16	by	by	ADP
fcis-31417	114	17	the	the	DET
fcis-31417	114	18	model	model	NOUN
fcis-31417	114	19	,	,	PUNCT
fcis-31417	114	20	adjuvant	adjuvant	ADJ
fcis-31417	114	21	chemotherapy	chemotherapy	NOUN
fcis-31417	114	22	is	be	AUX
fcis-31417	114	23	recommended	recommend	VERB
fcis-31417	114	24	to	to	PART
fcis-31417	114	25	increase	increase	VERB
fcis-31417	114	26	the	the	DET
fcis-31417	114	27	5	5	NUM
fcis-31417	114	28	-	-	PUNCT
fcis-31417	114	29	year	year	NOUN
fcis-31417	114	30	survival	survival	NOUN
fcis-31417	114	31	rate	rate	NOUN
fcis-31417	114	32	by	by	ADP
fcis-31417	114	33	12	12	NUM
fcis-31417	114	34	%	%	NOUN
fcis-31417	114	35	;	;	PUNCT
fcis-31417	114	36	second	second	ADJ
fcis-31417	114	37	,	,	PUNCT
fcis-31417	114	38	optimizing	optimize	VERB
fcis-31417	114	39	the	the	DET
fcis-31417	114	40	use	use	NOUN
fcis-31417	114	41	of	of	ADP
fcis-31417	114	42	targeted	target	VERB
fcis-31417	114	43	drugs	drug	NOUN
fcis-31417	114	44	[	[	X
fcis-31417	114	45	14	14	NUM
fcis-31417	114	46	]	]	PUNCT
fcis-31417	114	47	.	.	PUNCT
fcis-31417	115	1	for	for	ADP
fcis-31417	115	2	advanced	advanced	ADJ
fcis-31417	115	3	patients	patient	NOUN
fcis-31417	115	4	with	with	ADP
fcis-31417	115	5	a	a	DET
fcis-31417	115	6	predicted	predict	VERB
fcis-31417	115	7	survival	survival	NOUN
fcis-31417	115	8	period	period	NOUN
fcis-31417	115	9	of	of	ADP
fcis-31417	115	10	<	<	X
fcis-31417	115	11	18	18	NUM
fcis-31417	115	12	months	month	NOUN
fcis-31417	115	13	,	,	PUNCT
fcis-31417	115	14	the	the	DET
fcis-31417	115	15	use	use	NOUN
fcis-31417	115	16	of	of	ADP
fcis-31417	115	17	palliative	palliative	ADJ
fcis-31417	115	18	treatment	treatment	NOUN
fcis-31417	115	19	can	can	AUX
fcis-31417	115	20	reduce	reduce	VERB
fcis-31417	115	21	medical	medical	ADJ
fcis-31417	115	22	expenses	expense	NOUN
fcis-31417	115	23	by	by	ADP
fcis-31417	115	24	40	40	NUM
fcis-31417	115	25	%	%	NOUN
fcis-31417	115	26	;	;	PUNCT
fcis-31417	115	27	third	third	ADV
fcis-31417	115	28	,	,	PUNCT
fcis-31417	115	29	dynamically	dynamically	ADV
fcis-31417	115	30	evaluating	evaluate	VERB
fcis-31417	115	31	the	the	DET
fcis-31417	115	32	efficacy	efficacy	NOUN
fcis-31417	115	33	.	.	PUNCT
fcis-31417	116	1	during	during	ADP
fcis-31417	116	2	treatment	treatment	NOUN
fcis-31417	116	3	,	,	PUNCT
fcis-31417	116	4	if	if	SCONJ
fcis-31417	116	5	ct	ct	NOUN
fcis-31417	116	6	images	image	NOUN
fcis-31417	116	7	show	show	VERB
fcis-31417	116	8	that	that	SCONJ
fcis-31417	116	9	the	the	DET
fcis-31417	116	10	tumor	tumor	NOUN
fcis-31417	116	11	has	have	AUX
fcis-31417	116	12	shrunk	shrink	VERB
fcis-31417	116	13	but	but	CCONJ
fcis-31417	116	14	the	the	DET
fcis-31417	116	15	ctdna	ctdna	NOUN
fcis-31417	116	16	clearance	clearance	NOUN
fcis-31417	116	17	rate	rate	NOUN
fcis-31417	116	18	is	be	AUX
fcis-31417	116	19	<	<	X
fcis-31417	116	20	50	50	NUM
fcis-31417	116	21	%	%	NOUN
fcis-31417	116	22	,	,	PUNCT
fcis-31417	116	23	the	the	DET
fcis-31417	116	24	model	model	NOUN
fcis-31417	116	25	can	can	AUX
fcis-31417	116	26	warn	warn	VERB
fcis-31417	116	27	of	of	ADP
fcis-31417	116	28	drug	drug	NOUN
fcis-31417	116	29	resistance	resistance	NOUN
fcis-31417	116	30	4	4	NUM
fcis-31417	116	31	-	-	SYM
fcis-31417	116	32	6	6	NUM
fcis-31417	116	33	months	month	NOUN
fcis-31417	116	34	in	in	ADP
fcis-31417	116	35	advance	advance	NOUN
fcis-31417	116	36	(	(	PUNCT
fcis-31417	116	37	accuracy	accuracy	NOUN
fcis-31417	116	38	82	82	NUM
fcis-31417	116	39	%	%	NOUN
fcis-31417	116	40	)	)	PUNCT
fcis-31417	116	41	,	,	PUNCT
fcis-31417	116	42	which	which	PRON
fcis-31417	116	43	is	be	AUX
fcis-31417	116	44	2	2	NUM
fcis-31417	116	45	cycles	cycle	NOUN
fcis-31417	116	46	earlier	early	ADV
fcis-31417	116	47	than	than	ADP
fcis-31417	116	48	traditional	traditional	ADJ
fcis-31417	116	49	imaging	imaging	NOUN
fcis-31417	116	50	evaluation	evaluation	NOUN
fcis-31417	116	51	.	.	PUNCT
fcis-31417	117	1	compared	compare	VERB
fcis-31417	117	2	with	with	ADP
fcis-31417	117	3	traditional	traditional	ADJ
fcis-31417	117	4	clinical	clinical	ADJ
fcis-31417	117	5	staging	staging	NOUN
fcis-31417	117	6	,	,	PUNCT
fcis-31417	117	7	the	the	DET
fcis-31417	117	8	model	model	NOUN
fcis-31417	117	9	's	's	PART
fcis-31417	117	10	prediction	prediction	NOUN
fcis-31417	117	11	accuracy	accuracy	NOUN
fcis-31417	117	12	for	for	ADP
fcis-31417	117	13	3	3	NUM
fcis-31417	117	14	-	-	PUNCT
fcis-31417	117	15	year	year	NOUN
fcis-31417	117	16	survival	survival	NOUN
fcis-31417	117	17	rate	rate	NOUN
fcis-31417	117	18	increased	increase	VERB
fcis-31417	117	19	by	by	ADP
fcis-31417	117	20	19.3	19.3	NUM
fcis-31417	117	21	%	%	NOUN
fcis-31417	117	22	,	,	PUNCT
fcis-31417	117	23	and	and	CCONJ
fcis-31417	117	24	the	the	DET
fcis-31417	117	25	risk	risk	NOUN
fcis-31417	117	26	stratification	stratification	NOUN
fcis-31417	117	27	error	error	NOUN
fcis-31417	117	28	rate	rate	NOUN
fcis-31417	117	29	for	for	ADP
fcis-31417	117	30	stage	stage	NOUN
fcis-31417	117	31	ii	ii	PROPN
fcis-31417	117	32	patients	patient	NOUN
fcis-31417	117	33	decreased	decrease	VERB
fcis-31417	117	34	by	by	ADP
fcis-31417	117	35	35	35	NUM
fcis-31417	117	36	%	%	NOUN
fcis-31417	117	37	,	,	PUNCT
fcis-31417	117	38	significantly	significantly	ADV
fcis-31417	117	39	reducing	reduce	VERB
fcis-31417	117	40	clinical	clinical	ADJ
fcis-31417	117	41	decision	decision	NOUN
fcis-31417	117	42	-	-	PUNCT
fcis-31417	117	43	making	make	VERB
fcis-31417	117	44	bias	bias	NOUN
fcis-31417	117	45	.	.	PUNCT
fcis-31417	118	1	4.2	4.2	NUM
fcis-31417	118	2	.	.	PUNCT
fcis-31417	118	3	discussion	discussion	NOUN
fcis-31417	118	4	on	on	ADP
fcis-31417	118	5	model	model	NOUN
fcis-31417	118	6	limitations	limitation	NOUN
fcis-31417	118	7	data	data	NOUN
fcis-31417	118	8	heterogeneity	heterogeneity	NOUN
fcis-31417	118	9	poses	pose	VERB
fcis-31417	118	10	a	a	DET
fcis-31417	118	11	major	major	ADJ
fcis-31417	118	12	challenge	challenge	NOUN
fcis-31417	118	13	:	:	PUNCT
fcis-31417	118	14	although	although	SCONJ
fcis-31417	118	15	the	the	DET
fcis-31417	118	16	ct	ct	NUM
fcis-31417	118	17	equipment	equipment	NOUN
fcis-31417	118	18	of	of	ADP
fcis-31417	118	19	the	the	DET
fcis-31417	118	20	three	three	NUM
fcis-31417	118	21	medical	medical	ADJ
fcis-31417	118	22	institutions	institution	NOUN
fcis-31417	118	23	uses	use	VERB
fcis-31417	118	24	unified	unified	ADJ
fcis-31417	118	25	scanning	scanning	NOUN
fcis-31417	118	26	parameters	parameter	NOUN
fcis-31417	118	27	,	,	PUNCT
fcis-31417	118	28	the	the	DET
fcis-31417	118	29	image	image	NOUN
fcis-31417	118	30	grayscale	grayscale	NOUN
fcis-31417	118	31	value	value	NOUN
fcis-31417	118	32	deviation	deviation	NOUN
fcis-31417	118	33	still	still	ADV
fcis-31417	118	34	reaches	reach	VERB
fcis-31417	118	35	±15hu	±15hu	PROPN
fcis-31417	118	36	due	due	ADP
fcis-31417	118	37	to	to	ADP
fcis-31417	118	38	different	different	ADJ
fcis-31417	118	39	degrees	degree	NOUN
fcis-31417	118	40	of	of	ADP
fcis-31417	118	41	tube	tube	NOUN
fcis-31417	118	42	aging	aging	NOUN
fcis-31417	118	43	,	,	PUNCT
fcis-31417	118	44	resulting	result	VERB
fcis-31417	118	45	in	in	ADP
fcis-31417	118	46	a	a	DET
fcis-31417	118	47	coefficient	coefficient	NOUN
fcis-31417	118	48	of	of	ADP
fcis-31417	118	49	variation	variation	NOUN
fcis-31417	118	50	of	of	ADP
fcis-31417	118	51	8.7	8.7	NUM
fcis-31417	118	52	%	%	NOUN
fcis-31417	118	53	in	in	ADP
fcis-31417	118	54	the	the	DET
fcis-31417	118	55	"	"	PUNCT
fcis-31417	118	56	entropy	entropy	NOUN
fcis-31417	118	57	value	value	NOUN
fcis-31417	118	58	"	"	PUNCT
fcis-31417	118	59	indicator	indicator	NOUN
fcis-31417	118	60	in	in	ADP
fcis-31417	118	61	the	the	DET
fcis-31417	118	62	imaging	imaging	NOUN
fcis-31417	118	63	genomics	genomic	NOUN
fcis-31417	118	64	feature	feature	VERB
fcis-31417	118	65	;	;	PUNCT
fcis-31417	118	66	in	in	ADP
fcis-31417	118	67	terms	term	NOUN
fcis-31417	118	68	of	of	ADP
fcis-31417	118	69	liquid	liquid	ADJ
fcis-31417	118	70	biopsy	biopsy	NOUN
fcis-31417	118	71	,	,	PUNCT
fcis-31417	118	72	the	the	DET
fcis-31417	118	73	difference	difference	NOUN
fcis-31417	118	74	in	in	ADP
fcis-31417	118	75	ctdna	ctdna	NOUN
fcis-31417	118	76	extraction	extraction	NOUN
fcis-31417	118	77	efficiency	efficiency	NOUN
fcis-31417	118	78	(	(	PUNCT
fcis-31417	118	79	82%-90	82%-90	NUM
fcis-31417	118	80	%	%	NOUN
fcis-31417	118	81	)	)	PUNCT
fcis-31417	118	82	between	between	ADP
fcis-31417	118	83	different	different	ADJ
fcis-31417	118	84	centers	center	NOUN
fcis-31417	118	85	causes	cause	VERB
fcis-31417	118	86	mutation	mutation	NOUN
fcis-31417	118	87	detection	detection	NOUN
fcis-31417	118	88	sensitivity	sensitivity	NOUN
fcis-31417	118	89	to	to	PART
fcis-31417	118	90	fluctuate	fluctuate	VERB
fcis-31417	118	91	by	by	ADP
fcis-31417	118	92	5%-8	5%-8	NUM
fcis-31417	118	93	%	%	NOUN
fcis-31417	118	94	,	,	PUNCT
fcis-31417	118	95	which	which	PRON
fcis-31417	118	96	directly	directly	ADV
fcis-31417	118	97	affects	affect	VERB
fcis-31417	118	98	the	the	DET
fcis-31417	118	99	accuracy	accuracy	NOUN
fcis-31417	118	100	of	of	ADP
fcis-31417	118	101	tmb	tmb	PROPN
fcis-31417	118	102	calculation	calculation	NOUN
fcis-31417	118	103	,	,	PUNCT
fcis-31417	118	104	resulting	result	VERB
fcis-31417	118	105	in	in	ADP
fcis-31417	118	106	a	a	DET
fcis-31417	118	107	12	12	NUM
fcis-31417	118	108	%	%	NOUN
fcis-31417	118	109	difference	difference	NOUN
fcis-31417	118	110	in	in	ADP
fcis-31417	118	111	tmb	tmb	NOUN
fcis-31417	118	112	values	value	NOUN
fcis-31417	118	113	for	for	ADP
fcis-31417	118	114	the	the	DET
fcis-31417	118	115	same	same	ADJ
fcis-31417	118	116	patient	patient	NOUN
fcis-31417	118	117	in	in	ADP
fcis-31417	118	118	different	different	ADJ
fcis-31417	118	119	centers	center	NOUN
fcis-31417	118	120	[	[	X
fcis-31417	118	121	15	15	NUM
fcis-31417	118	122	]	]	PUNCT
fcis-31417	118	123	.	.	PUNCT
fcis-31417	119	1	this	this	DET
fcis-31417	119	2	heterogeneity	heterogeneity	NOUN
fcis-31417	119	3	caused	cause	VERB
fcis-31417	119	4	the	the	DET
fcis-31417	119	5	model	model	NOUN
fcis-31417	119	6	's	's	PART
fcis-31417	119	7	c	c	NOUN
fcis-31417	119	8	-	-	PUNCT
fcis-31417	119	9	index	index	NOUN
fcis-31417	119	10	to	to	PART
fcis-31417	119	11	reach	reach	VERB
fcis-31417	119	12	0.89	0.89	NUM
fcis-31417	119	13	in	in	ADP
fcis-31417	119	14	single	single	ADJ
fcis-31417	119	15	-	-	PUNCT
fcis-31417	119	16	center	center	NOUN
fcis-31417	119	17	validation	validation	NOUN
fcis-31417	119	18	,	,	PUNCT
fcis-31417	119	19	but	but	CCONJ
fcis-31417	119	20	dropped	drop	VERB
fcis-31417	119	21	to	to	ADP
fcis-31417	119	22	0.81	0.81	NUM
fcis-31417	119	23	in	in	ADP
fcis-31417	119	24	cross	cross	ADJ
fcis-31417	119	25	-	-	ADJ
fcis-31417	119	26	center	center	ADJ
fcis-31417	119	27	validation	validation	NOUN
fcis-31417	119	28	(	(	PUNCT
fcis-31417	119	29	p<0.05	p<0.05	NOUN
fcis-31417	119	30	)	)	PUNCT
fcis-31417	119	31	,	,	PUNCT
fcis-31417	119	32	among	among	ADP
fcis-31417	119	33	which	which	PRON
fcis-31417	119	34	the	the	DET
fcis-31417	119	35	prediction	prediction	NOUN
fcis-31417	119	36	error	error	NOUN
fcis-31417	119	37	of	of	ADP
fcis-31417	119	38	stage	stage	NOUN
fcis-31417	119	39	iii	iii	NUM
fcis-31417	119	40	patients	patient	NOUN
fcis-31417	119	41	increased	increase	VERB
fcis-31417	119	42	the	the	DET
fcis-31417	119	43	most	most	ADV
fcis-31417	119	44	(	(	PUNCT
fcis-31417	119	45	rmse	rmse	PROPN
fcis-31417	119	46	increased	increase	VERB
fcis-31417	119	47	from	from	ADP
fcis-31417	119	48	5.8	5.8	NUM
fcis-31417	119	49	months	month	NOUN
fcis-31417	119	50	to	to	ADP
fcis-31417	119	51	7.1	7.1	NUM
fcis-31417	119	52	months	month	NOUN
fcis-31417	119	53	)	)	PUNCT
fcis-31417	119	54	.	.	PUNCT
fcis-31417	120	1	the	the	DET
fcis-31417	120	2	generalizability	generalizability	NOUN
fcis-31417	120	3	of	of	ADP
fcis-31417	120	4	the	the	DET
fcis-31417	120	5	model	model	NOUN
fcis-31417	120	6	is	be	AUX
fcis-31417	120	7	limited	limit	VERB
fcis-31417	120	8	by	by	ADP
fcis-31417	120	9	three	three	NUM
fcis-31417	120	10	aspects	aspect	NOUN
fcis-31417	120	11	:	:	PUNCT
fcis-31417	120	12	first	first	ADJ
fcis-31417	120	13	,	,	PUNCT
fcis-31417	120	14	racial	racial	ADJ
fcis-31417	120	15	differences	difference	NOUN
fcis-31417	120	16	.	.	PUNCT
fcis-31417	121	1	the	the	DET
fcis-31417	121	2	median	median	ADJ
fcis-31417	121	3	fluorescence	fluorescence	NOUN
fcis-31417	121	4	intensity	intensity	NOUN
fcis-31417	121	5	of	of	ADP
fcis-31417	121	6	exosomal	exosomal	ADJ
fcis-31417	121	7	pd	pd	PROPN
fcis-31417	121	8	-	-	PROPN
fcis-31417	121	9	l1	l1	PROPN
fcis-31417	121	10	in	in	ADP
fcis-31417	121	11	asians	asians	PROPN
fcis-31417	121	12	(	(	PUNCT
fcis-31417	121	13	620au	620au	NOUN
fcis-31417	121	14	)	)	PUNCT
fcis-31417	121	15	is	be	AUX
fcis-31417	121	16	significantly	significantly	ADV
fcis-31417	121	17	higher	high	ADJ
fcis-31417	121	18	than	than	ADP
fcis-31417	121	19	that	that	PRON
fcis-31417	121	20	in	in	ADP
fcis-31417	121	21	caucasians	caucasian	NOUN
fcis-31417	121	22	(	(	PUNCT
fcis-31417	121	23	450au	450au	NOUN
fcis-31417	121	24	)	)	PUNCT
fcis-31417	121	25	,	,	PUNCT
fcis-31417	121	26	resulting	result	VERB
fcis-31417	121	27	in	in	ADP
fcis-31417	121	28	a	a	DET
fcis-31417	121	29	20	20	NUM
fcis-31417	121	30	%	%	NOUN
fcis-31417	121	31	increase	increase	NOUN
fcis-31417	121	32	in	in	ADP
fcis-31417	121	33	the	the	DET
fcis-31417	121	34	false	false	ADJ
fcis-31417	121	35	positive	positive	ADJ
fcis-31417	121	36	rate	rate	NOUN
fcis-31417	121	37	of	of	ADP
fcis-31417	121	38	the	the	DET
fcis-31417	121	39	threshold	threshold	NOUN
fcis-31417	121	40	optimized	optimize	VERB
fcis-31417	121	41	for	for	ADP
fcis-31417	121	42	asians	asians	PROPN
fcis-31417	121	43	(	(	PUNCT
fcis-31417	121	44	>	>	NOUN
fcis-31417	121	45	500au	500au	NOUN
fcis-31417	121	46	)	)	PUNCT
fcis-31417	121	47	in	in	ADP
fcis-31417	121	48	caucasians	caucasian	NOUN
fcis-31417	121	49	;	;	PUNCT
fcis-31417	121	50	second	second	ADJ
fcis-31417	121	51	,	,	PUNCT
fcis-31417	121	52	pathological	pathological	ADJ
fcis-31417	121	53	type	type	NOUN
fcis-31417	121	54	limitation	limitation	NOUN
fcis-31417	121	55	.	.	PUNCT
fcis-31417	122	1	small	small	ADJ
fcis-31417	122	2	cell	cell	NOUN
fcis-31417	122	3	lung	lung	NOUN
fcis-31417	122	4	cancer	cancer	NOUN
fcis-31417	122	5	samples	sample	NOUN
fcis-31417	122	6	account	account	VERB
fcis-31417	122	7	for	for	ADP
fcis-31417	122	8	only	only	ADV
fcis-31417	122	9	18	18	NUM
fcis-31417	122	10	%	%	NOUN
fcis-31417	122	11	,	,	PUNCT
fcis-31417	122	12	and	and	CCONJ
fcis-31417	122	13	its	its	PRON
fcis-31417	122	14	high	high	ADJ
fcis-31417	122	15	invasiveness	invasiveness	NOUN
fcis-31417	122	16	leads	lead	VERB
fcis-31417	122	17	to	to	ADP
fcis-31417	122	18	a	a	DET
fcis-31417	122	19	significantly	significantly	ADV
fcis-31417	122	20	higher	high	ADJ
fcis-31417	122	21	model	model	NOUN
fcis-31417	122	22	prediction	prediction	NOUN
fcis-31417	122	23	error	error	NOUN
fcis-31417	122	24	for	for	ADP
fcis-31417	122	25	its	its	PRON
fcis-31417	122	26	survival	survival	NOUN
fcis-31417	122	27	(	(	PUNCT
fcis-31417	122	28	rmse=7.2	rmse=7.2	NOUN
fcis-31417	122	29	months	month	NOUN
fcis-31417	122	30	)	)	PUNCT
fcis-31417	122	31	than	than	ADP
fcis-31417	122	32	non	non	ADJ
fcis-31417	122	33	-	-	ADJ
fcis-31417	122	34	small	small	ADJ
fcis-31417	122	35	cell	cell	NOUN
fcis-31417	122	36	lung	lung	NOUN
fcis-31417	122	37	cancer	cancer	NOUN
fcis-31417	122	38	(	(	PUNCT
fcis-31417	122	39	rmse=5.3	rmse=5.3	ADJ
fcis-31417	122	40	months	month	NOUN
fcis-31417	122	41	)	)	PUNCT
fcis-31417	122	42	;	;	PUNCT
fcis-31417	122	43	third	third	X
fcis-31417	122	44	,	,	PUNCT
fcis-31417	122	45	technical	technical	ADJ
fcis-31417	122	46	dependence	dependence	NOUN
fcis-31417	122	47	.	.	PUNCT
fcis-31417	123	1	if	if	SCONJ
fcis-31417	123	2	grassroots	grassroots	ADJ
fcis-31417	123	3	hospitals	hospital	NOUN
fcis-31417	123	4	use	use	VERB
fcis-31417	123	5	500×	500×	NOUN
fcis-31417	123	6	deep	deep	ADJ
fcis-31417	123	7	sequencing	sequencing	NOUN
fcis-31417	123	8	,	,	PUNCT
fcis-31417	123	9	the	the	DET
fcis-31417	123	10	detection	detection	NOUN
fcis-31417	123	11	rate	rate	NOUN
fcis-31417	123	12	of	of	ADP
fcis-31417	123	13	low	low	ADJ
fcis-31417	123	14	-	-	PUNCT
fcis-31417	123	15	frequency	frequency	NOUN
fcis-31417	123	16	mutations	mutation	NOUN
fcis-31417	123	17	(	(	PUNCT
fcis-31417	123	18	maf	maf	PROPN
fcis-31417	123	19	0.5%-1	0.5%-1	NUM
fcis-31417	123	20	%	%	NOUN
fcis-31417	123	21	)	)	PUNCT
fcis-31417	123	22	in	in	ADP
fcis-31417	123	23	liquid	liquid	ADJ
fcis-31417	123	24	biopsy	biopsy	NOUN
fcis-31417	123	25	features	feature	NOUN
fcis-31417	123	26	will	will	AUX
fcis-31417	123	27	decrease	decrease	VERB
fcis-31417	123	28	by	by	ADP
fcis-31417	123	29	35	35	NUM
fcis-31417	123	30	%	%	NOUN
fcis-31417	123	31	,	,	PUNCT
fcis-31417	123	32	which	which	PRON
fcis-31417	123	33	will	will	AUX
fcis-31417	123	34	lead	lead	VERB
fcis-31417	123	35	to	to	ADP
fcis-31417	123	36	a	a	DET
fcis-31417	123	37	23	23	NUM
fcis-31417	123	38	%	%	NOUN
fcis-31417	123	39	attenuation	attenuation	NOUN
fcis-31417	123	40	of	of	ADP
fcis-31417	123	41	model	model	NOUN
fcis-31417	123	42	performance	performance	NOUN
fcis-31417	123	43	[	[	X
fcis-31417	123	44	16	16	NUM
fcis-31417	123	45	]	]	PUNCT
fcis-31417	123	46	.	.	PUNCT
fcis-31417	124	1	in	in	ADP
fcis-31417	124	2	addition	addition	NOUN
fcis-31417	124	3	,	,	PUNCT
fcis-31417	124	4	the	the	DET
fcis-31417	124	5	model	model	NOUN
fcis-31417	124	6	does	do	AUX
fcis-31417	124	7	not	not	PART
fcis-31417	124	8	include	include	VERB
fcis-31417	124	9	dynamic	dynamic	ADJ
fcis-31417	124	10	factors	factor	NOUN
fcis-31417	124	11	such	such	ADJ
fcis-31417	124	12	as	as	ADP
fcis-31417	124	13	patient	patient	ADJ
fcis-31417	124	14	treatment	treatment	NOUN
fcis-31417	124	15	compliance	compliance	NOUN
fcis-31417	124	16	and	and	CCONJ
fcis-31417	124	17	combined	combined	ADJ
fcis-31417	124	18	diabetes	diabete	NOUN
fcis-31417	124	19	,	,	PUNCT
fcis-31417	124	20	and	and	CCONJ
fcis-31417	124	21	the	the	DET
fcis-31417	124	22	prediction	prediction	NOUN
fcis-31417	124	23	error	error	NOUN
fcis-31417	124	24	of	of	ADP
fcis-31417	124	25	long	long	ADJ
fcis-31417	124	26	-	-	PUNCT
fcis-31417	124	27	term	term	NOUN
fcis-31417	124	28	(	(	PUNCT
fcis-31417	124	29	>	>	SYM
fcis-31417	124	30	3	3	NUM
fcis-31417	124	31	years	year	NOUN
fcis-31417	124	32	)	)	PUNCT
fcis-31417	124	33	survival	survival	NOUN
fcis-31417	124	34	is	be	AUX
fcis-31417	124	35	18	18	NUM
fcis-31417	124	36	%	%	NOUN
fcis-31417	124	37	higher	high	ADJ
fcis-31417	124	38	than	than	ADP
fcis-31417	124	39	that	that	PRON
fcis-31417	124	40	of	of	ADP
fcis-31417	124	41	short	short	ADJ
fcis-31417	124	42	-	-	PUNCT
fcis-31417	124	43	term	term	NOUN
fcis-31417	124	44	survival	survival	NOUN
fcis-31417	124	45	,	,	PUNCT
fcis-31417	124	46	which	which	PRON
fcis-31417	124	47	may	may	AUX
fcis-31417	124	48	affect	affect	VERB
fcis-31417	124	49	the	the	DET
fcis-31417	124	50	long	long	ADJ
fcis-31417	124	51	-	-	PUNCT
fcis-31417	124	52	term	term	NOUN
fcis-31417	124	53	nature	nature	NOUN
fcis-31417	124	54	of	of	ADP
fcis-31417	124	55	clinical	clinical	ADJ
fcis-31417	124	56	decisionmaking	decisionmaking	NOUN
fcis-31417	124	57	.	.	PUNCT
fcis-31417	125	1	4.3	4.3	NUM
fcis-31417	125	2	.	.	PUNCT
fcis-31417	126	1	future	future	ADJ
fcis-31417	126	2	research	research	NOUN
fcis-31417	126	3	directions	direction	NOUN
fcis-31417	126	4	a	a	DET
fcis-31417	126	5	multi	multi	ADJ
fcis-31417	126	6	-	-	ADJ
fcis-31417	126	7	center	center	ADJ
fcis-31417	126	8	expansion	expansion	NOUN
fcis-31417	126	9	study	study	NOUN
fcis-31417	126	10	is	be	AUX
fcis-31417	126	11	planned	plan	VERB
fcis-31417	126	12	:	:	PUNCT
fcis-31417	126	13	1,500	1,500	NUM
fcis-31417	126	14	patients	patient	NOUN
fcis-31417	126	15	from	from	ADP
fcis-31417	126	16	12	12	NUM
fcis-31417	126	17	hospitals	hospital	NOUN
fcis-31417	126	18	of	of	ADP
fcis-31417	126	19	different	different	ADJ
fcis-31417	126	20	levels	level	NOUN
fcis-31417	126	21	(	(	PUNCT
fcis-31417	126	22	3	3	NUM
fcis-31417	126	23	tertiary	tertiary	ADJ
fcis-31417	126	24	hospitals	hospital	NOUN
fcis-31417	126	25	,	,	PUNCT
fcis-31417	126	26	6	6	NUM
fcis-31417	126	27	secondary	secondary	ADJ
fcis-31417	126	28	hospitals	hospital	NOUN
fcis-31417	126	29	,	,	PUNCT
fcis-31417	126	30	and	and	CCONJ
fcis-31417	126	31	3	3	NUM
fcis-31417	126	32	primary	primary	ADJ
fcis-31417	126	33	hospitals	hospital	NOUN
fcis-31417	126	34	)	)	PUNCT
fcis-31417	126	35	are	be	AUX
fcis-31417	126	36	planned	plan	VERB
fcis-31417	126	37	to	to	PART
fcis-31417	126	38	be	be	AUX
fcis-31417	126	39	included	include	VERB
fcis-31417	126	40	in	in	ADP
fcis-31417	126	41	the	the	DET
fcis-31417	126	42	next	next	ADJ
fcis-31417	126	43	2	2	NUM
fcis-31417	126	44	years	year	NOUN
fcis-31417	126	45	.	.	PUNCT
fcis-31417	127	1	standardized	standardize	VERB
fcis-31417	127	2	image	image	NOUN
fcis-31417	127	3	acquisition	acquisition	NOUN
fcis-31417	127	4	protocols	protocol	NOUN
fcis-31417	127	5	(	(	PUNCT
fcis-31417	127	6	including	include	VERB
fcis-31417	127	7	monthly	monthly	ADJ
fcis-31417	127	8	equipment	equipment	NOUN
fcis-31417	127	9	calibration	calibration	NOUN
fcis-31417	127	10	phantom	phantom	NOUN
fcis-31417	127	11	detection	detection	NOUN
fcis-31417	127	12	)	)	PUNCT
fcis-31417	127	13	and	and	CCONJ
fcis-31417	127	14	liquid	liquid	ADJ
fcis-31417	127	15	biopsy	biopsy	NOUN
fcis-31417	127	16	quality	quality	NOUN
fcis-31417	127	17	control	control	NOUN
fcis-31417	127	18	products	product	NOUN
fcis-31417	127	19	(	(	PUNCT
fcis-31417	127	20	containing	contain	VERB
fcis-31417	127	21	ctdna	ctdna	NOUN
fcis-31417	127	22	reference	reference	NOUN
fcis-31417	127	23	materials	material	NOUN
fcis-31417	127	24	with	with	ADP
fcis-31417	127	25	known	known	ADJ
fcis-31417	127	26	concentrations	concentration	NOUN
fcis-31417	127	27	,	,	PUNCT
fcis-31417	127	28	with	with	ADP
fcis-31417	127	29	a	a	DET
fcis-31417	127	30	concentration	concentration	NOUN
fcis-31417	127	31	gradient	gradient	NOUN
fcis-31417	127	32	of	of	ADP
fcis-31417	127	33	0.110ng	0.110ng	PROPN
fcis-31417	127	34	/	/	SYM
fcis-31417	127	35	μl	μl	CCONJ
fcis-31417	127	36	)	)	PUNCT
fcis-31417	127	37	are	be	AUX
fcis-31417	127	38	used	use	VERB
fcis-31417	127	39	to	to	PART
fcis-31417	127	40	eliminate	eliminate	VERB
fcis-31417	127	41	regional	regional	ADJ
fcis-31417	127	42	bias	bias	NOUN
fcis-31417	127	43	through	through	ADP
fcis-31417	127	44	multicenter	multicenter	ADJ
fcis-31417	127	45	cross	cross	NOUN
fcis-31417	127	46	-	-	NOUN
fcis-31417	127	47	validation	validation	NOUN
fcis-31417	127	48	.	.	PUNCT
fcis-31417	128	1	simultaneously	simultaneously	ADV
fcis-31417	128	2	establish	establish	VERB
fcis-31417	128	3	an	an	DET
fcis-31417	128	4	"	"	PUNCT
fcis-31417	128	5	imagemolecule	imagemolecule	NOUN
fcis-31417	128	6	"	"	PUNCT
fcis-31417	128	7	feature	feature	NOUN
fcis-31417	128	8	database	database	NOUN
fcis-31417	128	9	,	,	PUNCT
fcis-31417	128	10	and	and	CCONJ
fcis-31417	128	11	use	use	VERB
fcis-31417	128	12	federated	federated	ADJ
fcis-31417	128	13	learning	learn	VERB
fcis-31417	128	14	technology	technology	NOUN
fcis-31417	128	15	to	to	PART
fcis-31417	128	16	achieve	achieve	VERB
fcis-31417	128	17	data	datum	NOUN
fcis-31417	128	18	sharing	sharing	NOUN
fcis-31417	128	19	without	without	ADP
fcis-31417	128	20	leaking	leak	VERB
fcis-31417	128	21	privacy	privacy	NOUN
fcis-31417	128	22	.	.	PUNCT
fcis-31417	129	1	this	this	DET
fcis-31417	129	2	technology	technology	NOUN
fcis-31417	129	3	can	can	AUX
fcis-31417	129	4	increase	increase	VERB
fcis-31417	129	5	the	the	DET
fcis-31417	129	6	data	data	NOUN
fcis-31417	129	7	utilization	utilization	NOUN
fcis-31417	129	8	rate	rate	NOUN
fcis-31417	129	9	of	of	ADP
fcis-31417	129	10	each	each	DET
fcis-31417	129	11	center	center	NOUN
fcis-31417	129	12	by	by	ADP
fcis-31417	129	13	60	60	NUM
fcis-31417	129	14	%	%	NOUN
fcis-31417	129	15	,	,	PUNCT
fcis-31417	129	16	and	and	CCONJ
fcis-31417	129	17	is	be	AUX
fcis-31417	129	18	expected	expect	VERB
fcis-31417	129	19	to	to	PART
fcis-31417	129	20	increase	increase	VERB
fcis-31417	129	21	the	the	DET
fcis-31417	129	22	model	model	NOUN
fcis-31417	129	23	c	c	NOUN
fcis-31417	129	24	-	-	PUNCT
fcis-31417	129	25	index	index	NOUN
fcis-31417	129	26	to	to	ADP
fcis-31417	129	27	0.87	0.87	NUM
fcis-31417	129	28	,	,	PUNCT
fcis-31417	129	29	and	and	CCONJ
fcis-31417	129	30	reduce	reduce	VERB
fcis-31417	129	31	the	the	DET
fcis-31417	129	32	cross	cross	ADJ
fcis-31417	129	33	-	-	ADJ
fcis-31417	129	34	center	center	ADJ
fcis-31417	129	35	verification	verification	NOUN
fcis-31417	129	36	error	error	NOUN
fcis-31417	129	37	by	by	ADP
fcis-31417	129	38	15	15	NUM
fcis-31417	129	39	%	%	NOUN
fcis-31417	129	40	.	.	PUNCT
fcis-31417	130	1	technological	technological	ADJ
fcis-31417	130	2	innovation	innovation	NOUN
fcis-31417	130	3	focuses	focus	VERB
fcis-31417	130	4	on	on	ADP
fcis-31417	130	5	three	three	NUM
fcis-31417	130	6	aspects	aspect	NOUN
fcis-31417	130	7	:	:	PUNCT
fcis-31417	130	8	first	first	ADV
fcis-31417	130	9	,	,	PUNCT
fcis-31417	130	10	exploring	explore	VERB
fcis-31417	130	11	new	new	ADJ
fcis-31417	130	12	imaging	imaging	NOUN
fcis-31417	130	13	features	feature	NOUN
fcis-31417	130	14	.	.	PUNCT
fcis-31417	131	1	the	the	DET
fcis-31417	131	2	quantitative	quantitative	ADJ
fcis-31417	131	3	parameters	parameter	NOUN
fcis-31417	131	4	of	of	ADP
fcis-31417	131	5	iodine	iodine	NOUN
fcis-31417	131	6	concentration	concentration	NOUN
fcis-31417	131	7	based	base	VERB
fcis-31417	131	8	on	on	ADP
fcis-31417	131	9	dual	dual	ADJ
fcis-31417	131	10	-	-	PUNCT
fcis-31417	131	11	energy	energy	NOUN
fcis-31417	131	12	ct	ct	NOUN
fcis-31417	131	13	(	(	PUNCT
fcis-31417	131	14	1.2±0.3mg	1.2±0.3mg	NUM
fcis-31417	131	15	/	/	SYM
fcis-31417	131	16	ml	ml	NOUN
fcis-31417	131	17	in	in	ADP
fcis-31417	131	18	normal	normal	ADJ
fcis-31417	131	19	lung	lung	NOUN
fcis-31417	131	20	tissue	tissue	NOUN
fcis-31417	131	21	and	and	CCONJ
fcis-31417	131	22	3.5±0.8mg	3.5±0.8mg	NUM
fcis-31417	131	23	/	/	SYM
fcis-31417	131	24	ml	ml	NOUN
fcis-31417	131	25	in	in	ADP
fcis-31417	131	26	tumor	tumor	NOUN
fcis-31417	131	27	tissue	tissue	NOUN
fcis-31417	131	28	)	)	PUNCT
fcis-31417	131	29	can	can	AUX
fcis-31417	131	30	reflect	reflect	VERB
fcis-31417	131	31	the	the	DET
fcis-31417	131	32	tumor	tumor	NOUN
fcis-31417	131	33	microvessel	microvessel	NOUN
fcis-31417	131	34	density	density	NOUN
fcis-31417	131	35	and	and	CCONJ
fcis-31417	131	36	are	be	AUX
fcis-31417	131	37	positively	positively	ADV
fcis-31417	131	38	correlated	correlate	VERB
fcis-31417	131	39	with	with	ADP
fcis-31417	131	40	the	the	DET
fcis-31417	131	41	expression	expression	NOUN
fcis-31417	131	42	of	of	ADP
fcis-31417	131	43	the	the	DET
fcis-31417	131	44	angiogenic	angiogenic	ADJ
fcis-31417	131	45	factor	factor	NOUN
fcis-31417	131	46	vegf	vegf	NOUN
fcis-31417	131	47	(	(	PUNCT
fcis-31417	131	48	r=0.72	r=0.72	NUM
fcis-31417	131	49	)	)	PUNCT
fcis-31417	131	50	;	;	PUNCT
fcis-31417	131	51	second	second	ADV
fcis-31417	131	52	,	,	PUNCT
fcis-31417	131	53	expanding	expand	VERB
fcis-31417	131	54	the	the	DET
fcis-31417	131	55	dimension	dimension	NOUN
fcis-31417	131	56	of	of	ADP
fcis-31417	131	57	liquid	liquid	ADJ
fcis-31417	131	58	biopsy	biopsy	NOUN
fcis-31417	131	59	and	and	CCONJ
fcis-31417	131	60	introducing	introduce	VERB
fcis-31417	131	61	single	single	ADJ
fcis-31417	131	62	-	-	PUNCT
fcis-31417	131	63	cell	cell	NOUN
fcis-31417	131	64	sequencing	sequence	VERB
fcis-31417	131	65	data	datum	NOUN
fcis-31417	131	66	of	of	ADP
fcis-31417	131	67	circulating	circulate	VERB
fcis-31417	131	68	tumor	tumor	NOUN
fcis-31417	131	69	cells	cell	NOUN
fcis-31417	131	70	to	to	PART
fcis-31417	131	71	capture	capture	VERB
fcis-31417	131	72	tumor	tumor	NOUN
fcis-31417	131	73	clonal	clonal	ADJ
fcis-31417	131	74	evolution	evolution	PROPN
fcis-31417	131	75	information	information	NOUN
fcis-31417	131	76	,	,	PUNCT
fcis-31417	131	77	such	such	ADJ
fcis-31417	131	78	as	as	ADP
fcis-31417	131	79	tracking	track	VERB
fcis-31417	131	80	the	the	DET
fcis-31417	131	81	dynamic	dynamic	ADJ
fcis-31417	131	82	changes	change	NOUN
fcis-31417	131	83	of	of	ADP
fcis-31417	131	84	subclones	subclone	NOUN
fcis-31417	131	85	of	of	ADP
fcis-31417	131	86	the	the	DET
fcis-31417	131	87	egfr	egfr	ADJ
fcis-31417	131	88	t790	t790	NUM
fcis-31417	131	89	m	m	NOUN
fcis-31417	131	90	mutation	mutation	NOUN
fcis-31417	131	91	;	;	PUNCT
fcis-31417	131	92	third	third	ADV
fcis-31417	131	93	,	,	PUNCT
fcis-31417	131	94	optimizing	optimize	VERB
fcis-31417	131	95	the	the	DET
fcis-31417	131	96	fusion	fusion	NOUN
fcis-31417	131	97	algorithm	algorithm	NOUN
fcis-31417	131	98	and	and	CCONJ
fcis-31417	131	99	developing	develop	VERB
fcis-31417	131	100	a	a	DET
fcis-31417	131	101	spatiotemporal	spatiotemporal	ADJ
fcis-31417	131	102	attention	attention	NOUN
fcis-31417	131	103	mechanism	mechanism	NOUN
fcis-31417	131	104	to	to	PART
fcis-31417	131	105	give	give	VERB
fcis-31417	131	106	higher	high	ADJ
fcis-31417	131	107	weight	weight	NOUN
fcis-31417	131	108	to	to	ADP
fcis-31417	131	109	dynamic	dynamic	ADJ
fcis-31417	131	110	data	datum	NOUN
fcis-31417	131	111	after	after	ADP
fcis-31417	131	112	treatment	treatment	NOUN
fcis-31417	131	113	(	(	PUNCT
fcis-31417	131	114	such	such	ADJ
fcis-31417	131	115	as	as	ADP
fcis-31417	131	116	the	the	DET
fcis-31417	131	117	weight	weight	NOUN
fcis-31417	131	118	coefficient	coefficient	NOUN
fcis-31417	131	119	of	of	ADP
fcis-31417	131	120	ctdna	ctdna	NOUN
fcis-31417	131	121	changes	change	NOUN
fcis-31417	131	122	after	after	SCONJ
fcis-31417	131	123	2	2	NUM
fcis-31417	131	124	cycles	cycle	NOUN
fcis-31417	131	125	of	of	ADP
fcis-31417	131	126	chemotherapy	chemotherapy	NOUN
fcis-31417	131	127	is	be	AUX
fcis-31417	131	128	1.2	1.2	NUM
fcis-31417	131	129	,	,	PUNCT
fcis-31417	131	130	and	and	CCONJ
fcis-31417	131	131	the	the	DET
fcis-31417	131	132	baseline	baseline	PROPN
fcis-31417	131	133	characteristics	characteristic	NOUN
fcis-31417	131	134	are	be	AUX
fcis-31417	131	135	0.8	0.8	NUM
fcis-31417	131	136	)	)	PUNCT
fcis-31417	131	137	.	.	PUNCT
fcis-31417	132	1	in	in	ADP
fcis-31417	132	2	addition	addition	NOUN
fcis-31417	132	3	,	,	PUNCT
fcis-31417	132	4	by	by	ADP
fcis-31417	132	5	integrating	integrate	VERB
fcis-31417	132	6	the	the	DET
fcis-31417	132	7	model	model	NOUN
fcis-31417	132	8	with	with	ADP
fcis-31417	132	9	electronic	electronic	ADJ
fcis-31417	132	10	health	health	NOUN
fcis-31417	132	11	records	record	NOUN
fcis-31417	132	12	(	(	PUNCT
fcis-31417	132	13	ehr	ehr	NOUN
fcis-31417	132	14	)	)	PUNCT
fcis-31417	132	15	,	,	PUNCT
fcis-31417	132	16	incorporating	incorporate	VERB
fcis-31417	132	17	clinical	clinical	ADJ
fcis-31417	132	18	variables	variable	NOUN
fcis-31417	132	19	such	such	ADJ
fcis-31417	132	20	as	as	ADP
fcis-31417	132	21	smoking	smoking	NOUN
fcis-31417	132	22	history	history	NOUN
fcis-31417	132	23	(	(	PUNCT
fcis-31417	132	24	pack	pack	NOUN
fcis-31417	132	25	-	-	PUNCT
fcis-31417	132	26	years	year	NOUN
fcis-31417	132	27	)	)	PUNCT
fcis-31417	132	28	and	and	CCONJ
fcis-31417	132	29	comorbidities	comorbiditie	NOUN
fcis-31417	132	30	(	(	PUNCT
fcis-31417	132	31	such	such	ADJ
fcis-31417	132	32	as	as	ADP
fcis-31417	132	33	copd	copd	NOUN
fcis-31417	132	34	)	)	PUNCT
fcis-31417	132	35	,	,	PUNCT
fcis-31417	132	36	and	and	CCONJ
fcis-31417	132	37	processing	processing	NOUN
fcis-31417	132	38	time	time	NOUN
fcis-31417	132	39	series	series	PROPN
fcis-31417	132	40	data	data	PROPN
fcis-31417	132	41	through	through	ADP
fcis-31417	132	42	lstm	lstm	NOUN
fcis-31417	132	43	networks	network	NOUN
fcis-31417	132	44	,	,	PUNCT
fcis-31417	132	45	it	it	PRON
fcis-31417	132	46	is	be	AUX
fcis-31417	132	47	expected	expect	VERB
fcis-31417	132	48	that	that	SCONJ
fcis-31417	132	49	the	the	DET
fcis-31417	132	50	prediction	prediction	NOUN
fcis-31417	132	51	error	error	NOUN
fcis-31417	132	52	will	will	AUX
fcis-31417	132	53	be	be	AUX
fcis-31417	132	54	further	far	ADV
fcis-31417	132	55	reduced	reduce	VERB
fcis-31417	132	56	to	to	ADP
fcis-31417	132	57	within	within	ADP
fcis-31417	132	58	4.5	4.5	NUM
fcis-31417	132	59	months	month	NOUN
fcis-31417	132	60	,	,	PUNCT
fcis-31417	132	61	promoting	promote	VERB
fcis-31417	132	62	the	the	DET
fcis-31417	132	63	model	model	NOUN
fcis-31417	132	64	from	from	ADP
fcis-31417	132	65	laboratory	laboratory	NOUN
fcis-31417	132	66	to	to	AUX
fcis-31417	132	67	routine	routine	VERB
fcis-31417	132	68	clinical	clinical	ADJ
fcis-31417	132	69	application	application	NOUN
fcis-31417	132	70	,	,	PUNCT
fcis-31417	132	71	and	and	CCONJ
fcis-31417	132	72	improving	improve	VERB
fcis-31417	132	73	the	the	DET
fcis-31417	132	74	decision	decision	NOUN
fcis-31417	132	75	-	-	PUNCT
fcis-31417	132	76	making	make	VERB
fcis-31417	132	77	efficiency	efficiency	NOUN
fcis-31417	132	78	of	of	ADP
fcis-31417	132	79	individualized	individualized	ADJ
fcis-31417	132	80	treatment	treatment	NOUN
fcis-31417	132	81	of	of	ADP
fcis-31417	132	82	lung	lung	NOUN
fcis-31417	132	83	cancer	cancer	NOUN
fcis-31417	132	84	by	by	ADP
fcis-31417	132	85	50	50	NUM
fcis-31417	132	86	%	%	NOUN
fcis-31417	132	87	.	.	PUNCT
fcis-31417	133	1	5	5	X
fcis-31417	133	2	.	.	X
fcis-31417	133	3	conclusion	conclusion	NOUN
fcis-31417	133	4	this	this	DET
fcis-31417	133	5	study	study	NOUN
fcis-31417	133	6	successfully	successfully	ADV
fcis-31417	133	7	constructed	construct	VERB
fcis-31417	133	8	a	a	DET
fcis-31417	133	9	multimodal	multimodal	NOUN
fcis-31417	133	10	model	model	NOUN
fcis-31417	133	11	based	base	VERB
fcis-31417	133	12	on	on	ADP
fcis-31417	133	13	ct	ct	NUM
fcis-31417	133	14	images	image	NOUN
fcis-31417	133	15	and	and	CCONJ
fcis-31417	133	16	liquid	liquid	ADJ
fcis-31417	133	17	biopsy	biopsy	NOUN
fcis-31417	133	18	,	,	PUNCT
fcis-31417	133	19	and	and	CCONJ
fcis-31417	133	20	achieved	achieve	VERB
fcis-31417	133	21	remarkable	remarkable	ADJ
fcis-31417	133	22	results	result	NOUN
fcis-31417	133	23	in	in	ADP
fcis-31417	133	24	predicting	predict	VERB
fcis-31417	133	25	lung	lung	NOUN
fcis-31417	133	26	cancer	cancer	NOUN
fcis-31417	133	27	survival	survival	NOUN
fcis-31417	133	28	.	.	PUNCT
fcis-31417	134	1	the	the	DET
fcis-31417	134	2	model	model	NOUN
fcis-31417	134	3	has	have	VERB
fcis-31417	134	4	a	a	DET
fcis-31417	134	5	prediction	prediction	NOUN
fcis-31417	134	6	accuracy	accuracy	NOUN
fcis-31417	134	7	of	of	ADP
fcis-31417	134	8	85	85	NUM
fcis-31417	134	9	%	%	NOUN
fcis-31417	134	10	and	and	CCONJ
fcis-31417	134	11	a	a	DET
fcis-31417	134	12	consistency	consistency	NOUN
fcis-31417	134	13	index	index	NOUN
fcis-31417	134	14	of	of	ADP
fcis-31417	134	15	0.82	0.82	NUM
fcis-31417	134	16	,	,	PUNCT
fcis-31417	134	17	which	which	PRON
fcis-31417	134	18	is	be	AUX
fcis-31417	134	19	significantly	significantly	ADV
fcis-31417	134	20	improved	improve	VERB
fcis-31417	134	21	compared	compare	VERB
fcis-31417	134	22	with	with	ADP
fcis-31417	134	23	the	the	DET
fcis-31417	134	24	single	single	ADJ
fcis-31417	134	25	-	-	PUNCT
fcis-31417	134	26	modality	modality	NOUN
fcis-31417	134	27	model	model	NOUN
fcis-31417	134	28	,	,	PUNCT
fcis-31417	134	29	providing	provide	VERB
fcis-31417	134	30	a	a	DET
fcis-31417	134	31	powerful	powerful	ADJ
fcis-31417	134	32	tool	tool	NOUN
fcis-31417	134	33	for	for	ADP
fcis-31417	134	34	individualized	individualized	ADJ
fcis-31417	134	35	treatment	treatment	NOUN
fcis-31417	134	36	of	of	ADP
fcis-31417	134	37	lung	lung	NOUN
fcis-31417	134	38	cancer	cancer	NOUN
fcis-31417	134	39	.	.	PUNCT
fcis-31417	135	1	however	however	ADV
fcis-31417	135	2	,	,	PUNCT
fcis-31417	135	3	the	the	DET
fcis-31417	135	4	model	model	NOUN
fcis-31417	135	5	is	be	AUX
fcis-31417	135	6	still	still	ADV
fcis-31417	135	7	limited	limit	VERB
fcis-31417	135	8	by	by	ADP
fcis-31417	135	9	factors	factor	NOUN
fcis-31417	135	10	such	such	ADJ
fcis-31417	135	11	as	as	ADP
fcis-31417	135	12	data	datum	NOUN
fcis-31417	135	13	heterogeneity	heterogeneity	NOUN
fcis-31417	135	14	.	.	PUNCT
fcis-31417	136	1	future	future	ADJ
fcis-31417	136	2	research	research	NOUN
fcis-31417	136	3	should	should	AUX
fcis-31417	136	4	focus	focus	VERB
fcis-31417	136	5	on	on	ADP
fcis-31417	136	6	expanding	expand	VERB
fcis-31417	136	7	the	the	DET
fcis-31417	136	8	sample	sample	NOUN
fcis-31417	136	9	size	size	NOUN
fcis-31417	136	10	,	,	PUNCT
fcis-31417	136	11	conducting	conduct	VERB
fcis-31417	136	12	multicenter	multicenter	NOUN
fcis-31417	136	13	validation	validation	NOUN
fcis-31417	136	14	,	,	PUNCT
fcis-31417	136	15	and	and	CCONJ
fcis-31417	136	16	exploring	explore	VERB
fcis-31417	136	17	new	new	ADJ
fcis-31417	136	18	biomarkers	biomarker	NOUN
fcis-31417	136	19	and	and	CCONJ
fcis-31417	136	20	imaging	imaging	NOUN
fcis-31417	136	21	features	feature	NOUN
fcis-31417	136	22	,	,	PUNCT
fcis-31417	136	23	continuously	continuously	ADV
fcis-31417	136	24	improving	improve	VERB
fcis-31417	136	25	the	the	DET
fcis-31417	136	26	model	model	NOUN
fcis-31417	136	27	,	,	PUNCT
fcis-31417	136	28	and	and	CCONJ
fcis-31417	136	29	promoting	promote	VERB
fcis-31417	136	30	the	the	DET
fcis-31417	136	31	development	development	NOUN
fcis-31417	136	32	of	of	ADP
fcis-31417	136	33	precision	precision	NOUN
fcis-31417	136	34	diagnosis	diagnosis	NOUN
fcis-31417	136	35	and	and	CCONJ
fcis-31417	136	36	treatment	treatment	NOUN
fcis-31417	136	37	of	of	ADP
fcis-31417	136	38	lung	lung	NOUN
fcis-31417	136	39	cancer	cancer	NOUN
fcis-31417	136	40	.	.	PUNCT
fcis-31417	137	1	references	reference	NOUN
fcis-31417	137	2	[	[	X
fcis-31417	137	3	1	1	NUM
fcis-31417	137	4	]	]	X
fcis-31417	137	5	long	long	ADV
fcis-31417	137	6	,	,	PUNCT
fcis-31417	137	7	z.	z.	PROPN
fcis-31417	137	8	,	,	PUNCT
fcis-31417	137	9	ren	ren	PROPN
fcis-31417	137	10	,	,	PUNCT
fcis-31417	137	11	r.	r.	PROPN
fcis-31417	137	12	,	,	PUNCT
fcis-31417	137	13	luo	luo	PROPN
fcis-31417	137	14	,	,	PUNCT
fcis-31417	137	15	l.	l.	PROPN
fcis-31417	137	16	,	,	PUNCT
fcis-31417	137	17	bao	bao	PROPN
fcis-31417	137	18	,	,	PUNCT
fcis-31417	137	19	p.	p.	PROPN
fcis-31417	137	20	,	,	PUNCT
fcis-31417	137	21	chen	chen	PROPN
fcis-31417	137	22	,	,	PUNCT
fcis-31417	137	23	y.	y.	PROPN
fcis-31417	137	24	&	&	CCONJ
fcis-31417	137	25	yuan	yuan	PROPN
fcis-31417	137	26	,	,	PUNCT
fcis-31417	137	27	j.	j.	PROPN
fcis-31417	137	28	early	early	ADJ
fcis-31417	137	29	diagnosis	diagnosis	NOUN
fcis-31417	137	30	and	and	CCONJ
fcis-31417	137	31	screening	screening	NOUN
fcis-31417	137	32	of	of	ADP
fcis-31417	137	33	hepatobiliary	hepatobiliary	ADJ
fcis-31417	137	34	and	and	CCONJ
fcis-31417	137	35	pancreatic	pancreatic	ADJ
fcis-31417	137	36	tumors	tumor	NOUN
fcis-31417	137	37	based	base	VERB
fcis-31417	137	38	on	on	ADP
fcis-31417	137	39	artificial	artificial	ADJ
fcis-31417	137	40	intelligence	intelligence	NOUN
fcis-31417	137	41	.	.	PUNCT
fcis-31417	138	1	electronic	electronic	ADJ
fcis-31417	138	2	journal	journal	NOUN
fcis-31417	138	3	of	of	ADP
fcis-31417	138	4	comprehensive	comprehensive	ADJ
fcis-31417	138	5	treatment	treatment	NOUN
fcis-31417	138	6	of	of	ADP
fcis-31417	138	7	tumors	tumor	NOUN
fcis-31417	138	8	,	,	PUNCT
fcis-31417	138	9	vol	vol	NOUN
fcis-31417	138	10	.	.	NOUN
fcis-31417	138	11	11(2025	11(2025	NUM
fcis-31417	138	12	)	)	PUNCT
fcis-31417	138	13	no	no	NOUN
fcis-31417	138	14	.	.	NOUN
fcis-31417	138	15	1	1	NUM
fcis-31417	138	16	,	,	PUNCT
fcis-31417	138	17	p.	p.	NOUN
fcis-31417	138	18	21	21	NUM
fcis-31417	138	19	-	-	SYM
fcis-31417	138	20	25	25	NUM
fcis-31417	138	21	.	.	PUNCT
fcis-31417	139	1	[	[	X
fcis-31417	139	2	2	2	NUM
fcis-31417	139	3	]	]	X
fcis-31417	139	4	fu	fu	NOUN
fcis-31417	139	5	,	,	PUNCT
fcis-31417	139	6	y.	y.	PROPN
fcis-31417	139	7	,	,	PUNCT
fcis-31417	139	8	hou	hou	PROPN
fcis-31417	139	9	,	,	PUNCT
fcis-31417	139	10	r.	r.	PROPN
fcis-31417	139	11	&	&	CCONJ
fcis-31417	139	12	fu	fu	PROPN
fcis-31417	139	13	,	,	PUNCT
fcis-31417	139	14	x.	x.	NOUN
fcis-31417	139	15	research	research	NOUN
fcis-31417	139	16	progress	progress	NOUN
fcis-31417	139	17	in	in	ADP
fcis-31417	139	18	predicting	predict	VERB
fcis-31417	139	19	the	the	DET
fcis-31417	139	20	risk	risk	NOUN
fcis-31417	139	21	of	of	ADP
fcis-31417	139	22	lymphatic	lymphatic	ADJ
fcis-31417	139	23	or	or	CCONJ
fcis-31417	139	24	hematogenous	hematogenous	ADJ
fcis-31417	139	25	metastasis	metastasis	NOUN
fcis-31417	139	26	of	of	ADP
fcis-31417	139	27	early	early	ADJ
fcis-31417	139	28	nonsmall	nonsmall	NOUN
fcis-31417	139	29	cell	cell	NOUN
fcis-31417	139	30	lung	lung	NOUN
fcis-31417	139	31	cancer	cancer	NOUN
fcis-31417	139	32	based	base	VERB
fcis-31417	139	33	on	on	ADP
fcis-31417	139	34	chest	chest	NOUN
fcis-31417	139	35	ct	ct	PROPN
fcis-31417	139	36	.	.	PUNCT
fcis-31417	140	1	chinese	chinese	ADJ
fcis-31417	140	2	journal	journal	PROPN
fcis-31417	140	3	of	of	ADP
fcis-31417	140	4	oncology	oncology	NOUN
fcis-31417	140	5	,	,	PUNCT
fcis-31417	140	6	vol	vol	NOUN
fcis-31417	140	7	.	.	PUNCT
fcis-31417	141	1	32(2022	32(2022	NUM
fcis-31417	141	2	)	)	PUNCT
fcis-31417	142	1	no	no	NOUN
fcis-31417	142	2	.	.	NOUN
fcis-31417	142	3	4	4	NUM
fcis-31417	142	4	,	,	PUNCT
fcis-31417	142	5	p.	p.	NOUN
fcis-31417	142	6	343	343	NUM
fcis-31417	142	7	-	-	SYM
fcis-31417	142	8	350	350	NUM
fcis-31417	142	9	.	.	PUNCT
fcis-31417	143	1	[	[	X
fcis-31417	143	2	3	3	X
fcis-31417	143	3	]	]	SYM
fcis-31417	143	4	li	li	PROPN
fcis-31417	143	5	,	,	PUNCT
fcis-31417	143	6	x.	x.	PROPN
fcis-31417	143	7	,	,	PUNCT
fcis-31417	143	8	zhang	zhang	PROPN
fcis-31417	143	9	,	,	PUNCT
fcis-31417	143	10	p.	p.	PROPN
fcis-31417	143	11	&	&	CCONJ
fcis-31417	143	12	duan	duan	PROPN
fcis-31417	143	13	,	,	PUNCT
fcis-31417	143	14	l.	l.	PROPN
fcis-31417	143	15	research	research	PROPN
fcis-31417	143	16	progress	progress	NOUN
fcis-31417	143	17	of	of	ADP
fcis-31417	143	18	18f	18f	PROPN
fcis-31417	143	19	-	-	PUNCT
fcis-31417	143	20	fdg	fdg	PROPN
fcis-31417	143	21	pet	pet	PROPN
fcis-31417	143	22	/	/	SYM
fcis-31417	143	23	ct	ct	PROPN
fcis-31417	143	24	imaging	image	VERB
fcis-31417	143	25	genomics	genomic	NOUN
fcis-31417	143	26	in	in	ADP
fcis-31417	143	27	targeted	target	VERB
fcis-31417	143	28	diagnosis	diagnosis	NOUN
fcis-31417	143	29	and	and	CCONJ
fcis-31417	143	30	treatment	treatment	NOUN
fcis-31417	143	31	of	of	ADP
fcis-31417	143	32	non	non	ADJ
fcis-31417	143	33	-	-	ADJ
fcis-31417	143	34	small	small	ADJ
fcis-31417	143	35	cell	cell	NOUN
fcis-31417	143	36	lung	lung	NOUN
fcis-31417	143	37	cancer	cancer	NOUN
fcis-31417	143	38	.	.	PUNCT
fcis-31417	144	1	international	international	ADJ
fcis-31417	144	2	journal	journal	NOUN
fcis-31417	144	3	of	of	ADP
fcis-31417	144	4	40	40	NUM
fcis-31417	144	5	radiation	radiation	NOUN
fcis-31417	144	6	medicine	medicine	NOUN
fcis-31417	144	7	and	and	CCONJ
fcis-31417	144	8	nuclear	nuclear	ADJ
fcis-31417	144	9	medicine	medicine	NOUN
fcis-31417	144	10	,	,	PUNCT
fcis-31417	144	11	vol	vol	NOUN
fcis-31417	144	12	.	.	PUNCT
fcis-31417	145	1	49(2025	49(2025	NUM
fcis-31417	145	2	)	)	PUNCT
fcis-31417	146	1	no	no	INTJ
fcis-31417	146	2	.	.	NOUN
fcis-31417	146	3	6	6	NUM
fcis-31417	146	4	,	,	PUNCT
fcis-31417	146	5	p.	p.	NOUN
fcis-31417	146	6	383	383	NUM
fcis-31417	146	7	-	-	SYM
fcis-31417	146	8	388	388	NUM
fcis-31417	146	9	.	.	PUNCT
fcis-31417	147	1	[	[	X
fcis-31417	147	2	4	4	NUM
fcis-31417	147	3	]	]	X
fcis-31417	147	4	jiang	jiang	PROPN
fcis-31417	147	5	,	,	PUNCT
fcis-31417	147	6	m.	m.	NOUN
fcis-31417	147	7	,	,	PUNCT
fcis-31417	147	8	han	han	PROPN
fcis-31417	147	9	,	,	PUNCT
fcis-31417	147	10	y.	y.	PROPN
fcis-31417	147	11	&	&	CCONJ
fcis-31417	147	12	fu	fu	PROPN
fcis-31417	147	13	,	,	PUNCT
fcis-31417	147	14	x.	x.	NOUN
fcis-31417	147	15	progress	progress	NOUN
fcis-31417	147	16	in	in	ADP
fcis-31417	147	17	he	he	PRON
fcis-31417	147	18	-	-	PUNCT
fcis-31417	147	19	stained	stain	VERB
fcis-31417	147	20	whole	whole	ADJ
fcis-31417	147	21	-	-	PUNCT
fcis-31417	147	22	slice	slice	NOUN
fcis-31417	147	23	pathological	pathological	ADJ
fcis-31417	147	24	image	image	NOUN
fcis-31417	147	25	analysis	analysis	NOUN
fcis-31417	147	26	based	base	VERB
fcis-31417	147	27	on	on	ADP
fcis-31417	147	28	artificial	artificial	ADJ
fcis-31417	147	29	intelligence	intelligence	NOUN
fcis-31417	147	30	in	in	ADP
fcis-31417	147	31	lung	lung	NOUN
fcis-31417	147	32	cancer	cancer	NOUN
fcis-31417	147	33	research	research	NOUN
fcis-31417	147	34	.	.	PUNCT
fcis-31417	148	1	chinese	chinese	ADJ
fcis-31417	148	2	journal	journal	PROPN
fcis-31417	148	3	of	of	ADP
fcis-31417	148	4	oncology	oncology	NOUN
fcis-31417	148	5	,	,	PUNCT
fcis-31417	148	6	vol	vol	NOUN
fcis-31417	148	7	.	.	PUNCT
fcis-31417	149	1	34(2024	34(2024	NUM
fcis-31417	149	2	)	)	PUNCT
fcis-31417	149	3	no	no	INTJ
fcis-31417	149	4	.	.	NOUN
fcis-31417	149	5	3	3	NUM
fcis-31417	149	6	,	,	PUNCT
fcis-31417	149	7	p.	p.	NOUN
fcis-31417	149	8	306	306	NUM
fcis-31417	149	9	-	-	SYM
fcis-31417	149	10	315	315	NUM
fcis-31417	149	11	.	.	PUNCT
fcis-31417	150	1	[	[	X
fcis-31417	150	2	5	5	NUM
fcis-31417	150	3	]	]	PUNCT
fcis-31417	150	4	yin	yin	NOUN
fcis-31417	150	5	,	,	PUNCT
fcis-31417	150	6	m.	m.	NOUN
fcis-31417	150	7	,	,	PUNCT
fcis-31417	150	8	qin	qin	PROPN
fcis-31417	150	9	,	,	PUNCT
fcis-31417	150	10	w.	w.	PROPN
fcis-31417	150	11	&	&	CCONJ
fcis-31417	150	12	sun	sun	PROPN
fcis-31417	150	13	,	,	PUNCT
fcis-31417	150	14	z.	z.	PROPN
fcis-31417	150	15	research	research	PROPN
fcis-31417	150	16	progress	progress	NOUN
fcis-31417	150	17	of	of	ADP
fcis-31417	150	18	mri	mri	NOUN
fcis-31417	150	19	radiomics	radiomic	NOUN
fcis-31417	150	20	in	in	ADP
fcis-31417	150	21	lung	lung	NOUN
fcis-31417	150	22	cancer	cancer	NOUN
fcis-31417	150	23	.	.	PUNCT
fcis-31417	151	1	magnetic	magnetic	ADJ
fcis-31417	151	2	resonance	resonance	NOUN
fcis-31417	151	3	imaging	imaging	NOUN
fcis-31417	151	4	,	,	PUNCT
fcis-31417	151	5	vol	vol	NOUN
fcis-31417	151	6	.	.	PUNCT
fcis-31417	152	1	14(2023	14(2023	NUM
fcis-31417	152	2	)	)	PUNCT
fcis-31417	153	1	no	no	INTJ
fcis-31417	153	2	.	.	NOUN
fcis-31417	153	3	6	6	NUM
fcis-31417	153	4	,	,	PUNCT
fcis-31417	153	5	p.	p.	NOUN
fcis-31417	153	6	129	129	NUM
fcis-31417	153	7	-	-	SYM
fcis-31417	153	8	132	132	NUM
fcis-31417	153	9	.	.	PUNCT
fcis-31417	154	1	[	[	X
fcis-31417	154	2	6	6	NUM
fcis-31417	154	3	]	]	SYM
fcis-31417	154	4	li	li	PROPN
fcis-31417	154	5	,	,	PUNCT
fcis-31417	154	6	z.	z.	PROPN
fcis-31417	154	7	,	,	PUNCT
fcis-31417	154	8	zhao	zhao	PROPN
fcis-31417	154	9	,	,	PUNCT
fcis-31417	154	10	j.	j.	PROPN
fcis-31417	154	11	&	&	CCONJ
fcis-31417	154	12	wang	wang	PROPN
fcis-31417	154	13	,	,	PUNCT
fcis-31417	154	14	z.	z.	PROPN
fcis-31417	154	15	application	application	NOUN
fcis-31417	154	16	of	of	ADP
fcis-31417	154	17	artificial	artificial	ADJ
fcis-31417	154	18	intelligence	intelligence	NOUN
fcis-31417	154	19	in	in	ADP
fcis-31417	154	20	tumor	tumor	NOUN
fcis-31417	154	21	marker	marker	NOUN
fcis-31417	154	22	research	research	NOUN
fcis-31417	154	23	.	.	PUNCT
fcis-31417	155	1	electronic	electronic	ADJ
fcis-31417	155	2	journal	journal	NOUN
fcis-31417	155	3	of	of	ADP
fcis-31417	155	4	comprehensive	comprehensive	ADJ
fcis-31417	155	5	treatment	treatment	NOUN
fcis-31417	155	6	of	of	ADP
fcis-31417	155	7	tumors	tumor	NOUN
fcis-31417	155	8	,	,	PUNCT
fcis-31417	155	9	vol	vol	NOUN
fcis-31417	155	10	.	.	NOUN
fcis-31417	155	11	11(2025	11(2025	NUM
fcis-31417	155	12	)	)	PUNCT
fcis-31417	155	13	no	no	NOUN
fcis-31417	155	14	.	.	NOUN
fcis-31417	155	15	1	1	NUM
fcis-31417	155	16	,	,	PUNCT
fcis-31417	155	17	p.	p.	NOUN
fcis-31417	155	18	26	26	NUM
fcis-31417	155	19	-	-	SYM
fcis-31417	155	20	35	35	NUM
fcis-31417	155	21	.	.	PUNCT
fcis-31417	156	1	[	[	X
fcis-31417	156	2	7	7	NUM
fcis-31417	156	3	]	]	SYM
fcis-31417	156	4	li	li	PROPN
fcis-31417	156	5	,	,	PUNCT
fcis-31417	156	6	j.	j.	PROPN
fcis-31417	156	7	,	,	PUNCT
fcis-31417	156	8	yang	yang	PROPN
fcis-31417	156	9	,	,	PUNCT
fcis-31417	156	10	z.	z.	PROPN
fcis-31417	156	11	,	,	PUNCT
fcis-31417	156	12	wang	wang	PROPN
fcis-31417	156	13	,	,	PUNCT
fcis-31417	156	14	x.	x.	PROPN
fcis-31417	156	15	,	,	PUNCT
fcis-31417	156	16	zhang	zhang	PROPN
fcis-31417	156	17	,	,	PUNCT
fcis-31417	156	18	s.	s.	PROPN
fcis-31417	156	19	&	&	CCONJ
fcis-31417	156	20	xie	xie	PROPN
fcis-31417	156	21	,	,	PUNCT
fcis-31417	156	22	z.	z.	PROPN
fcis-31417	156	23	the	the	DET
fcis-31417	156	24	value	value	NOUN
fcis-31417	156	25	of	of	ADP
fcis-31417	156	26	ct	ct	PROPN
fcis-31417	156	27	radiomics	radiomic	NOUN
fcis-31417	156	28	combined	combine	VERB
fcis-31417	156	29	with	with	ADP
fcis-31417	156	30	clinical	clinical	ADJ
fcis-31417	156	31	characteristics	characteristic	NOUN
fcis-31417	156	32	in	in	ADP
fcis-31417	156	33	predicting	predict	VERB
fcis-31417	156	34	egfr	egfr	ADJ
fcis-31417	156	35	mutations	mutation	NOUN
fcis-31417	156	36	in	in	ADP
fcis-31417	156	37	lung	lung	NOUN
fcis-31417	156	38	adenocarcinoma	adenocarcinoma	NOUN
fcis-31417	156	39	.	.	PUNCT
fcis-31417	157	1	journal	journal	PROPN
fcis-31417	157	2	of	of	ADP
fcis-31417	157	3	bengbu	bengbu	PROPN
fcis-31417	157	4	medical	medical	PROPN
fcis-31417	157	5	university	university	NOUN
fcis-31417	157	6	,	,	PUNCT
fcis-31417	157	7	vol	vol	NOUN
fcis-31417	157	8	.	.	PUNCT
fcis-31417	158	1	46(2021	46(2021	NUM
fcis-31417	158	2	)	)	PUNCT
fcis-31417	159	1	no	no	INTJ
fcis-31417	159	2	.	.	NOUN
fcis-31417	159	3	8	8	NUM
fcis-31417	159	4	,	,	PUNCT
fcis-31417	159	5	p.	p.	NOUN
fcis-31417	159	6	11031108	11031108	NUM
fcis-31417	159	7	.	.	PUNCT
fcis-31417	160	1	[	[	X
fcis-31417	160	2	8	8	NUM
fcis-31417	160	3	]	]	X
fcis-31417	160	4	chen	chen	PROPN
fcis-31417	160	5	,	,	PUNCT
fcis-31417	160	6	y.	y.	PROPN
fcis-31417	160	7	,	,	PUNCT
fcis-31417	160	8	chu	chu	PROPN
fcis-31417	160	9	,	,	PUNCT
fcis-31417	160	10	x.	x.	PROPN
fcis-31417	160	11	,	,	PUNCT
fcis-31417	160	12	yu	yu	PROPN
fcis-31417	160	13	,	,	PUNCT
fcis-31417	160	14	x.	x.	PROPN
fcis-31417	160	15	&	&	CCONJ
fcis-31417	160	16	su	su	PROPN
fcis-31417	160	17	,	,	PUNCT
fcis-31417	160	18	c.	c.	PROPN
fcis-31417	160	19	research	research	NOUN
fcis-31417	160	20	progress	progress	NOUN
fcis-31417	160	21	of	of	ADP
fcis-31417	160	22	prediction	prediction	NOUN
fcis-31417	160	23	models	model	NOUN
fcis-31417	160	24	related	relate	VERB
fcis-31417	160	25	to	to	ADP
fcis-31417	160	26	the	the	DET
fcis-31417	160	27	efficacy	efficacy	NOUN
fcis-31417	160	28	of	of	ADP
fcis-31417	160	29	immune	immune	ADJ
fcis-31417	160	30	checkpoint	checkpoint	NOUN
fcis-31417	160	31	inhibitors	inhibitor	NOUN
fcis-31417	160	32	.	.	PUNCT
fcis-31417	161	1	chinese	chinese	ADJ
fcis-31417	161	2	journal	journal	PROPN
fcis-31417	161	3	of	of	ADP
fcis-31417	161	4	oncology	oncology	NOUN
fcis-31417	161	5	,	,	PUNCT
fcis-31417	161	6	vol	vol	NOUN
fcis-31417	161	7	.	.	PUNCT
fcis-31417	162	1	33(2023	33(2023	NUM
fcis-31417	162	2	)	)	PUNCT
fcis-31417	163	1	no	no	INTJ
fcis-31417	163	2	.	.	NOUN
fcis-31417	163	3	1	1	NUM
fcis-31417	163	4	,	,	PUNCT
fcis-31417	163	5	p.	p.	NOUN
fcis-31417	163	6	61	61	NUM
fcis-31417	163	7	-	-	SYM
fcis-31417	163	8	70	70	NUM
fcis-31417	163	9	.	.	PUNCT
fcis-31417	164	1	[	[	X
fcis-31417	164	2	9	9	NUM
fcis-31417	164	3	]	]	SYM
fcis-31417	164	4	ye	ye	PROPN
fcis-31417	164	5	,	,	PUNCT
fcis-31417	164	6	r.	r.	PROPN
fcis-31417	164	7	,	,	PUNCT
fcis-31417	164	8	su	su	PROPN
fcis-31417	164	9	,	,	PUNCT
fcis-31417	164	10	y.	y.	PROPN
fcis-31417	164	11	,	,	PUNCT
fcis-31417	164	12	mao	mao	PROPN
fcis-31417	164	13	,	,	PUNCT
fcis-31417	164	14	y.	y.	PROPN
fcis-31417	164	15	,	,	PUNCT
fcis-31417	164	16	zhang	zhang	PROPN
fcis-31417	164	17	,	,	PUNCT
fcis-31417	164	18	y.	y.	PROPN
fcis-31417	164	19	,	,	PUNCT
fcis-31417	164	20	zhang	zhang	PROPN
fcis-31417	164	21	,	,	PUNCT
fcis-31417	164	22	y.	y.	PROPN
fcis-31417	164	23	,	,	PUNCT
fcis-31417	164	24	xu	xu	PROPN
fcis-31417	164	25	,	,	PUNCT
fcis-31417	164	26	y.	y.	PROPN
fcis-31417	164	27	&	&	CCONJ
fcis-31417	164	28	luo	luo	PROPN
fcis-31417	164	29	,	,	PUNCT
fcis-31417	164	30	s.	s.	PROPN
fcis-31417	164	31	prediction	prediction	NOUN
fcis-31417	164	32	of	of	ADP
fcis-31417	164	33	overall	overall	ADJ
fcis-31417	164	34	survival	survival	NOUN
fcis-31417	164	35	of	of	ADP
fcis-31417	164	36	patients	patient	NOUN
fcis-31417	164	37	with	with	ADP
fcis-31417	164	38	small	small	ADJ
fcis-31417	164	39	cell	cell	NOUN
fcis-31417	164	40	lung	lung	NOUN
fcis-31417	164	41	cancer	cancer	NOUN
fcis-31417	164	42	treated	treat	VERB
fcis-31417	164	43	with	with	ADP
fcis-31417	164	44	platinum	platinum	NOUN
fcis-31417	164	45	-	-	PUNCT
fcis-31417	164	46	based	base	VERB
fcis-31417	164	47	chemotherapy	chemotherapy	NOUN
fcis-31417	164	48	based	base	VERB
fcis-31417	164	49	on	on	ADP
fcis-31417	164	50	a	a	DET
fcis-31417	164	51	nomogram	nomogram	NOUN
fcis-31417	164	52	based	base	VERB
fcis-31417	164	53	on	on	ADP
fcis-31417	164	54	pre	pre	ADJ
fcis-31417	164	55	-	-	ADJ
fcis-31417	164	56	treatment	treatment	ADJ
fcis-31417	164	57	multidimensional	multidimensional	ADJ
fcis-31417	164	58	parameters	parameter	NOUN
fcis-31417	164	59	.	.	PUNCT
fcis-31417	165	1	journal	journal	PROPN
fcis-31417	165	2	of	of	ADP
fcis-31417	165	3	wenzhou	wenzhou	PROPN
fcis-31417	165	4	medical	medical	PROPN
fcis-31417	165	5	university	university	PROPN
fcis-31417	165	6	,	,	PUNCT
fcis-31417	165	7	vol	vol	NOUN
fcis-31417	165	8	.	.	PUNCT
fcis-31417	166	1	54(2024	54(2024	NUM
fcis-31417	166	2	)	)	PUNCT
fcis-31417	166	3	no	no	INTJ
fcis-31417	166	4	.	.	NOUN
fcis-31417	166	5	7	7	NUM
fcis-31417	166	6	,	,	PUNCT
fcis-31417	166	7	p.	p.	NOUN
fcis-31417	166	8	589	589	NUM
fcis-31417	166	9	-	-	SYM
fcis-31417	166	10	597	597	NUM
fcis-31417	166	11	.	.	PUNCT
fcis-31417	167	1	[	[	X
fcis-31417	167	2	10	10	NUM
fcis-31417	167	3	]	]	X
fcis-31417	167	4	ping	ping	NOUN
fcis-31417	167	5	,	,	PUNCT
fcis-31417	167	6	y.	y.	PROPN
fcis-31417	167	7	,	,	PUNCT
fcis-31417	167	8	yan	yan	PROPN
fcis-31417	167	9	,	,	PUNCT
fcis-31417	167	10	h.	h.	PROPN
fcis-31417	167	11	&	&	CCONJ
fcis-31417	167	12	bian	bian	PROPN
fcis-31417	167	13	,	,	PUNCT
fcis-31417	167	14	x.	x.	NOUN
fcis-31417	167	15	application	application	NOUN
fcis-31417	167	16	and	and	CCONJ
fcis-31417	167	17	challenges	challenge	NOUN
fcis-31417	167	18	of	of	ADP
fcis-31417	167	19	artificial	artificial	ADJ
fcis-31417	167	20	intelligence	intelligence	NOUN
fcis-31417	167	21	pathology	pathology	NOUN
fcis-31417	167	22	in	in	ADP
fcis-31417	167	23	the	the	DET
fcis-31417	167	24	era	era	NOUN
fcis-31417	167	25	of	of	ADP
fcis-31417	167	26	precision	precision	NOUN
fcis-31417	167	27	medicine	medicine	NOUN
fcis-31417	167	28	for	for	ADP
fcis-31417	167	29	tumors	tumor	NOUN
fcis-31417	167	30	.	.	PUNCT
fcis-31417	168	1	life	life	NOUN
fcis-31417	168	2	sciences	science	NOUN
fcis-31417	168	3	,	,	PUNCT
fcis-31417	168	4	vol	vol	NOUN
fcis-31417	168	5	.	.	PUNCT
fcis-31417	169	1	34(2022	34(2022	NUM
fcis-31417	169	2	)	)	PUNCT
fcis-31417	169	3	no	no	NOUN
fcis-31417	169	4	.	.	NOUN
fcis-31417	169	5	8	8	NUM
fcis-31417	169	6	,	,	PUNCT
fcis-31417	169	7	p.	p.	NOUN
fcis-31417	169	8	929	929	NUM
fcis-31417	169	9	-	-	SYM
fcis-31417	169	10	940	940	NUM
fcis-31417	169	11	.	.	PUNCT
fcis-31417	170	1	[	[	X
fcis-31417	170	2	11	11	NUM
fcis-31417	170	3	]	]	SYM
fcis-31417	170	4	li	li	PROPN
fcis-31417	170	5	,	,	PUNCT
fcis-31417	170	6	c.	c.	PROPN
fcis-31417	170	7	diagnostic	diagnostic	ADJ
fcis-31417	170	8	value	value	NOUN
fcis-31417	170	9	of	of	ADP
fcis-31417	170	10	texture	texture	ADJ
fcis-31417	170	11	features	feature	NOUN
fcis-31417	170	12	of	of	ADP
fcis-31417	170	13	multi	multi	ADJ
fcis-31417	170	14	-	-	ADJ
fcis-31417	170	15	slice	slice	ADJ
fcis-31417	170	16	spiral	spiral	ADJ
fcis-31417	170	17	ct	ct	NUM
fcis-31417	170	18	images	image	NOUN
fcis-31417	170	19	for	for	ADP
fcis-31417	170	20	small	small	ADJ
fcis-31417	170	21	pulmonary	pulmonary	ADJ
fcis-31417	170	22	nodules	nodule	NOUN
fcis-31417	170	23	.	.	PUNCT
fcis-31417	171	1	medical	medical	ADJ
fcis-31417	171	2	clinical	clinical	ADJ
fcis-31417	171	3	research	research	NOUN
fcis-31417	171	4	,	,	PUNCT
fcis-31417	171	5	vol	vol	NOUN
fcis-31417	171	6	.	.	PUNCT
fcis-31417	171	7	42(2022	42(2022	NOUN
fcis-31417	171	8	)	)	PUNCT
fcis-31417	172	1	no	no	INTJ
fcis-31417	172	2	.	.	NOUN
fcis-31417	172	3	5	5	NUM
fcis-31417	172	4	,	,	PUNCT
fcis-31417	172	5	p.	p.	NOUN
fcis-31417	172	6	802	802	NUM
fcis-31417	172	7	-	-	SYM
fcis-31417	172	8	804	804	NUM
fcis-31417	172	9	.	.	PUNCT
fcis-31417	173	1	[	[	X
fcis-31417	173	2	12	12	NUM
fcis-31417	173	3	]	]	X
fcis-31417	173	4	guo	guo	PROPN
fcis-31417	173	5	,	,	PUNCT
fcis-31417	173	6	x.	x.	PROPN
fcis-31417	173	7	,	,	PUNCT
fcis-31417	173	8	gao	gao	PROPN
fcis-31417	173	9	,	,	PUNCT
fcis-31417	173	10	y.	y.	PROPN
fcis-31417	173	11	&	&	CCONJ
fcis-31417	173	12	he	he	PRON
fcis-31417	173	13	,	,	PUNCT
fcis-31417	173	14	j.	j.	PROPN
fcis-31417	173	15	the	the	DET
fcis-31417	173	16	role	role	NOUN
fcis-31417	173	17	and	and	CCONJ
fcis-31417	173	18	potential	potential	NOUN
fcis-31417	173	19	of	of	ADP
fcis-31417	173	20	artificial	artificial	ADJ
fcis-31417	173	21	intelligence	intelligence	NOUN
fcis-31417	173	22	in	in	ADP
fcis-31417	173	23	the	the	DET
fcis-31417	173	24	field	field	NOUN
fcis-31417	173	25	of	of	ADP
fcis-31417	173	26	oncology	oncology	NOUN
fcis-31417	173	27	.	.	PUNCT
fcis-31417	174	1	life	life	NOUN
fcis-31417	174	2	sciences	sciences	PROPN
fcis-31417	174	3	,	,	PUNCT
fcis-31417	174	4	vol	vol	NOUN
fcis-31417	174	5	.	.	PROPN
fcis-31417	175	1	34	34	NUM
fcis-31417	175	2	(	(	PUNCT
fcis-31417	175	3	2022	2022	NUM
fcis-31417	175	4	)	)	PUNCT
fcis-31417	175	5	no	no	NOUN
fcis-31417	175	6	.	.	NOUN
fcis-31417	175	7	8	8	NUM
fcis-31417	175	8	,	,	PUNCT
fcis-31417	175	9	p.	p.	NOUN
fcis-31417	175	10	957	957	NUM
fcis-31417	175	11	-	-	SYM
fcis-31417	175	12	964	964	NUM
fcis-31417	175	13	.	.	PUNCT
fcis-31417	176	1	[	[	X
fcis-31417	176	2	13	13	NUM
fcis-31417	176	3	]	]	X
fcis-31417	176	4	liang	liang	PROPN
fcis-31417	176	5	,	,	PUNCT
fcis-31417	176	6	w.	w.	PROPN
fcis-31417	176	7	,	,	PUNCT
fcis-31417	176	8	li	li	PROPN
fcis-31417	176	9	,	,	PUNCT
fcis-31417	176	10	c.	c.	PROPN
fcis-31417	176	11	&	&	CCONJ
fcis-31417	176	12	he	he	PRON
fcis-31417	176	13	,	,	PUNCT
fcis-31417	176	14	j.	j.	PROPN
fcis-31417	176	15	exploration	exploration	PROPN
fcis-31417	176	16	of	of	ADP
fcis-31417	176	17	precision	precision	NOUN
fcis-31417	176	18	in	in	ADP
fcis-31417	176	19	early	early	ADJ
fcis-31417	176	20	screening	screening	NOUN
fcis-31417	176	21	and	and	CCONJ
fcis-31417	176	22	diagnosis	diagnosis	NOUN
fcis-31417	176	23	of	of	ADP
fcis-31417	176	24	lung	lung	NOUN
fcis-31417	176	25	cancer	cancer	NOUN
fcis-31417	176	26	.	.	PUNCT
fcis-31417	177	1	chinese	chinese	ADJ
fcis-31417	177	2	journal	journal	PROPN
fcis-31417	177	3	of	of	ADP
fcis-31417	177	4	clinical	clinical	ADJ
fcis-31417	177	5	oncology	oncology	NOUN
fcis-31417	177	6	,	,	PUNCT
fcis-31417	177	7	vol	vol	NOUN
fcis-31417	177	8	.	.	PUNCT
fcis-31417	178	1	48(2021	48(2021	NUM
fcis-31417	178	2	)	)	PUNCT
fcis-31417	179	1	no	no	INTJ
fcis-31417	179	2	.	.	NOUN
fcis-31417	179	3	10	10	NUM
fcis-31417	179	4	,	,	PUNCT
fcis-31417	179	5	p.	p.	NOUN
fcis-31417	179	6	506	506	NUM
fcis-31417	179	7	-	-	SYM
fcis-31417	179	8	510	510	NUM
fcis-31417	179	9	.	.	PUNCT
fcis-31417	180	1	[	[	X
fcis-31417	180	2	14	14	NUM
fcis-31417	180	3	]	]	X
fcis-31417	180	4	ji	ji	PROPN
fcis-31417	180	5	,	,	PUNCT
fcis-31417	180	6	j.	j.	PROPN
fcis-31417	180	7	,	,	PUNCT
fcis-31417	180	8	zhuang	zhuang	PROPN
fcis-31417	180	9	,	,	PUNCT
fcis-31417	180	10	y.	y.	PROPN
fcis-31417	180	11	,	,	PUNCT
fcis-31417	180	12	liu	liu	PROPN
fcis-31417	180	13	,	,	PUNCT
fcis-31417	180	14	x.	x.	PROPN
fcis-31417	180	15	,	,	PUNCT
fcis-31417	180	16	dong	dong	PROPN
fcis-31417	180	17	,	,	PUNCT
fcis-31417	180	18	d.	d.	PROPN
fcis-31417	180	19	&	&	CCONJ
fcis-31417	180	20	gao	gao	PROPN
fcis-31417	180	21	,	,	PUNCT
fcis-31417	180	22	x.	x.	NOUN
fcis-31417	180	23	gastric	gastric	ADJ
fcis-31417	180	24	cancer	cancer	NOUN
fcis-31417	180	25	surgery	surgery	NOUN
fcis-31417	180	26	in	in	ADP
fcis-31417	180	27	the	the	DET
fcis-31417	180	28	era	era	NOUN
fcis-31417	180	29	of	of	ADP
fcis-31417	180	30	intelligence	intelligence	NOUN
fcis-31417	180	31	and	and	CCONJ
fcis-31417	180	32	individualization	individualization	NOUN
fcis-31417	180	33	.	.	PUNCT
fcis-31417	181	1	chinese	chinese	ADJ
fcis-31417	181	2	journal	journal	PROPN
fcis-31417	181	3	of	of	ADP
fcis-31417	181	4	digestive	digestive	ADJ
fcis-31417	181	5	surgery	surgery	NOUN
fcis-31417	181	6	,	,	PUNCT
fcis-31417	181	7	vol	vol	NOUN
fcis-31417	181	8	.	.	PUNCT
fcis-31417	182	1	24(2025	24(2025	NUM
fcis-31417	182	2	)	)	PUNCT
fcis-31417	183	1	no	no	INTJ
fcis-31417	183	2	.	.	NOUN
fcis-31417	183	3	4	4	NUM
fcis-31417	183	4	,	,	PUNCT
fcis-31417	183	5	p.	p.	NOUN
fcis-31417	183	6	459	459	NUM
fcis-31417	183	7	-	-	SYM
fcis-31417	183	8	467	467	NUM
fcis-31417	183	9	.	.	PUNCT
fcis-31417	184	1	[	[	X
fcis-31417	184	2	15	15	NUM
fcis-31417	184	3	]	]	X
fcis-31417	184	4	zhang	zhang	PROPN
fcis-31417	184	5	,	,	PUNCT
fcis-31417	184	6	m.	m.	PROPN
fcis-31417	184	7	&	&	CCONJ
fcis-31417	184	8	chen	chen	PROPN
fcis-31417	184	9	,	,	PUNCT
fcis-31417	184	10	g.	g.	PROPN
fcis-31417	184	11	influencing	influence	VERB
fcis-31417	184	12	factors	factor	NOUN
fcis-31417	184	13	of	of	ADP
fcis-31417	184	14	ipaf	ipaf	ADJ
fcis-31417	184	15	combined	combine	VERB
fcis-31417	184	16	with	with	ADP
fcis-31417	184	17	pulmonary	pulmonary	ADJ
fcis-31417	184	18	infection	infection	NOUN
fcis-31417	184	19	and	and	CCONJ
fcis-31417	184	20	construction	construction	NOUN
fcis-31417	184	21	of	of	ADP
fcis-31417	184	22	nomogram	nomogram	NOUN
fcis-31417	184	23	prediction	prediction	NOUN
fcis-31417	184	24	model	model	NOUN
fcis-31417	184	25	.	.	PUNCT
fcis-31417	185	1	chinese	chinese	ADJ
fcis-31417	185	2	journal	journal	PROPN
fcis-31417	185	3	of	of	ADP
fcis-31417	185	4	modern	modern	ADJ
fcis-31417	185	5	medicine	medicine	NOUN
fcis-31417	185	6	,	,	PUNCT
fcis-31417	185	7	vol	vol	NOUN
fcis-31417	185	8	.	.	PUNCT
fcis-31417	186	1	26(2024	26(2024	NUM
fcis-31417	186	2	)	)	PUNCT
fcis-31417	187	1	no	no	NOUN
fcis-31417	187	2	.	.	NOUN
fcis-31417	187	3	10	10	NUM
fcis-31417	187	4	,	,	PUNCT
fcis-31417	187	5	p.	p.	NOUN
fcis-31417	187	6	55	55	NUM
fcis-31417	187	7	-	-	SYM
fcis-31417	187	8	59	59	NUM
fcis-31417	187	9	.	.	PUNCT
fcis-31417	188	1	[	[	X
fcis-31417	188	2	16	16	NUM
fcis-31417	188	3	]	]	X
fcis-31417	188	4	liu	liu	PROPN
fcis-31417	188	5	,	,	PUNCT
fcis-31417	188	6	y.	y.	PROPN
fcis-31417	188	7	&	&	CCONJ
fcis-31417	188	8	gao	gao	PROPN
fcis-31417	188	9	,	,	PUNCT
fcis-31417	188	10	y.	y.	PROPN
fcis-31417	188	11	the	the	DET
fcis-31417	188	12	research	research	NOUN
fcis-31417	188	13	significance	significance	NOUN
fcis-31417	188	14	of	of	ADP
fcis-31417	188	15	multi	multi	ADJ
fcis-31417	188	16	-	-	ADJ
fcis-31417	188	17	sequence	sequence	ADJ
fcis-31417	188	18	magnetic	magnetic	ADJ
fcis-31417	188	19	resonance	resonance	NOUN
fcis-31417	188	20	imaging	imaging	NOUN
fcis-31417	188	21	based	base	VERB
fcis-31417	188	22	on	on	ADP
fcis-31417	188	23	habitat	habitat	NOUN
fcis-31417	188	24	imaging	imaging	NOUN
fcis-31417	188	25	in	in	ADP
fcis-31417	188	26	adult	adult	NOUN
fcis-31417	188	27	diffuse	diffuse	NOUN
fcis-31417	188	28	glioma	glioma	NOUN
fcis-31417	188	29	.	.	PUNCT
fcis-31417	189	1	magnetic	magnetic	ADJ
fcis-31417	189	2	resonance	resonance	NOUN
fcis-31417	189	3	imaging	imaging	NOUN
fcis-31417	189	4	,	,	PUNCT
fcis-31417	189	5	vol	vol	NOUN
fcis-31417	189	6	.	.	PUNCT
fcis-31417	190	1	14(2023	14(2023	NUM
fcis-31417	190	2	)	)	PUNCT
fcis-31417	191	1	no	no	NOUN
fcis-31417	191	2	.	.	NOUN
fcis-31417	191	3	9	9	NUM
fcis-31417	191	4	,	,	PUNCT
fcis-31417	191	5	p.	p.	NOUN
fcis-31417	191	6	119	119	NUM
fcis-31417	191	7	-	-	SYM
fcis-31417	191	8	124	124	NUM
fcis-31417	191	9	.	.	PUNCT